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A steroid alcohol that functions to regulate membrane fluidity and is a precursor in 
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The sudden obstruction of a blood vessel by an abnormal particle (as a bubble) 




 A folded membranous compartment with the cytoplasm responsible for various cellular 
tasks.  It functions in lipid synthesis and enzymes of numerous pathways of intermediate 








Flat or slightly elevated lesions that contain intracellular and extracellular lipids in 
intima. They are found in the early stages of atherosclerosis. 
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 Cardiovascular disease, primarily atherosclerosis involves a number of distinct processes 
that are associated with plaque development.  The use of differential gel electrophoresis to 
determine differences between proteins produced in native and bypass coronary arteries from the 
same heart has been studied. The analytical techniques presented in this study to characterize 
plaque samples include two dimensional gel electrophoresis, sodium dodecylsulfate 
polyacrylamide gel electrophoresis, mass spectrometry, differential gel electrophoresis, and high 
performance liquid chromatography.  
 An overview of the stages involved in atherosclerosis and the theories implicated in the 
manifestation of atherosclerosis was presented. A design study using the Box Behnken method 
was used to optimize the components in lysis buffer to solubilize the membrane proteins present 
in the intima in atherosclerotic plaques. The number of proteins located as spots in the gel were 
optimized in this study. 
 The isolation and characterization of proteins in intima and media extracts of diseased 
aortas were separated using two dimensional gel electrophoresis followed by excision of gel 
spots and tryptic digestion to peptides. Mass analysis (MS and MS/MS) of the digested peptides 
with a linear quadrupole trap Fourier transform ion cyclotron resonance mass spectrometer was 
used to determine the amino acid sequences.  
  Protein extracts of normal and diseased aortas and native and bypass arteries were 
analyzed using differential gel electrophoresis system. Cydye 3 (1-(5-carboxypentyl)-1`-
propylindocarbocyanine halide N-hydroxy-succinimidyl ester) and Cydye 5 (1-(5-
carboxypentyl)-1΄-methylindodicarbocyanine halide N-hydroxy-succinimidyl ester) are  
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fluorescent  dyes used in our study to identify differentially expressed proteins of interest in the 
same gel using matrix assisted laser desorption ionization time-of-flight mass spectrometry. 
Several proteins in normal and diseased tissues were identified 
 A study of the separation and quantification of cholesterol and cholesteryl esters was 
performed using reverse phase high performance liquid chromatograph interfaced with 
atmospheric pressure chemical ionization probe that was introduced into a quadrupole mass 
analyzer. Thirty-five samples were analyzed by principal component analysis that produced two 
distinct age groups based on age.  In addition, a disease severity index was generated from the 
data. This study concluded that age and low disease severity index were indicators of the 
atherogenic states of the extracts analyzed.  






 1.1 Background on Atherosclerosis 
Cardiovascular disease continues to be one of the major causes of death in developed 
countries despite recent advances in understanding the risk factors associated with heart diseases 
[1-3].  Cardiovascular disease or ischemic heart disease in the United States is among the highest 
in the world and has been reported to be 5 times higher than in Japan [4].  It should be noted that 
atherosclerosis, the pathogenic degenerative form of the disease is less prevalent in Central and 
South America, Africa, and Asia in particular [4].  Atherosclerosis accounts for approximately 
half of deaths and serious morbidity in the Western world with 20 to 25% due specifically to 
myocardial infarction in the United States [4]. 
Atherosclerosis involves many complications including ischemic heart disease, 
myocardial infarction, stroke, and gangrene of the extremities.  Ischemic heart disease is the 
predominant source of death.  Its occurrence in the United States and other Western countries 
rose progressively from the turn of the century to a peak in the late 1960’s. However it has since 
fallen by more than 30 % [4].  The present mortality rate is around 26%. Numerous disparities 
have been found geographically and racially for incidences of this disease.  For example, in 
Sweden the mortality from ischemic heart disease is eightfold higher than in Japan.  
The prevalence and severity of the disease can be attributed to risk factors that have been 
identified by a number of studies of well defined groups (Table 1.1) [5].  The two notably 
comprehensive studies are the Framingham (Massachusetts) Study and the Multiple Risk Factor 
Intervention Trial [6].  From these studies, it was concluded that the factors that are not 




Table 1.1 – Risk factors for atherosclerosis  [ 4] 
Major  
Uncontrollable Controllable with lifestyle modifications 
Increasing age Obesity 
Male gender Physical Activity 
Family history Stress (“type A” personality) 
Genetic abnormalities Postmenopausal estrogen deficiency 
 High carbohydrate intake 
Potentially Controllable  
Hyperlipidemia Alcohol 
Hypertension Lipoprotein-A 
Cigarettes smoking Hardened (trans) unsaturated fat intake 
Diabetes Chlamydia pneumoniae 
 
Age is a dominant nonmodifiable factor in atherosclerosis with an increase in the death 
rate that rises with each decade of life [7].  The question of aging is seldom investigated as the 
dominant variable in arterial tissue in preparation for later intrusion by atheroma.  Time ordered 
incremental thickening of the intimal layer, begins before age 20 or around the cessation of 
puberty. . Tracy [8] has provided two conclusions in this regard.  The first influence of age is on 
the evolution of fibro plastic arteriosclerosis which was summarized in the formula: 
F = βA2 (1-αA);                                                                       (1.1)  
where F is a quantitative measure of fibro plastic arteriosclerosis, and A is age in years.  The 
coefficients β and α are empirical parameters that serve to transform the effects of time, A in the 
morphological consequences, F.  These parameters are reported to vary between groups of 
subjects such as between men and women and between nations, such that aging is not viewed as 
identical in every group.  The second conclusion from Tracey [8] is that intrusion of atheroma is 
also stated to be governed by another formula, i.e. 
W = bF – a                   (1.2) 
where W>0 marks the higher probability of atheroma and W<0 is indicative of a low probability.  
The empirical parameters, a and b, can be influenced by fatty deposits (i.e. “fatty streaks”), 
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arterial size, and some other factors.  Underlying views have been reported in numerous 
scientific investigations on the concept of intimal thickening with regards to aging and the onset 
of atherosclerosis [9-14].  
Sex or gender is reported as another risk factor for the onset of cardiovascular disease.  
Males are much more prone to atherosclerosis and its consequence than females.  Complications 
from atherosclerosis are uncommon in premenstrual woman, unless they are predisposed by 
diabetes, hyperlipidemia, or severe hypertension.  Post menopausal incidences of atherosclerosis 
increases, possibly due to a decrease in natural estrogen levels and equalizes by the seventh to 
eighth decade [4]. 
Genetics play another key role in the propensity of atherosclerosis.  This relates to 
familial clustering of other risk factors such as hypertension or diabetes, and less commonly 
involving hereditary genetic derangement in lipoprotein metabolism from excessively high blood 
lipid levels, such as familial hypercholesterolemia [4].  Other controllable risk factors responsive 
to change are hyperlipidemia, hypertension, cigarette smoking, and diabetes mellitus. 
1.1.1 Pathogenesis of Atherosclerosis 
The “responses to injury theory” was formulated in an attempt to explain the molecular 
and cellular events leading to lesion formation [15].  The inflammatory response to the 
endothelial injury is normally a protective one, however prolonged and excessive.  The more 
excessive time interval causes an inflammatory fibroproliferative response causing the disease. 
Numerous pathophysiologic processes have been postulated as specific cellular and molecular 
responses to an inflammatory disease such as atherosclerosis.  Several theories have been 
postulated to explain inflammatory responses to atherosclerosis. Ross et al. [16] proposed a 
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response to injury theory accounting for the most prominent initiation of the disease.  Endothelial 
denudation was proposed as the first step in this process.  
The actual cause of endothelial injury is uncertain.  However, experimental inducements 
suggest several factors including hemodynamic forces, immune complex deposition, irradiation, 
and chemically induced intimal thickening [17].  Specific causes are unknown, although 
speculation is that culprits include circulatory physiologic imbalances induced by smoking, 
homocysteine, viruses, and other infectious agents such as herpes and chlamydia.  Two main 
factors reported to act in concert in the progression of atherosclerosis are hemodynamic 
disturbances and the adverse effects of hypercholesterolemia. Hemodynamic effects produce 
plaques at ostia of vessels arising from aorta, branch points, and additional points along the 
vessel walls where disturbed patterns are predominant [17].  Disturbed areas produce turbulent 
blood flow and low stress which are prone to atherosclerotic events; however, smooth laminar 
flow protects vessel injury.  
It has been reported that laminar flow blocks inflammation that mediates or causes 
endothelial dysfunction and protects against the development of lesions [17, 18]. Additionally, 
when nonlaminar flow is prevalent, the production of leukocyte adhesion molecules occurs 
which have been observed to augment wall stresses and promote arterial smooth muscle cells 
that bind and retain lipoprotein particles [19].  These particles facilitate oxidative modification of 
the protein inflammatory responses at sites of lesion formation [20].   
When normal endothelium is present, leukocytes exhibit poor adhesion; however 
inflammation causes adhesive expression that binds to various receptor sites on leukocytes.  
Several adhesive molecules such as selectins with rolling interactions induce inflamed 
endothelium.  Cytokines, secreted by cells in the immune sytem, provide cellular movement to 
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leukocytes causing migration into the intima.  Epidemiological studies have implicated basal 
cytokines such as interleukin-6 (IL-6), tumor necrosis factor (TNFα) , cell adhesion molecules as 
(intercellular adhesion molecule-1 (ICAM-1), P selectin, and E selectin as well as down stream 
reactants as C-reactive protein (CRP), fibrinogen, and serum amyloid A  [21, 22-31]. 
1.1.2 Inflammation and Oxidized Lipoprotein 
 Lipids have been implicated as one of the primary agents causing atherosclerosis [32]. 
This class of compounds was studied with animal models producing various inflammatory 
responses as progression of the disease occurs [32]. Oxidized low density lipoproteins (LDL) are 
known to be retained in the intima by covalently binding to proteins such as glycoproteins [32-
35]. Examples of proteins present in the lipid fraction of specific oxidative processes have been 
elucidated [36]. Modification of lipids or hydrophobic fatty acid proteins promotes induction of 
adhesive molecules and other cells that trigger immune responses creating macrophages in 
vascular cell walls.  Experimental evidence points to oxidation of the LDL hypothesis promoting 
atherosclerosis in plaques; however it still remains unproven. The majority of evidence of LDL 
oxidation stems from in vitro studies of cell cultures by treatment with transition metals [36]. An 
LDL oxidative product from the reaction with hypochlorus acid has been proven to be present in 
human atherosclerotic plaques [36].    
A primary risk factor which is known to predispose to heart disease is the elevated level 
of cholesterol in human plasma [36].  When allowed to accumulate over a period of time, 
cholesterol contributes to the development of atherosclerotic plaques where fatty acids deposit 
onto the lining of the inner surface of coronary arteries.  Cholesterol exists in plasma lipoproteins 
both as free sterol and as cholesterol esters.  Low density lipoprotein (LDL) contains more 
cholesterol than five other LDL classes [36].  Cholesterol and its esters comprise two thirds of 
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the total plasma cholesterol with greater than 40% of the LDL particle attributed to these two 
sterols.  The actual LDL particle contains a single molecule of apoprotein B-100 (Mr=513,000) 
as its primary protein component. Since cholesterol is primarily synthesized in the liver, the LDL 
plays a key role in delivering cholesterol to other tissues in the body [36].  A key to 
understanding the role of LDL and cholesterol homeostasis and the prevalent condition of 
atherosclerosis relies on understanding the mechanism of cholesterol cellular uptake.  The 
findings of Brown et al. demonstrated that cholesterol uptake by cells is a receptor mediated 
process and the receptors are themselves regulated [37]. 
 To understand the relationship between cholesterol levels and atherogenesis, the 
mechanism for cholesterol uptake from LDL to cells is required.  Cholesterol esters present 
hydrophobicity problems when transversing the cell membrane.  Brown and Goldstein [37] 
suggested that cholesterol is taken into the cells through the action of a specific LDL receptor. 
This receptor was found to be clustered in a structure called a coated pit, or invagination whose 
abundant protein is clathrin.  In a mediated process called endocytosis, a large molecule such as 
LDL is taken into the cell.  LDL thus binds to its receptor, through recognition of the B-100 
apoprotein by the receptor.  The cellular plasma membrane fuses in the vicinity of the LDL 
receptor complex and the coated pits are endocytotic vesicles.  Lysozymes interact due to their 
hydrolytic properties and the LDL apoprotein becomes hydrolyzed to amino acids and the 
cholesterol esters which later under hydrolysis produces free cholesterol.  The receptor becomes 
recycled back to the plasma membrane where additional LDL can be picked up. 
 Cholesterol is present in the endoplasmic reticulum where it is adjusted by: 1) reducing 
HMG-CoA; 2) Enhances acyl-CoA: cholesterol acyltransferase (ACAT) production with similar 
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increases in cholesterol esters; 3) It decreases mRNA at the LDL site.   Cholesterol will not be 
absorbed into the cell if the LDL receptor is reduced thus cholesterol content is increased [36]. 
Studies of gene cloning and DNA sequence have identified four mutations that affect the 
LDL receptor [38, 39].  First, are mutations leading to insufficient receptor synthesis.  When 
these receptors are synthesized, a second mutation occurs when no migration is seen from the 
endoplasmic reticulum to the Golgi complex.  A third mutation occurs when the synthesized 
LDL receptor fails to bind LDL.  A final mutation may occur at the cell surface that has bound 
LDL receptors but no clustering in the coated pits occurs, preventing endocytosis. 
As is evident, lipoproteins play a major contribution in the atherogenetic process in three 
different ways.  First, these macromolecules are the main carriers of lipid and phospholipids 
modified in the vessel wall.  Second, lipoproteins are the main transporters of dietary fats which 
serve as raw materials for membrane synthesis which affects the lubricity of the membrane and 
its function.  Third these also serve as precursors of lipid secondary messengers with activitiy. 
The function of lipoprotein also serves as mediators of cellular modulations that are associated 
with atherogenesis. 
Additional evidence suggests LDL as the principal agent of atherosclerosis can be based 
on five criteria.  One of the most compelling evidence can be observed from the genetic  
elevation of LDL that is a consequence of a mutation from the receptor gene [40].  Homozygous 
familial hypercholesterolemia points to LDL at the prototype of an atherogenic lipoprotein [40].   
Mutations for animal models such as the bovine affects the structure of apoprotein B and LDL so 
that its clearance from the plasma can be directly associated with the development of 
atherosclerosis [41].  There exists a well documented correlation between plasma and 
concentration of low density lipoprotein and the risk of atherosclerosis as well as cardiovascular 
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disease [42]. Atherosclerosis can be induced in various animal models that indicate a strong 
correlation with the levels of plasma LDL concentrations [43].  The presences of reporters of 
LDL apoprotein B, the protein of LDL and cholesterol ester, in human and animal atherosclerotic 
plaques reveal additional roles of the protein in the disease.  LDL–like entities have been 
extracted from plaques [43].  In addition, the LDL influences the cells in various ways to 
facilitate the evolution of plaques. 
1.1.3 Development of Atherosclerotic Plaques 
A number of distinct processes are associated with plaque development: lipid 
accumulation, inflammation, cell proliferation, cell death, and thrombosis.  Some of the 
molecular events underlying each of these processes and the stimuli for these events have been 
identified [44].  However many other processes require clarification.  Atherosclerosis is the 
result of accumulation of numerous components in the coronary arteries, resulting in the 
formation of plaque deposits.  It is a passive progressive disease characterized by the 
accumulation of lipids and fibrous elements in the large arteries.  Lipids from the lipoprotein 
component are influenced by the monocytes [44] that liberate growth factors causing the 
proliferation of smooth muscle cells.  When the endothelial cell becomes permeable, 
macromolecules such as LDL which have been modified as macrophage scavengers and other 
receptors are loaded with lipid and foam cells [45].  The foams cells deteriorate and stored lipids 
or other sterols become trapped.  Fibrous plaques become evident due to accumulation of lipids, 
mostly cholesterol and cholesterol esters and smooth muscle cells.  Lesions develop from this 
complicated process which may be expressed as fatty streaks or complicated [46].  Variability of 
lesions has led to classification of these lesions based on the American Heart Association Study 
[47, 48].  These classifications are depicted in Table 1.2.  Such lesions are described from initial 
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fatty streaks to complicated lesions based on the advancement and severity of the disease [49].  
Plaques may exhibit different degrees of stability and rupture capability causing myocardial 
infarction or stokes.  The composition of the plaques is of importance in pathological studies of 
composition and vulnerability of plaques.  Plaque rupture often occurs at the lesion edges that 
contain foam cells.  
Table 1.2. American Heart Association classification of human atherosclerotic lesions [4] 
Nomenclature and main histology Description of disease 
progression 
Sequences in Progression 
Type I (initial) lesion   Macrophage foam cells I 
Type II ( fatty streak) 
 
Lesions and lipid 
accumulation 
II 
Type III (intermediate)lesion 
 
Excellular lipid pools III 
Type IV (atheroma) lesion 
 
Atheroma lesions lipid pools IV 
Type V (fibroatheroma) lesion  
 
Lipid core and fibrotic 
layers, calcification 
V 
Type VI (complicated)lesion 
 




The early lesions of atherosclerosis consist of sub endothelial accumulations of cholesterol-
engorged macrophages, often referred as foam cells.  In humans, such fatty streak lesions can 
usually be found in the aorta in the second decade and coronary arteries in the second decade and 
the cerebral arteries in the third or fourth decades.  Due to differences in blood flow dynamics, 
there are preferred sites of lesion formation within the arteries.  Fatty streaks are not clinically 
significant, but they do accumulate as a result of lipid-rich necrotic debris and smooth muscle 
cells.  Plaques that develop are complex, with calcification, ulceration at the luminal surface, and 
hemorrhage from small vessel walls.  Although advanced lesions can grow sufficiently large to 
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block blood flow, the most important clinical complication is an acute occlusion due to the 
formation of a thrombus or blood clot, resulting in myocardial infarction or stroke. 
Stary et al. [48] presented evidence that atherosclerosis causes lesions that are isolated in 
large and medium sized arteries, the brain, the heart, and legs.  This process occurs during 
childhood and involves macrophages that develop into foam cells that are deposited within the 
junction of the tunica intima and tunica media layers of the artery during the first week of life. 
Foam cells further progress into a fibrous atheroma beginning at about 30 years of age.  A further 
association has been suggested between the endothelial cells and the macrophage.  This 
suggestion has later developed into the “response to injury” hypothesis. 
 Proteins play a major role in the development of atherosclerosis; however, they act in 
concert with fats in the pathogenesis of the disease [36,48].  Fats are insoluble products 
complexed in saturated and unsaturated forms as triglycerides and cholesterol.  Fats are 
transported between the intestine, liver, and peripheral plasma in the form of soluble complexes 
called lipoproteins.  The name of the lipid with which fat is associated is apoprotein.  The 
lipoprotein circulates in spherical particles that consist of an envelope of phospholipid and 
apoprotein with a lipid core.  Lipoproteins can be differentiated by density, configuration, and 
electrophoretic mobility into chylomicrons, very low-density lipoproteins (VLDL), low density 
lipoproteins (LDL), intermediate density lipoproteins (IDL), and high density lipoproteins 
(HDL)... The major characteristics of proteins that are involved in the metabolic pathway of 
cholesterol and their proatherogenic composition are given in Tables 1.3 and 1.4.  
On the cellular surface, LDL undergoes oxidation in the presence of free radicals in 
addition to interactions with metal ions such as copper.  The macrophages and monocytes 
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consume the oxidized LDL and forms fatty streaks and lesions.  These precursors often result in 
the formation of plaque in the arteries, the final degenerative form of atherosclerosis. 
Table 1.3  Properties of major human plasma lipoprotein classes [35] 
 
 Chylomicron VLDL IDL LDL HDL 
Density < 0.95 0.95-1.006 1.006 -1.019 1.019 -1.063 1.063-1.210 
Components (% 
dry weight 
     
Protein 2 8 15 22 40-55 
Triacyglycerol 86 55 31 6 4 
Free Cholesterol 2 7 7 8 4 
Cholesterol 
esters 
3 12 23 42 12-20 












      
VLDL=very low-density lipoprotein  LCAT = lecithin: cholesterol acyltransferase 
IDL    = intermediate-density lipoprotein                LPL    = lipoprotein lipase 
LDL   = low-density lipoprotein 
HDL = high-density protein 
 
Table 1.4  Apoproteins of the human plasma lipoproteins [35] 
 
Apoprotein Molecular Weight Characteristics 
A-I 28,300 Major protein in HDL; activates 
LCAT 
A-II 17,400 Major protein in HDL 
B-48 241,000 Found in chylomicrons 
B-100 513,000 Major protein in LDL 
C-I 7,000 Found in chylomicrons; activated 
LCAT and LPL 
C-II 10,000 Found in VLDL; activates LPL 
C-III 9,300 Found in chylomicrons, 
VLDL,HDL, inhibits LPL 
D 35,000 HDL protein, cholesterol ester 
transfer protein 
E 33,000 Found in VLDL,LDL,HDL 
 
1.1.4 Vascular Calcification 
Vascular calcification is observed in the progression of atherosclerosis that has been 
regarded as a passive unregulated degenerative process [49].  However, the concept of   
ossification has been recently documented [50, 51].  The process of ossification that is normally 
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observed in bone mineral formation can be found in arterial walls. Similar bone formation 
regulators and bone structural proteins are expressed in atherosclerotic plaques including bone 
morphogenetic protein -2 (BMP-2), osteopontin, matrix γ carboxyglutamic acid protein (MGP), 
and osteoprotegerin [49]. 
 Vascular calicification was first reported by Anderson who found matrix vesicles from 
osteogenesis in human calcified aortas [52]. Giachelli [53] later proved similar expressions at the 
molecular level of bone matrix proteins in vascular smooth muscle.  Expression of osteogenic 
factors was also found by Bostrom [54] and Shanahan [55] in cultured vascular cells.  Cultures 
of vascular smooth cell express bone proteins in the presence of alkaline phosphatase [56]. 
Several cells in the process have been implicated including macrophages, mass cells and vascular 
smooth muscle cells are involved in the atherosclerotic intimal calcification [57]. TNF- α is 
released as macrophage that respond to oxidized LDL and vascular smooth muscle cells 
differentiate into osteoblasts, alkaline phosphatase expression and mineralization.  Mast cells as 
extracellular tryptase initiate calcification by an unknown mechanism and are often observed at 
sites of some calcium deposits.  These cells are known to release cytokines which release tumor 
necrosis factor (TNF) α and interleukin-1 [58, 59]. Calcification of vascular cells is similar to 
SMC’s and has osteoblastic characteristics forming calcifying nodules in vitro.  Several types of 
cells may be categorized.  Pericytes possess microvascular smooth muscle phenotypic 
characteristics [60].They form high nodules that mineralize with hydroxyapatite and express 
MGP through osteogenic differentiation with calcified matrix.  The abundance of microvessels 
facilitates avenues that contribute to arterial calcification [61].  Vascular dendritic cells also 
contribute to the calcification as demonstrated in the expression of S-100 [62].  These cells are 
apparent in aortocoronary saphenous vein bypass grafts. 
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 Molecular mediators are proteins that are notably responsible for arterial calcification. 
BMP 1-7 [63] are growth factors that share homology with tissue derived growth factor Beta and 
belong to the same family of proteins.  BMP-2 and BMP-4 induce osteoblast differentiation and 
tissue events that are required for bone formation. MGP (matrix GLa protein) is a class of 
proteins that has approximately 14KDa mass units that is formed in vascular smooth muscle cells 
and the intima by macrophages and endothelial cells [64].  It contains 5 gamma carboxyglutamic 
acid residues which are derived from the action of gamma carboxylase using Vitamin K.  
Although GLa proteins are not confined to the vessel tissues, a common origin is shared with the 
γ carboxylation pathway of these proteins.  Only Gla residues are the site for binding 
hydroxyapatite.  This pathway is illustrated in Figure 1.1.  Table 1.5 illustrates various Gla 
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Figure 1.1. Metabolic pathway of the generation of gamma carboxy glutamic acid proteins in the 
Vitamin K process.  Warfarin inhibits the process causing calcification 
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Table 1.5 Glutamic acid proteins and their tissue location [65] 
PROTEIN FUNCTION Immunochemical 
Detection 
IN ARTERY? 
MGP Ca-inhibitor Antibody Unavailable Yes 
BGP Ca-inhibitor Antibody Yes 
PGP Ca-inhibitor Antibody Yes 
Prothrombin* Coagulation Antibody Yes 
Factor VII* Coagulation Antibody Unknown 
Factor IX* Coagulation Antibody Unknown 
Factor X* Coagulation Antibody Unknown 
Factor Z Coagulation Antibody Unknown 
Protein C* Anticoagulation Antibody Unknown 
PRGP1 Unknown Unknown Unknown 




null mouse studies it is a potent inhibitor of vascular calcification particularly hydroxyapatite 
[65-67].  It has been implicated in numerous studies; however it also inhibits the effects of BMP-
2.  The antagonistic effects of MGP as well as MGP mRNA can be seen by oxidative stress and 
medications such as warfarin and diphenylhydantoin.  When the ability to generate vitamin K in 
the reduced form is minimized or the ability to use vitamin KH2 co-factor, arterial calcification 
and osteoporosis occurs.  Other antagonists and regulators of MGP and MGP mRNA production 
include retinoic acid [68], vitamin D3, growth factors [69, 70], and apoptosis [71, 72]. 
   Fatty streaks that have been studied containing microzones of calcification predominantly 
located in the musculoelastic layer of the intima.  Bobrystev et al. [73] examined the 
development of atherosclerotic lesions and the presence of calcified deposits formed due to 
physiochemical processes.  A major observation produced evidence that the calcification process 
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was a result of a preexisting structural base of unesterified cholesterol in extracellular matrices or 
altered elastin fibres.  Association of calcification deposit with elastin fibres, collagen fibres, 
lipid vesicles as well as unesterifed cholesterol was also studied.  Osteopontin and osteonectin 
are two proteins noted by Hirota et al. that involve physiochemical and pathological calcification 
[74].  Insitu hybridization and immunohistochemistry indicated that levels of osteopontin mRNA 
expression increased plaque formation and macrophages.  The atheromatous plaques were 
determined to be positive for osteopontin. 
1.2 Research Goals and Objectives  
In this study, the goal is to elucidate differences in the structure and molecular weight of 
the proteins that are associated with the atherosclerotic plaques from native and bypass arteries 
from the same heart.  To this end, analytical techniques that will be used in the separation and 
identification of proteins found in plaque samples extracted from the intima and media layers of 
the vessels include: 1) SDS PAGE, 2) high pressure liquid chromatography, 3) 2-D gel 
electrophoresis, 4) matrix assisted laser desorption ionization mass spectrometry, and 5) 
electrospray ionization coupled to a quadrupole mass spectrometer.  The first objectives in the 
research will optimize the extraction and separation aspects of the proteins in the tissue samples.  
The second objective will involve the analysis and characterization of crude protein extracts 
using mass spectrometry. 
 The samples, acquired from Louisiana State University Health Science Center –
Department of Pathology, contain tissues including arterial membranes and muscular material. 
The separation of these components from the arteries is somewhat difficult due to the size of the 
artery including some plaque material during the dissecting procedure.  Extraction of the intima 
layer of the inner wall using organics is well suited for fats including triglycerides, cholesterol 
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and its esters.  However, proteins present a more difficult problem due to their hydrophobic and 
hydrophilic properties.  This fact is compounded by the fact that some proteins are known to 
denature in the presence of organics.  Therefore, the method for protein extraction will be 
conducted in aqueous medium in the presence of phosphate buffer saline or a similar buffer at a 
pH of 7.4.  Liquid nitrogen is commonly used both to keep the proteins from denaturing due to 
temperature and various effects of proteases.  This was shown to be effective in grinding the 
crude samples prior to extraction.  
 The widely accepted protocol for separating proteins is typically by the use of SDS 
polyacrylamide gel electrophoresis.  Achieving optimum separation and gel performance is 
important in this study because it will be necessary to monitor differences in protein composition 
between two arteries.   Once the proteins are loaded on the gel and separation occurs, excision of 
the proteins from the gel is necessary.  This is followed by further extractions to remove the 
proteins from the gels.  The efficiency of this method is low and quite often in gel digestion is 
used in the identification of proteins.  To improve recovery, addition of detergents such as 
Tween 20 or sodium dodecylsulfate, may be needed.  Additionally, different volatile organics 
have been used.  The procedures for protein removal from gels are vital from the standpoint of 
ensuring that the detection limits of the mass spectrometer have been exceeded.  The most 
common technique for mass detection of proteins is the use of MALDI- time of flight (TOF) 
mass spectrometers.  
In order to determine extraction efficiency, MALDI TOF has been used initially to 
monitor the extract for proteins with high molecular weights (>25 kilodaltons) typical lipoprotein 
masses.  Protein masses of this magnitude have not been achieved at this point; therefore 
additional methods must be evaluated to enhance this procedure. 
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1.3 Analytical Techniques Used in this Study 
1.3.1 Sodium Dodecylsulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
British workers measured the mobilities of inorganic ions using gel media. Consden et al. 
[75] first used gels specific for protein separations. Later Smithies used starch as a medium that 
produced larger gains in resolution.  The first introduction of synthetic polyacrylamide as a 
technique for active molecular size separations was conducted by Reymond [76].  Alternative 
procedures by Ornstein [77] and Davis [78] devised methods for gels consisting of disc gels that 
resulted in narrow protein zones.  Maizel and collaborators [79] discovered the widely used 
method for molecular size distribution analysis with sodium dodecylsulfate polyacrylamide gel 
electrophoresis (SDS-PAGE).  The physio-chemical basis of the concept is based on the mobility 
of a protein that is proportional to its charges in a small charge range [80].  Historically, higher 
charges produce reduced mobility’s with further enhancement of the charge, the mobility reach a 
limiting value.  Analysis of protein molecules is possible with additional increases in charge. 
SDS is an anionic detergent or surfactant that has an effect on the protein size analysis when it is 
hydrophobically bound to the protein reversibly. The limit in mobility of the complex has been 
shown to be a linear decreasing function of the logarithm of its molecular weight.  
 SDS-PAGE employs three fundamental properties of proteins: size, net charge and its 
relative hydrophobicity [81].  During the electrophoretic process, a particle with an electric 
charge Q is forced through a viscous medium (liquid or gel) by the action of an electric field with 
a potential gradient E.  The frictional resistance f must be overcome to migrate through the 
supporting medium while the driving is acting on the moving particle.  This mathematical 
phenomenon is related by the equation below: 
 QE=f                                (1.3) 
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In solution, the resistance obeys Stoke’s law: 
 f = 6πrvη                     (1.4) 
where r equals the particle radius, v its velocity and η the viscosity of the medium.  The behavior 
in gels is more complex as a function of pore size and particle size. 
The mobility of an analyte during electrophoresis m of a particle is defined by 
 m = d/tE = v/E = Q/f                  (1.5) 
where d  represents the migration distance of the particle in time t. 
As the particle migrates through the medium a potential gradient or field strength is observed 
that corresponds to the ratio of current density J, to the specific conductivity χ   as follows : 
 E = J/ χ                   (1.6)  
When a particle migrates through the gel, its velocity is given by 
 
 v = Em = mJ/ χ                                                                                              (1.7) 
where J equals current density and χ equals specific conductivity. 
 The ionic strength of monovalent or divalent buffers affects the mobility of the ionic 
species.  Analytes with high migration velocities have low ionic strengths with little heat 
evolution where as high ionic strength buffers lead to slower migration velocities.  Heat 
generation is enhanced despite sharper zones.  The equation for ionic strength is represented as:                   
            i = n 
 µ = ½ Σ cizi                     (1.8) 
                      i = 1 
where ci      is the molar concentration of a single ionic species and zi is the charge of the species in 
a solution with n ions. 
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 As previously discussed, SDS-PAGE is composed of polyacrylamide gels that are 
synthesized using the following reactions: 
 
Figure1.2. Polymerization of acrylamide for protein separations    
The acrylamide monomer is reacted with NN methylene bisacrylamide in the presence of 
tetramethylethylenediamine (TEMED) to yield the corresponding polymer.  The polymerization 
is free radical base catalyzed with ammonium persulfate and TEMED.  The polymer provides 
advantages over other media support by: 1) free charge state that is free of electroendosmotic 
flow effects on the components, 2) it is a clear gel that is suitable for densitometry measurements 
and 3) the method is versatile in  pore size distribution that can be controlled by changing the 
monomer and the comonomer concentrations.  
Proteins are amphoteric compounds in which their net charge is determined by the 
medium in which they are suspended.  When the protein solution is at a pH above its protein 
isoelectric point, the protein bears a net negative charge and will migrate towards the anode in an 
electric field.  For solutions at pH below its isoelectric point, the protein is positively charged 
and migrates towards the cathode.  Proteins are separated based the solution pH under both 
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native and denaturing conditions.  The most widely used method for analyzing mixtures of 
proteins is sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE).  In this 
technique, proteins are reacted with the anionic detergent SDS (or sodium lauryl sulfate) to form 
negatively charged complexes [82].  The aqueous detergent solution forms globular micelles 
composed of 70-80 molecules with the dodecyl hydrocarbon moiety in the core and the sulfate 
head groups in the hydrophilic shell.  When SDS and protein interact, complexes form that 
resembles necklace-like structures composed of proteins micelles connected by flexible 
polypeptide segments [83].  These structures result in large amounts of SDS incorporated into 
the SDS-protein complex in a ratio of approximately 1.4g / SDS g protein.  Under non-
denaturing conditions, the electrophoretic separation of proteins is determined by both size and 
charge of the molecules.  During the non-denaturing process, the charge of the protein is 
determined by size and charge of the molecules.  However, the SDS masks the charge of the 
protein and the anionic moieties have a roughly constant net negative charge per unit mass. 
Reduction of disulphide bonds is necessary to adopt the protein to the random coil configuration 
necessary for separation by size using either 2-mercaptoethanol or dithiothreitol (DTT).  The 
charge of the micelle is thus negative so that the separation is now determined by molecular 
weight.  The commonly used protocol for proteins is described by Laemmli [84]. 
Experimentally, a slab gel base on the Laemmli process consists of two types of gels, a 
stacker gel and a resolving gel.  The usual method denatures the protein with SDS followed by 
complete denaturation by heat and disulfide breakage by a reducing agent such as β 
mercaptoethanol.  The proteins are placed into wells in the stacker and under buffering 
conditions using TRIS: glycine: SDS mixture under an applied voltage.  The proteins   migrate 
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through the stacker gel to the resolving gel where separation occurs.  For running native proteins, 
neither SDS nor the heating of the protein mixture are used.   
 The molecular weight distribution of the proteins in a gel may be resolved by changing 
the effective size of the media.  The effective pore size of the gel is an inverse function of total 
monomer concentration (%T and C) which is the sum of the concentration of the monomer and 
cross linking material.  In practice the lower the concentrations of the gel, the smaller the 
proteins that are entrained.  Increases in molecular weight are observed from the top of the gels 
as the protein migrates downward.  The porosities of the polyacrylamide developed by Raymond 
and Nikimichi [85], Toombs [85], Rodbard and Chrambach [86], and Righeti et al. [87] are 
predicted by the following equations: 
 1. p = K' d / C1/2        (1.9) 
2. p = K' d / C + K"        (1.10) 
3. p = 1 / C 1/3         (1.11) 
4. p = 140.7 x C -07        (1.12) 
where p is the mean porosity, d is the distance migrated, c is the concentration and K is a 
constant. 
Gel electrophoresis determines proteins and nucleic acid molecular weight based on the 
comparison of migration distances by a single gel concentration or a pore size gradient.  This 
technique has the capability of measuring both size and net surface charge densities.  A 
procedure by Ferguson [Ferguson 88-91] directly correlates the mobility values or relative 
mobility Rf to the migration distance of the analyte to the migration distance of a dye or a marker 
with a tracking dye or silver stain.  This protocol is based on the plot of log mobility vs the gel 
concentration that is often expressed as percent T.  These plots are very useful for molecular 
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determination and to quantitatively determine the maximum resolution between two components 
and the optimal gel concentration for best separation.   
1.3.2 Visualization of SDS PAGE 
 Visualization of proteins in polyacrylamide gel and electroblot mainly rely on 
noncovalent interactions.  Rabilloud [93] enhanced the availability of these interactions.  In 
noncovalent interactions which are generally reversible, staining methods are used that are 
compatible with proteins as well as a variety of proteomic applications.  This staining use gels or 
blots directly.  The visualization techniques that are noncovalently bound to proteins may be 
categorized in three areas: organic dyes such as Coomassie brilliant blue [94,95], fluorescent 
probes such as Sypro dyes or Nile red based on fluorescent detection[96] and metal ion binding 
such as negative and positive staining with zinc imidazole.  Silver staining of gels is commonly 
used for gel visualization [93, 97, and 98].  The advantages of using this procedure is due to its 
low sensitivity in nanogram  range which is 50 to 100 times more sensitive than the Coomassie 
blue, ten times more than the colloidal blue, and at least twice as sensitive as the negative 
staining zinc / imidazole method. 
1.3.3 Two Dimensional Gel Electrophoresis (2DE) 
 Two dimensional electrophoresis (2DE) is another tool for separating complex mixtures 
of proteins into many components.  When proteins are in an electric field, they migrate at a rate 
that is dependent on their conformation, size, and electric charge.  In 2DE, the use of size and 
charge allow high resolution separation of proteins.  This technique was first described by 
O’Farrell and Klose [99] in 1975.  The original separation technique was performed in carrier 
ampholyte containing polyacrylamide gels cast in narrow tubes.  The first-dimension step allows 
separation by isoelectric focusing, based on charge.  The second-dimension step, SDS 
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polyacrylamide gel electrophoresis (SDS-PAGE), separates proteins according to their molecular 
weights. Isoelectric focusing separates proteins based on their isoelectric points (pI).  Proteins 
can possess positive, negative or zero net charge depending on the pH of the environment 
resulting in amphoteric properties.  The sum of the negative and positive charges of the amino 
acid side chains along with the amino and carboxyl termini a net charge can be determined on 
the molecule.  The isoelectric point occurs at the specific pH that produces a net charge of zero. 
When proteins produce a positive charge, the pH value lies below the respective pI. Additionally, 
a negative charge results when the pH value is above its pI.  If the net charge of a protein is 
plotted against the pH, the observed isoelectric exists when the net charge intersects the abscissa 
or a net charge of zero. 
Proteins in a pH gradient using the IEF technique under an electric field move to the 
position where its net charge is zero.  The protein will migrate towards the cathode with a 
positive charge.  A negative charge is observed when the protein migrates towards the anode and 
becomes less charged as it reaches a net charge of zero.  Carrier ampholytes generate pH 
gradients originally cast in tubes [99].  These ampholytes are small soluble, amphoteric 
molecules possessing high buffering capacities near their pI’s.  Hundreds of polymeric species 
exist at various pI’s over a range of pH units.  The carrier ampholyte with the lowest pI (most 
negative charge) moves toward the anode and the ampholyte with the highest pI (more positive 
charge) moves towards the cathode.  Other carrier ampholytes will align between the two pH 
extremes according to their pI’s and buffer environment. 
Despite the unique properties of carrier ampholytes, several limitations are observed: 1) 
batch to batch variations, 2) instability and tendency to drift, and 3) low mechanically stability 
causing bending or breakage of the rods.  The limitations of the carrier ampholyte lead to 
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development of an alternative technique for pH gradient formulations. Bjellqvist et al. [100] 
developed immobilized pH gradients or IPG that are covalently incorporated consisting of an 
acidic and a buffering group in a polyacrylamide gel with it is cast. As polymerization occurs, 
the acrylamide portions of the buffers are copolymerized along with the acrylamide and 
bisacrylamide monomers to form the corresponding gel [85].  A pH gradient formed similar to 
pouring a polyacrylamide slab gel.  However instead of two solutions of different % T, the two 
solutions contain acidic and basic mixtures of acrylamido buffers that are cast onto a plastic 
backing.  Prior isoelectric focusing, the gel strips must be rehydrated in solutions that are 
comparable to the separation without compromising protein solubilities. Immobilised pH 
gradients in the first dimension also have advantages over carrier ampholyte-based separations.  
The cathodic drifts that are apparent in ampholyte based separations are eliminated due to the pH 
gradient covalently fixed within the gels allowing a broader pH range for separations.  
Additionally, this provides for the separation of more highly acidic and highly basic proteins.  
The IPG possess a higher load capacity for proteins than the carrier ampholytes [101].  
Reproducibility of the IPG strips that are well characterized eliminates batch to batch variability.  
Others advantages include reduction of preparation time, prevention of stretching , breaking, 
ease of handling and samples can be applied to the gel strips during gel rehydration [102,103].  
The normal pH range of 3.5-10 is used in protein separations; however other immobiline ranges 
are possible. 
Separation and resolution of complex biological samples depends on the appropriate 
preparation of the tissues prior to IEF [82].  The proteins in the sample must remain in solution 
during the entire process and devoid of interfering analytes such as salts.  To assure protein 
solubility, various agents are employed in the sample preparation step. 
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 The solubilization of proteins is important in high resolution in separations in 2D gel 
electrophoresis [104].  This process breaks down interactions between the substances to be 
analyzed and interfering substances as well as preventing reaggregation during the sample 
preparation.  Analytical techniques used in protein chemistry are important and proteins to be 
analyzed must be 1) extracted from the biological sample; 2) freed from any substances 
interfering with the technique or other processes; 3) and must remain in solution during the entire 
separation process.  To provide a suitable environment for proteins for electrophoresis some 
knowledge of the cohesive forces maintaining the macromolecular structure of the biological 
complexes and the interactions with other molecules is necessary.  There are numerous forces 
that are attributed to protein cohesion and interactions with other molecules.  These factors 
include disulfide bonds, hydrogen bonding, and electrostatic interactions.  Other forces related to 
protein-protein interactions are charge-dipole, dipole-dipole, Van der Waals, and hydrophobic 
forces.  The lateral chain of apolar amino acid (L, V, I, F, W, Y) are examples of specific cores 
in the proteins which are responsible for protein-protein interactions and binding of lipids and 
other apolar molecules to proteins. 
Numerous interfering substances as nonprotein substances may be present in biological 
extracts for separation by gel electrophoresis.  Such impurities can interfere with the separation 
aspect and subsequent visualization.  These impurities can cause problems by increasing the 
conductivity in the first dimension and reduce IEF effectiveness.  These substances can 
accumulate at the anode or cathode or within the strip causing streaking either vertically or 
horizontally on the final SDS separation in the second dimension.  The contaminates can be 
removed by a variety of precipitation techniques that require resuspension in a salt free medium. 
Guy et al. [105] used trichloroacetic acid as the method of precipitation and organics such as 
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acetone [106], ethanol or a mixture of chloroform and methanol [107] were shown to be equally 
as effective.  Dialysis has been proven to be another to remove impurities such as salts from the 
protein extract particularly those with lower molecular weights.  Some devices are capable of 
concentrating and dialyzing the sample (ie vacuum dialysers, or centrifugeable devices) [108]. 
However, the major problems that exist in these devices are due to loss of proteins by adsorption 
onto the membrane of losses due to diffusion through the membrane for low molecular weight 
proteins [104].  In some cases, the problems can be minimized by denaturing detergents, thereby 
reducing the effects of absorption to the membrane.  Often caution must be taken in the presence 
of detergents with micelles that are large enough in molecular weight that can be retained onto 
the membrane. 
Deoxyribonucleic (DNA) and ribonucleic (RNA) acids in high concentrations can result 
in poor focusing in the acidic region of the IEF gel.  Additionally, high background can be seen 
when using silver staining techniques for visualizing the gels.  DNA increases the viscosity of 
samples that may by too high to be effective.  Nucleases can be used to mitigate the problems 
encountered with these contaminants.  Blomberg and others [109] accomplished this by the 
addition of one-tenth volume of a solution containing 1 mg/ml DNase I, 0.25 mg/ml RNase A, 
and 50 mM MgCl2 to the protein samples followed by incubation on ice. 
Lipids are also present interferences with respect to IEF depending on their 
supramolecular structure by binding to proteins usually lipid carriers when they exist as 
monomers.  The binding alters the characteristics used for the electrophoretic separation and 
often gives rise to artifactual heterogeneity [109].  Supramolecular assemblies of lipids 
(membranes and vesicles) produce more severe problems during electrophoresis.  Resolution to 
this problem can minimized using detergents to disrupt the membranes, solubilize the lipids, 
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delipidate and solubilize the proteins bound to the membranes or vesicles.  Others techniques 
require organic solvent precipitation for the removal of salts or lipids.  Organic solvents such 
methylene chloride, acetone, hexane, isopropanol and methanol are effective in minimizing the 
presence of lipids however these solvents can cause denaturation of most proteins.  
Uncharged polysaccharides pose problems due to their large molecule weights which, 
cause the molecules to clog the pores in polyacrylamide gels.  These entities can be removed 
using ultracentrifugation or selective precipitation with trichloroacetic acid, ammonium sulfate, 
phenol ammonium acetate [110], or dyes [111,112] and resolubilization of the protein pellet. 
Proteolysis from cell lysis liberates proteases that contribute to the degradation of 
proteins.  These proteases must be inhibited during sample preparation. Denaturants as urea are 
usually effective, but some proteases retain activity.  Some protease inhibitors are needed in 
additional to denaturing variants.  Phenylmethylsulfonyl fluoride and aminoethybensenesulfonyl 
fluoride irreversibly inhibits serine and cysteine proteases [82].  Ethylenediaminetetraacetic acid 
(EDTA) with the ability to chelates metal ions inhibits metalloproteinases.  Peptide proteases 
such as leupeptin, pepstatin, aprotinin, and bestatin are active against different classes or 
proteases in micromolar concentrations. 
Protein samples properly treated for the interfering substances mentioned above must be 
fully solubilized, disaggregated, denatured, and reduced prior to IEF processing.  To achieve 
optimum separation, samples for 2D electrophoresis must contain a neutral chaotrope, usually 
urea or a mixture of urea derivatives, a neutral or zwitterionic detergent, and a reductant that is 
capable of reducing protein disulfide bonds to sulfhydryls and maintaining their reduced stated 
during electrophoresis.  
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Chaotropes such as urea are used in 2D electrophoresis in concentrations of 7M to 9M as 
a denaturing agent.  Rabilloud et al. [113] has shown that urea and thiourea used in combinations 
can effective in solubilizing proteins particularly those associated with membranes.  Optimal 
ratios of the two may differ depending on the samples [114].  The use of thiourea may result in 
disturbances and loss in resolution in the acidic range of pH 3-5 in IEF separations due to 
possible impurities in the commercial preparations. 
Detergents are also effective to completely solublize proteins.  Nonionic detergents that 
are used for this procedure are Triton X-100 or Nonidet P-40 as well as the use of zwitterionic  
detergents as cholamidosulfobetaines as (3-[3-cholamidopropyl) dimethylammonio]-1-propane 
sulfonate (CHAPS) and CHAPSO [115].  Alkylsulfobetaine detergents as SB 3-10 [116] are 
often used but are less effective due to their limited solubility in urea solutions.  Such reagents 
that require lower concentrations of urea and thiourea reduces the effective solubilization of the 
proteins.  Amidoalkylsulfobetaines have been developed that are highly soluble in urea and 
thiourea solutions and are amenable to proteins that present solubility problems; however, many 
of these are not available commercially [117].  SDS has been the reagent of choice for 
denaturing in electrophoresis; however it cannot be used as the sole agent for IEF although rapid 
solubilization and extraction are demonstrated.  
Reductions of the disulfide bonds provide greater susceptibility for solubilization. This is 
performed by exposing disulfide bonds.  2-mercaptoethanol was normally used to reduce 
samples for 2D electrophoresis, but has been largely replaced by the sulfhydryl reductant 
dithiothreitol (DTT) and dithioerythritol (DTE) usually effective at lower concentrations and 
higher purity.  The 2-mercaptoethanol introduces unwanted keratins despite stringent 
commercial processing. 
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The first dimension of isoelectric focusing (IEF) requires complete protein solubility as 
they are subjected to an electric field in which they migrate to their respective isoelectric point 
(pI).  By definition, the pI is state of lowest possible net charge and thus lowest solubility in 
aqueous media.  The protein studies in this study are mainly membrane proteins that involve the 
intima and media and diseases that are associated with them.  Many integral membranes proteins 
tend to be hydrophobic with large masses > 100 kilodaltons.  Two major problems exist in the 
preparation of membrane proteins for 2DE.  First, detergent compatibility with IEF is necessary 
for effectively extracting membrane proteins.  Second, protein solubility must be maintained 
throughout IPG loading doing first dimension separation.  SDS although normally used in one –
dimensional separation, is incompatible with IEF due to the charged head. Extracts of proteins 
that are solubilized with SDS must undergo solvent or acid precipitation, removing or reducing 
SDS or lipids.  These processes may result in significant loss or modification of proteins during 
precipitation. Optimization of extraction conditions by altering buffers, choatropes, and 
detergents demonstrate reliability in achieving high resolution maps of membrane proteins.   An 
array of proteins spots result that assigns molecular weight and pH based on an x and y 
coordinate system.  Thousands of proteins can be separated using this method.  
The protein extract must be aliquoted into a rehydration buffer containing urea, DTT and 
the immobilized pH gradient (IPG) buffer.  The mixture is absorbed into a dry strip containing 
IPG gel with a same pH gradient contained in the rehydration buffer.   The strip is placed into a 
focusing cup and voltage up to 8000 can be applied for effective separation. Further treatment of 
the strip is necessary to prevent oxidation of the sulfhydryl groups using DTT.  Residual DTT 
must be reacted using iodoacetamide.  Second dimension gel electrophoresis follows by applying 
the dry strip directly to the gel and performing electrophoresis in the presence of running buffers 
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usually containing TRIS-glycine with SDS for denaturing purposes.  Detection of proteins is 
performed using similar staining methods as previously discussed depending on the types of 
molecules and compatibility with mass spectrometry.  An illustration of the 2D gel 
electrophoretic process can be summarized in Figure 1.3.  
 
 
Figure 1.3 2D Illustration of 2DE gel electrophoresis and the separation of proteins using SDS-
PAGE 
 
Numerous advances have been employed for 2D electrophoresis proteomic technologies to 
characterize proteins expressed by an organism or tissue.   Advances in pretreatment of samples 
for solubilization, denaturation, and reduction provide many aspects of the technology. Although 
entire genomes for many species known, the actual identification of proteins is low for 2D 
analysis.  Databases are constantly being updated to produce protein maps of diseased and 
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such as phosphorylation and glycosylation, are being added to global databases.  A major 
complement to the area of protein identification and one of the main tools for sequencing the 
separated entities has become the rapid advancement of mass spectrometry of biological 
compounds. 
1.3.4 Mass Spectrometry  
 One of the most versatile and comprehensive tools used by chemists and biochemists for 
the ultrahigh detection, sensitivity, and high molecular weight specificity has been mass 
spectrometry [118].  The mass spectrometry was initially conceptualized by Sir Joseph J. 
Thomson [119] in 1897 through his cathode ray tube experiments in which he measured the 
mass-to-charge ratio of the positively charged kanal ray particles when passing the collimated 
beam through crossed electric and magnetic fields.  The actual work credited to the concept of 
mass spectrometry was conducted on the analysis of positive rays with a parabola mass 
spectrograph.  The field continued with the discovery of new isotopes and determination of their 
relative abundances and exact masses. 
 The uniqueness of mass spectrometry as an analytical tool is due to the several unique 
capabilities [120].  The analytical technique determines the molecular mass and structure of 
fragment ions. It also provides for ultra high detection sensitivities in the attomole and zeptomole 
ranges.  The analytical technique can be used for a variety of analytes that includes volatile or 
nonvolatile, polar or nonpolar, as well as solid, liquid, or gaseous materials 
Mass spectrometry measures the masses of individual analytes that are converted into 
molecules in the gas phase ionic species capable of being manipulated by their motions and can 
be detected.  The energy that is generated during the ionization process promotes fragmentation 
with the exception of soft ionization processes as electrospray and matrix assisted laser 
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desorption ionization. The mass analyzer is required to separate the molecular ions and their 
fragments according to their mass to charge ratios.  The current used to generate the masses is 
detected by a suitable detector and a mass spectrum is displayed.  The ions that are generated 
must move freely without collision or interactions so that a high vacuum is necessary [120].  
Originally, mass spectrometers were restricted to small thermostable compounds due to lack of 
effective techniques to ionize and transfer ionized molecules from condensed phase into the gas 
phase without excessive fragmentation of molecular ions of intact bimolecular [121]. 
Proteomics involves the systematic analysis of all the proteins in a tissue or cell which 
has mass spectrometry as the central strategy for identification and amino sequencing. Mass 
spectrometers typically consist of an ion source, mass analyzer, and a detector that registers the 
ions mass to charge (m/z) ratio.  Two ionization techniques that are commonly used to volatilize 
and ionize proteins and peptides for mass spectrometric analyses are matrix assisted laser 
desorption ionization (MALDI) and electrospray ionization (ESI) [122].  
1.3.4.1 Matrix Assisted Laser Desorption Ionization (MALDI) 
  MALDI was first introduced in 1988 [123] and has become a popular tool for peptides, 
proteins, and other biomolecules such as oligonucleotides, carbohydrates, natural products, and 
lipids.  MALDI is advantageous for the analysis of biomolecules due to its nondestructive 
vaporization and ionization of both large and small biomolecules.  In this analysis the analyte is 
first co-crystallized with a large molar excess of matrix compound that normally consists of a UV 
absorbing weak organic acid that is irradiated with a pulsed UV laser and results in the 
vaporization of the matrix that carries the analyte with it.  The matrix absorbs the energy from 
the laser source and serves and a proton donor and receptor which ultimately ionizes the analyte 
in both positive and negative ionization modes [124].  MALDI technique mixes the analyte with 
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a suitable matrix compound in ratios ranging from 1000 to 10,000 times molar excess in an 
organic solvent which upon evaporation co-crystallization occurs.  The crystallized surface is 
exposed to an ultraviolet laser devices such as Nd-YAG laser (Yttrium-aluminum-garnet-crystals 
doped with neodymium) for pulse durations of about 5-15 ns and at wave lengths of 266 or 355 
nm or a N2 –laser at a wavelength of 337 nm  with a pulse duration of 1-5 ns, in a high vacuum 
ion source.  The matrix typically absorbs the energy from the laser, ionizes and then dissociates.  
A solid phase change to a supercompressed gas and the ions assume a charge that protonates the 
analyte (Figure1.4) [125-127]. 
 
Nitrogen Laser 337 nm 







Figure 1.4 Matrix assisted laser desorption ionization concept producing gaseous phase ions 
with a nitrogen laser 
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1.3.4.2 Electrospray Ionization 
 Electrospray ionization is a soft ionization technique applicable to a large array of 
compounds present in liquid.  It is beneficial in the analysis and characterization of biomolecules 
and their noncovalent interactions.  This technique is unique due to its capability to interface 
with high performance liquid chromatography, capillary electrophoresis [128] and numerous 
other separation techniques [129].  ESI draws on its popular use due to continuous-flow 
operation, tolerance to different types of solvents (such as acetonitrile, methanol, water, etc),  
variability of flow rates, and the unique characteristic of generating intact multiply charged ions 
of fragile chemical and biological analytes.  The use of this technique occurs as an atmospheric 
pressure ionization process. 
 Electrospray is a technique that allows the transfer of solution phase ions to the gas 
phase. Ions in electrospray may be singly or multiply charged inorganic ions, (2) the alkaline 
earth ions; (3) singly and doubly charged transition metal ions; (4) anions of inorganic and 
organic acids;(5) singly and multiply charged protonated organic bases; and (6) singly and 
multiply deprotonated organic acids or organophosphates [130].  Solvents may include polar 
solvents such as water, methanol, or ethanol and aprotic solvents such as acetone, acetonitrile, 
and dimethyl sulfoxide [130]. 
 The first ESI experiments generated gas phase ions from electrically charged liquids 
droplets resulting from electrospraying the solution of an analyte at atmospheric pressure [131].  
Fenn and co-workers [132] further established the technique to mass spectrometry.  Additional 
efforts were used in the developed in the use of ESIMS for biomolecules in which the 
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biopolymers with a mass range of over 100 kDa was determined with mass accuracies of >.01% 
[133-135].  
The electrospray ionization process has various designs and operations for the analysis of 
peptides and proteins; however the most basic design is illustrated in Figure 1.6.  In the 
ionization process of peptides, a solution of an acidic aqueous media containing the peptide or 
protein is sprayed or aspirated through a small diameter needle.  A high voltage, usually at a 
maximum of 4 kilovolts, is applied to this needle that produces what is termed a Taylor cone 
from which droplets of the solution are emitted.  As the ions drift downfield towards the 
meniscus of the liquid, negative ions move towards the center away from the surface.  During 
these conditions, the mutual repulsion between the positive ions at the surface overcomes the 
surface tension of the liquid causing the surface to expand allowing the ions to move downfield. 
The cone emerges as a fine jet mist which breaks up into small charged droplets.  Protons 
emanating from the acidic and the peptides produce positive charges that are attracted towards 
the plate from the instrument [136]. 
Charged droplets 
 
Figure 1.5 Electrospray ionization process demonstration of charged droplets generation of 
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 Pfeifer and Hendricks [137] have applied equations to predict the dependence of the 
current, radius and the charge of the droplets.  As droplets are produced by the solvent and 
charged ionic species, a reduction in the number of aspirated analytes is observed due to solvent 
evaporation under atmospheric conditions under constant charge.  The energy needed for the 
elimination of some of the molecules is provided by the thermal energy of the air.  The charges 
of the droplets are constant as a consequence of the emission of ions from the solution in the gas 
phase and are highly endogeric [137]. 
The radius R of the droplet is decreased at a constant charge q that leads to an increase in 
the electrostatic repulsion of the charges at the surface until the droplets reach the Rayleigh 
stability limit [130]: 
 q = 8π (ε0γR3)1/2    (1.15) 
where : 
           q = the charge of the droplet 
           ε = permittivity of the vacuum 
            γ = surface tension of solvent 
            R = radius of droplets produced          
The equation provides the conditions at which the electrostatic repulsion equals the force due to 
the surface tension that holds the droplets together.  The instability of the charged droplets occurs 
as the radius and charge are satisfied.  The droplets undergo fission at a point close to the 
Rayleigh limit and smaller droplets are ejected.  The time for droplet with radius R0 and charge 
to reach a certain size R1 is estimated with the use of expression providing the rate of solvent 
evaporation for small droplets involved.  This phenomenon is solvent dependent so that when 
volatile solvents such as methanol, water, and acetonitrile are used the droplets are a few 
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micrometers of less in diameter and leads to a dependence of the radius of the droplet radius on 
the time t: 
R = R0 – (αυpºM/4ρRgT) t                      (1.16) 
where: 
 υ = the average thermal velocity of the solvent vapor 
pº  = the saturation vapor pressure of the solvent at the temperature of the droplet 
M = molar mass of the solvent molecule 
ρ    =   density of solvent 
Rg    = gas constant 
T =   temperature of droplet 
α = condensation coefficient of solvent 
 
1.3.4.5 Time-of-Flight Mass Analyzer (TOF)      
The mass analyzer most often coupled to the MALDI is the time-of-flight mass 
spectrometer.  As ions are generated in the ion source under a single electric field a constant 
kinetic energy can obtained and passes a drift region at a certain time.  The kinetic energy of the 
ions is given by: 
 KE = mv2/2 and        (1.17) 
KE = zeVs        (1.18) 
Thus, the equation then can be given as: 
 mv2 /2 = zeVs        (1.19) 
Where m is the mass of the ion, v is the velocity, z is the unit of charge, e is the charge of a 
proton, and Vs is the accelerating voltage. 
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The time required to drift through the flight tube can described as: 
 t = d/v         (1.20) 
where t denotes the time, d is the flight distance and v is the velocity.  
Replacing v by the value in 3.1 gives: 
 t2 = m / z (d2/Vse)       (1.21) 
The relationship indicates that the m/z (mass to charge) can be calculated from a 
measurement of t2 provided the term in parenthesis is constant.  The mass range in the linear 
time of flight instrument can be calculated from the above equation and in theory has no mass 
limit making the method suitable for soft ionization of biomolecules [138]. 
Linear TOF instruments have been regarded as low resolution techniques due to the 
spread of velocities of the ions that are ejected from the target.  The resolution can be defined in 
the equation: 
 R= m / ∆m = t/2∆t       (1.22) 
where m is the difference in mass between the m and m+1 peaks and the ∆t is the width of an ion 
packet of constant mass. 
   Additionally, large background peaks arise for the products from unimolecular decay in 
the flight tube.  The resolution can be improved by using an electrostatic mirror in a reflectron 
mass analyzer.  The initial kinetic energy dispersion of ions can be compensated by using the 
reflectron.  The relationship of the flight times in the reflectron can be defined as: 
 t = (m/2eV)1/2[L1 + L2 +4d]         (1.23) 
where L1 and L2  are the lengths of the drift regions and d is the distance the ion traveled  in the 
reflectron mirror.  Figure 1.6 illustrates the differences between the two modes of MALDI 
instrumentation. The majority of information in the field of proteomics provided by MALDI-
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TOF analysis results from proteins excised gel bands or spots that are subjected to reduction, 
alkylation, and finally enzymatic digestin with trypsin.  The peptides must be effectively 
digested and extracted from the polyacrylamide matris of 2DE. 
 
A Linear mode 
B Reflectron mode 
 
 
Figure 1.6 Time-of-flight mass analyzer. A) Linear mode B) Reflectron mode 
  Trypsin, the main protease used in the digested process is present in the gel at concentrations 
significantly below the Michaelis constant of the enzyme.  Other proteases commonly used in 
proteomics are listed in Table 5.  Peptide masses obtained in the initial elucidation of the 
molecular structure of the protein may consist of average masses; however, for high mass 
accuracy, monoisotopic masses are needed. 
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Table 1.6 Methods of enzyme cleavages of proteins for proteomics 
Method of Protein 
Cleavage 
Site of Cleavage Exception pH Range 





C-Terminus of Glutamic 
and Aspartic Acid 
Proline 4-8 





C-Terminus of Lysine Proline 8.5-8.8 
Arginine-C C-Terminus of Arginine Proline 7.5-8.5 




Pepsin C-Terminus F.L.E  2-4 
Pronase Any Peptide  7-8 
 
Peptide masses acquired through tryptic digest for MALDI-MS require the use of highly 
developed databases containing amino acid sequences or peptide finger print matching to achieve 
positive identification of the proteins of interest.  Algorithms [139-141] for the identification of 
proteins by mass spectrometry data is matched to a database.  Using this method, a mass 
fingerprint of the peptides is obtained and compared to the expected tryptic peptide masses for 
each entry in the database.  The resulting proteins can be ranked according to the number of 
peptide matches and scoring algorithms which considers the mass accuracy and the percentage of 
the protein sequence covered calculates a level of confidence of the match [142]. High mass 
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accuracy ( 10 to 50 ppm) with at least five peptide masses as a rule is needed for positive  protein 
matches and 15% of the protein sequence coverage for an unambiguous identification.  One 
drawback of using peptide mass fingerprinting occurs when protein mixtures are found in one 
spot. The mixture is converted to peptides and adds to the complexity of identifying proteins. 
  1.3.4.6 Quadrupole Mass Analyzer 
The quadrupole mass analyzer is one of the most widely used mass spectrometer that 
separates masses of analytes based on electric field parameters.  Ion trajectories are the basis in 
which the quadrupole operate and are controlled by a set of time-dependent forces generated by 
the application of direct and radiofrequency potentials to a set of electrodes.  The quadrupole is 
two dimensional field device consisting of four rods aligned parallel arranged in a square array. 
A field is created in the rods by connecting opposite pairs.  As ions are injected from one in the 
direction of the quadrupoles (z direction), those with very narrow m/z ranges produce stable 
ranges and their motion is confined with the field defined by the electrode.  These ions are 
detected; however, unstable ions are not due to trajectories in the quadrupoles. 
 The field induced by the quadrupole is supplied by a direct current potential U and a 
superimposed radiofrequency (rf) potential V cos ωt (U-V cosωt) to one pair of rods (where ω is 
the angular frequency related to the frequency f, in hertz, by ω = 2πf , V the amplitude of rf 
voltage, and t the time).  The rods at the opposing end possess the opposite dc potential (-U) and 
rf potential with the same magnitude but out of phase by 180º (-U-Vcosωt).  An oscillating field 
is created such that the potential at any given point within the rods is given by: 
Φ (x,y) = Φ x2 – y2 / r20         (1.24) 
where Φ0, is the applied potential that is equal to U-Vcosωt, r0  the inscribed radius located 
between the rods and x and y represents the distances from the center of the field. 
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1.3.4.7 Ion Trap Mass Analyzer 
Ion trap (IT) mass spectrometers are used in the detection of biomolecules; however the 
principle of analysis varies from the beam-type instruments.  The quadrupole ion trap is a three 
dimensional analogue of the linear quadrupole mass filter [143].  Ions are in the presence of 
forces induced by an applied RF field that is applied in three directions.  The ions in the trap 
have no degrees of freedom and are trapped within the three ring electrode and two end cap 
electrodes of hyperbolic cross sections.  IT actually store and manipulate ions in time rather than 
space with central electrodes at two ends.   At one of the end cap electrode, a small opening 
gated allows electron beams to enter the trap.  This can produce in situ ionization of the sample 
molecules.  The other cap electrode usually has perforations through which ions escape for 
detection [129].  The ions contained in the trap are stable in the r and z direction whose exact 
position is depicted by the Mathieu stability diagram.  The motion of the ions in the r and z 
directions may be described in by the solutions of the Mathieu equation below: 
  az =-2ar = -16zU/m(r2 + 2z2)ω2       (1.25) 
  qz =  -2qz = 8zV/m(r2 + 2z2)ω2          (1.26) 
where az and qz represent the Mathieu parameters, U the dc potential, V the rf potential applied 
between the ring and end cap electrodes, ω is the angular frequency.  The radial stability of the 
ions in the trap is expressed by az and qz and must be maintained at the same time with the 
stability in the z direction.  The optimum operation of the trap requires that the ions initial 
conditions of the ion are favorable by using a helium buffer gas to remove kinetic energy form 
the ions and cause them to exist in the central core of the trap.  To obtain mass spectra the 
quadrupole is operated in an unstable scan mode condition by increasing the amplitude V of the 
applied rf that move the ions in the qz direction until the boundaries are reached to give a value 
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of qz = .908.  When this region of instability is reached, the kinetic energy of the ions and z 
direction excursions increase resulting in the ions leaving the trap in the end-cap electrode where 
the detector is located.  The mass analysis of the trap can be obtained by rearranging the Mathieu 
parameter qz that can be represented by the following equation: 
  m/z =  8V / qz (r2 + 2z2)ω2       (1.27) 
  Application of appropriate dc and rf voltages to the electrodes produces ions of a broad m/z 
range that are trapped with in the boundaries of the electrodes.  
IT possesses the capability of providing multiple stages of MS with high sensitivity and 
fast data acquisition.  The mass analyzers allow high throughput; however limited resolution 
anad low ion trapping results in mass measurements that lack mass accuracy [144]. Ion traps 
allow isolation of only one ion species while ejecting others from the trap.  The ion can fragment 
by collisional induced dissociation and be detected or multiple fragmentations can be performed 
without the need for multiple analyzers. 
Traditional quadrupole ion traps are widely used for proteomics; however their 
developmental use for the identification of cellular proteomes is limited.  This limitation is due to 
the complexity of samples in the proteomes analysis where thousands of proteins and peptides 
may be eluted.  A slow scan rate and limited ion capacity and trapping efficiency is observed. 
[145].  
  To enhance the capability of the quadrupole ion trap mass analyzer, a novel design was 
introduced by Schartz [145].   The linear quadrupole trap or 2D trap is composed of a quadrupole  
with four hyperbolic cross-sectional rods giving it linear features.  Ions in the LIT are trapped in 
an axial fashion as opposed to central trapping in the 3D trap.  Linear ion traps (LIT) higher 
trapping capacities expand the dynamic range and the overall sensitivity of 3-D traps.  The LIT 
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have an optional slow scanning function that increases resolution and a multiple stage sequential 
MS/MS capability in which fragment ions are isolated and further fragmented.  This is useful for 
the analysis of post translational modifications such as phosphorylation [146].  The utility and 
performance of the 2D ion trap mass spectrometer in proteomic analyses has been compared by 
Mayya [147] and Blackler [148].  The 2D trap is operated analogous to the ion trap however 
several advantages can be observed with respect to performance characteristics [146]. The linear 
quadrupole has no rf field in the ion injection axis for the ions to overcome before entering the 
trap improving the trapping efficiency.  The linear configuration of the mass analyzer provides a 
larger volume improves the overall ion capacity before space charge effects can be achieved.  
The increased ion capacity is enhanced by the ability of the trap to eject ions radially on each 
side as opposed to the axial direction.  Two detectors can be used resulting in a two-fold increase 
in detection efficiency. 
1.3.4.8 Fourier Transform Ion Cyclotron Resonance Mass Analyzer 
The quantitative identification of proteins in low part per million ranges can be achieved 
using the Fourier Transform ion cyclotron resonance mass spectrometer.  Fourier transform 
resonance mass spectrometry (FTICRMS / FTMS) is a unique mass analyzer due to its capability 
for high mass, high resolution, and multiple detectors.  Advantages can be observed in high mass 
accuracy, multistage tandem mass spectrometry, and ability to trap ions for extended periods of 
time.  The analyzers can be useful for ion molecule reaction as well as structure elucidation 
studies [129].  
The principle of ion cyclotron resonance involves several techniques occurring in the 
same region of space and time.  The steps involve ionization, mass analysis, and detection.  The 
takes place in a 1.0 centimeter cell that is placed in a strong magnetic field.  Ions are constrained 
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by a magnetic and electric field.  Ions placed in a magnetic field will precess at a frequency (ωc) 
that is characteristic of its m/z values.  The ions move in circular orbits defined by equations 1.28 
and 1.29 describe the time to complete a single revolution.  The cyclotron frequency, number of 
revolutions per second can be given by Equation 1.30: 
   t = 2πr / υ             (1.28) 
   t = 2πm / zβ          (1.29) 
   ωc = z β / 2πm       (1.30) 
where t denotes the time, r is the radius, m is the mass of the ions, and ω is the cyclotron 
frequency which is the number of revolutions per second.  
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CHAPTER 2 
OPTIMIZATION OF MEMBRANE PROTEIN SOLUBILIZATION IN HUMAN 
AORTAS USING TWO DIMENSIONAL GEL ELECTROPHORESIS 
 
2.1 Introduction 
 Proteomics is defined as the analysis of protein mixtures that are derived from tissues, 
cells or other matrixes of complex extracts from animals or plants that contain differences in the 
protein expression or modifications [1].  It encompasses large scale studies of gene expression at 
the proteome level in areas such as protein function, characterization of post translational 
modifications, protein interactions and protein analysis.  The detection of proteins that may be 
markers for numerous diseases are studied using this technique followed by mass spectrometry.  
Three areas best describe this technique: (1) protein microcharacterization for identification of 
proteins and their post translational modification; (2) comparison of differential expression 
proteomics in a wide range of diseases; (3) and studies of protein-protein interactions and post 
translational modifications [1-3]. 
 The separation of proteins from their native environment such as in tissues, cells, or 
plasma presents a challenge especially when the isolation and analysis of each component is the 
goal of the investigation.  One of the most widely used methods for isolating and characterizing 
protein for the tissues lysates is two dimensional gel electrophoresis.  Proteins migrate in an 
electric field at a rate that is dependent on their conformation, size, and electric charge.  
O’Farrell and J. Klose used the latter of these characteristics to separate proteins in the first 
dimension, isoelectric focusing based on their charge [4].  The second dimension for the 
separation is according to molecular weight using sodium dodecyl sulfate polyacrylamide gel 
electrophoresis [4, 5].  The proteins are displayed as spots on x- and y-coordinates rather than 
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bands in one dimensional separation.  As a result of this technique, thousands of proteins can be 
resolved that permits identification when combined further with mass spectrometry. 
Isoelectric focusing method developed by O’Farrell [4] depended on carrier ampholytes 
generated pH gradients in polyacrylamide tube gels.  The carrier ampholytes consisted of small 
amphoteric molecules possessing high buffering capacity near their isoelectric points (pI) [6]. 
When a voltage is applied, the carrier ampholytes will align according to their pI’s.  The 
buffering capacity results in a continuous pH gradient across the gel.  The isoelectric point of 
protein is defined as the pH value at which the protein exhibits a net zero charge.  At pH values 
above the pI, a protein carries a net negative charge and carries a net positive charge at pH values 
below the pI.  When proteins are placed in a pH gradient under an electric field, they migrate to 
the pH value where no net charge occurs which is the pI for the molecule.  The use of carrier 
ampholytes is limited for several reasons including batch to batch variability, instability with 
tendencies to cause drifting towards the cathode with time, and the difficulty in working with 
soft acrylamide gels in tubes [6]. 
The development of immobilized pH gradients (IPG) for isoelectric focusing by 
Bjellqvist et al. [7] incorporated acrylamido buffers into a polyacrylamide gel at the time it is 
cast.  The polymer is placed onto a plastic backing and then placed onto strips with various pH 
gradients.  The pH range used for most studies is usually from 3-10; however, narrower ranges 
are available depending on the range of the analytes. 
Our study is aimed at the investigation of the separation and differentiation of proteins 
that are components of thoracic aortas in diseased and nondiseased states.  The pathogenesis of 
atherosclerosis occurs in the membrane lining the vessels that carry the blood supply to the heart. 
The membranes affected by the disease in the coronary artery and aortas are the intima, the 
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media, and the adventita.  The site of disease or plaque formation for atherosclerosis is 
predominantly located in the intimal membrane.  When extensive thrombosis or plaques are 
formed the intima and media are indistinguishable.  The membrane proteins, which are 
components of the two diseased tissues, are highly hydrophobic and present solubility problems 
in IPG dry strips.  Overcoming these barriers require an analysis of proteins solubility and 
methods that disaggregate the molecules for inclusion into the polyacrylamide gels.  
 To achieve solubilization of membrane proteins in addition to high resolution on 
polyacrylamide gels, disruption of molecular interactions is necessary to obtain single 
polypeptides that are essential throughout the separation process.  Proteins fold by covalent and 
noncovalent interactions in their native state.  Molecular interactions through covalent linkages 
of cysteine residues are the strongest while weaker forces or noncovalent forces consist of Van 
der Waals forces such as hydrogen bonding, ionic bonds, and other hydrophobic interactions [8]. 
Complete solubility of proteins for isoelectric focusing (IEF) must be achieved by 
disaggregation, denaturation, and reduction. 
 During the denaturation process, sodium dodecylsulfate (SDS) disrupts hydrogen 
bonding, blocks hydrophobic interactions, and partially unfolds the protein and eliminates 
secondary and tertiary structures.  The process of using SDS in gel electrophoresis is performed 
by heating the sample in concentrations of 2% (w/v) or higher in the presence of 2- 
mercaptoethanol. The use of SDS however is limited in IEF in the first dimension.  As the 
solubilization process occurs, simultaneous goals that must be achieved are: breaking 
macromolecular interactions to yield separate polypeptide chains, preventing artefactual 
modifications of the polypeptides during the solubilization medium, removal of substances that 
may interfere with 2DE and maintaining the protein in solution during the entire process [10].  
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Many compounds that bind to proteins and interfere with the electrophoretic process must be 
eliminated if their amounts exceed a critical interference threshold.  These compounds include 
salts, lipids, polysaccharides and nucleic acids [10].  Salts are disruptive in the electrophoresis of 
proteins by producing joule heating as they migrate through the pH gradient and accumulate at 
both the cathode and electrode.  The accumulation produces high conductivity zones that depend 
on the quantity of salts in the sample.  Low electric fields are present due to high conductivity 
and voltage drops. Protein focusing is affected and appears as streaks interfering with resolution. 
Detergents in 2DE must have a zero net charge and must be either nonionic or zwitterionic. Ionic 
detergents such as SDS can be tolerated in the initial solubilisation; however, lower amounts are 
necessary for effective separation during IEF.  SDS must be diluted with nonionic or zwitterionic 
surfactant to reduce its final concentration to approximately 0.25%.  The reduction of SDS for 
tolerable IEF similarly reduces the amount of protein loading and increases losses for separation. 
 Reagents to overcome restrictive uses of SDS were developed that proved to be amenable 
to 2D separation for protein solubilization.  The alternative process involved a multiple approach 
to protein solubility with chaotropes, surfactants, reducing agents and alkylating agents [6].  Urea 
is a choice of chaotrope that is commonly used as a replacement for SDS in concentrations range 
of 7-9M.  Thiourea at a concentration of 2M is also used in combination with urea to enhance the 
solubility of membrane proteins.  Several detergents have proven to be effective but the most 
common nonionic detergent use is (3-[3-cholamidopropyl)dimethylammonio]-1-propane 
sulfonate) (CHAPS).  Detergents are useful in 2DE to prevent hydrophobic interactions between 
the hydrophobic protein domains as well as avoiding loss of proteins due to aggregation and 
precipitation [7].   The more commonly used ionic detergents for protein solubilization include 
Triton X-100, Nonidet P-40, dodecyl maltoside and some phosphines.  Those detergents that are 
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more effective for hydrophobic membranes proteins are CHAPS, sulfobetaines as SB-10 or 
ASB-14 which show compatibility with urea and thiourea.  
 A reducing agent for disulfide bonds and prevention of reoxidation is a critical step in the 
preparation for IEF.  The agents are necessary for cleavage of intra and intermolecular disulfide 
bonds that promotes complete unfolding of the protein.  The more commonly used reductants for 
IEF are dithiothretol and dithioerythritol.  The choice however is predominantly sample specific 
[8].    
 The most efficient techniques of 2DE may be achieved by optimizing each component in 
the extraction or sampled preparation steps.  Our study was focused on the methods of 
optimization of the choatrope, detergent, and the reductant as well as the use of IPG buffer for 
solubilization of highly membrane protein for maximum spot detection in the gels.  Few 
systematic studies were found that reported the concentrations of the critical ingredients for 
protein solubilization in biological components.  The use of Taguchi method is well known in the 
development of industrial processes and recently in the life sciences [9, 10]  
To find the optimal and most robust conditions for 2DE a designed study was conducted 
similar to the Taguchi method in the characterization of proteins that were bound to chromatin at 
defined stages of the cell cycle in cell free extracts derived from Xenopus eggs [11].  The use of 
tissue from a heterogeneous surface of human aortas or arteries would be irreproducible since 
areas that are diseased and nondiseased exist.  It was necessary, by physical means, to mix the 
entire intimal surfaces to study the effectiveness of the solubilization process as well as produce 
a homogeneous matrix. 
  The performance of 2DE depends on the ability of proteins to become solubilized during 
tissue interaction with the lysis buffer.  The combination of the lysis buffer concentrations is 
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extensive in the literature for optimum solubilization.  However, there are no defined or 
systematic studies that address the optimum concentrations of the critical ingredients because the 
use of conventional methods is time consuming and investigation of one variables at a time is 
labor intensive and costly.  There are methods particularly in industry that address multi-
parametric matrices.  One method is the Taguchi method that has been used for decades in the 
optimization of industrial processes [11].  These methods have found wide use in the biological 
sciences [9, 10, 12]. 
2.2 Research Goals and Objectives 
 This study investigate the influence of four variables such as IPG buffer (v/v), CHAPS 
(wt/v), ASB-14 (wt/v), and DTT (wt/v) at three concentration levels on membrane protein 
solubility using experimental design.  To obtain all interactions including optimum conditions 
various experimental designs must be examined with emphasis on number of experiments, time 
constraint, and cost.  The full factorial design using four variables with at three levels enables 
one to study the all the main effect and interactions, however, the number of experiments needed 
is 34 or 81 experiments.  This exceeds the quantity, time and labor permitted for the use of the 
aorta and artery samples.  A fraction factorial would allow the study of a reduced number of 
main effects from the full factorial design depending on the confounding pattern of the design. 
Deciding the interactions are of importance for optimum responses may not produce the 
optimum conditions.  The Plackett Burmann designs enable the study of the main effects and 
may be used only for screening purposes.  Central Composite experimental design is typically 
used to study the variables at 5 levels and can be used to investigate both the main as well as 
interaction effect of variables on the response.  The Box-Behnken experimental design is used 
for optimization purposes for one or several responses with 3 to 6 design variables at three levels 
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(low, center, and high).  The use of Box-Behnken design for the optimization involving the 
investigation of biological samples such as human aorta is prefereable because of the limited 
samples and the cost of analysis.  Therefore, we used a Box-Behnken design for the optimization 
of lysis buffer for membrane protein solubilization of human aorta samples.  The number of 
experiments in a Box Behnken design remains fixed based on a certain number of variables.  For 
our study, four variables are to be monitored and three levels which gives a total of 27 runs to 
complete the optimization.  With constraints of time of experiments, cost, and limited sample 
quantity per subject, the Box-Behnken gives the desired information for the biological system 
studied. 
2.3 Experimental 
2.3.1 Materials and Reagents 
 Urea, glycerol, glycine, thiourea, ASB -14, iodoacetamide, and Sigma Markers (for 
molecular standards) and guanidium hydrochloride were purchased from Sigma Aldrich Corp     
(St. Louis, MO USA).  All of the reagents were of the highest purity and when available 
specified electrophoresis grade.  Sodium dodecyl sulfate (SDS) was obtained from BioRad (San 
Diego, CA USA) for electrophoresis.  
Tris(hydroxymethyl)aminomethane (TRIS) was obtained form Invitrogen (San Diego, 
CA USA). 3-[(3-Cholamidopropyl)dimethyl-ammonio]-1-propanesulfonate (CHAPS was 
purchased for Calbiochem (San CA USA).  Dithiothreitol was obtained from Fluka Biochemika 
(Sigma Aldrich, St Louis, MO USA).  Trichloroacetic acid was purchased from Fisher Scientific 
(Rockville MD, USA).  The immobiline pH gradient dry strips, immobiline pH gradient buffer 
pH 3-10 NL and mineral oil, and Drystreak were obtained from GE Healthcare Inc. (Piscataway, 
 60
New Jersey USA).  The colloidal blue coomassie blue stain was obtained from Invitrogen (CA 
USA). Methanol (HPLC grade) was obtained from EMD Chemical (City USA). 
 Isoelectric focusing was performed using an Ettan IPGphor unit (GE Healthcare, 
Piscataway, NJ USA.  The gel electrophoresis in the second dimension was conducted using a 
BioRad Criterion electrophoresis unit with a Powerset 1000.  The gels were 12 % 
polyacrylamide that were precast and purchased from BioRad (San Diego, CA USA).  
2.3.2 Methods 
Thoracic aortas and arteries from human hearts were obtained from Louisiana State 
University Health Science Center in New Orleans, Louisiana.  The samples were frozen 
immediately with dry ice and stored at -70ºC until dissection.  During the extraction procedure, 
the tissue was allowed to thaw to room temperature.  The intima membrane from normal and 
diseased tissue was carefully removed from the media and adventitia. Approximately 250 to 350 
mg of tissue was isolated then placed in liquid nitrogen and ground with a mortar and pestle into 
a powder.  The powder was placed in lysis buffer composed of 7M urea, 2M thiourea, 2M 
guanidium hydrochloride with the other reagents varied according to the parameters from the 
design study.  The temperature of the lysis was maintained at 4ºC and precaution was taken to 
prevent the urea containing solution not to exceed 30ºC.  Tissue extract was homogenized with a 
Tarazen Homogeniser for 1 minute followed by sonication at 4ºC for 4 minutes.  The mixture 
was centrifuged at 12,000 x g for 20 minutes at 20ºC in an Eppendorf 540 microcentrifuge.  The 
supernatant was maintained at < 20ºC until the precipitation steps.  
The procedure for precipitation of the cell lysates was used for optimal protein recovery 
and accurate assays.  Acetone used in this procedure was prechilled and stored at -20ºC and kept 
on dry ice during the entire experimental procedure.  Solutions of supernatant, acetone and 
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trichloroacetic acid were mixed in 1:8:1 ratio by volume.  The mixture was allowed to precipitate 
at -20ºC for 1 hr and centrifuged at 11,500 rpm (18,000 x g) for 15 minutes at 4ºC in a 
microcentrifuge. 
The supernatant was then discarded and washed with 1 milliliter of cold acetone followed 
by centrifugation at 11,500 rpm for 15 minutes at 4ºC.  The supernatant was discarded and the 
protein pellet was dissolved in the appropriate volume of rehydration buffer containing 7M urea, 
2M thiourea, 12 µl IPG buffer, 12 µl destreak reagent and 7 mg dithiothreotol.  The sample was 
allowed to sit at room temperature for 1 hour while vortexing intermittently every ten minutes. 
Following protein pellet solubilization, the sample was placed in Eppendorf microcentrifuge 
tubes and centrifuged at 14,000 rpm for 10 minutes at room temperature.  The supernatant was 
removed and stored at -70ºC until ready for use. 
2.3.2.1 Rehydration Buffer 
 
The selection of rehydration solution depends on the protein solubility requirement.  The 
rehydration buffer was composed of 7M urea, 2M thiourea, 12 µl IPG buffer (pH range 3-10), 7 
mg DTT, 12 µl Destreak solution, 20 µl 1% bromophenol solution.  Approximately 60 µl of 
tissue extract was mixed carefully with 160 µl rehydration buffer without causing air 
entrainment.  The solution was pipetted evenly into an 11 cm ceramic strip holder covering the 
entire length.  The immobiline dry strip was carefully removed from the cover foil starting with 
the anodic end (+ end).  Using forceps, the immobiline drystrip gel was lowered gel side down 
and the anodic end (+) of the strip directed toward the pointed end of the ceramic holder.  With 
the acidic end, the strip was lowered and slide back and forth along the surface of the solution, 
tilting the strip holder slightly to ensure complete wetting of the gel surface.  The cathodic end 
was lowered in the channel making sure that the gel contacts the strip holder electrodes at each 
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end.  It is important not to allow air bubble entrainment under the strip to prevent oxidation 
during isoelectric focusing.  The strip is overlayed with immobiline drystrip cover fluid to 
minimize evaporation and thus prevent urea crystallization.  Cover fluid was pippetted dropwise 
at one end of the holder, then at the other end until the entire gel is sufficiently covered.  The 
strip holder is covered with the plastic holder cover with pressure blocks on the underside so that 
good contact is made as the gel swells.  The holder was placed onto the Ettan IPGphor II (GE 
Healthcare) platform for the rehydration protocol.  The following summarizes the rehydration 
and focusing conditions:    
IEF (Isoelectric Focusing) Conditions: 
Rehydraton: 12:00 Hr at 20° C 
IEF Params: 50µA/Strip at 20° C 
Step 1: Step 500V   500 Vhr 
Step 2: Grad 1000V   700 Vhr 
Step 3: Grad 6000V 7000 Vhr 
Step 4: Grad 6000V 4000 Vhr 
Total Volt Hours: ≈12,000 
2.3.2.2 Equilibration of Immobiline Dry Strips 
 Following the isoelectric focusing step, equilibration was performed immediately prior to 
the second-dimension run.  The strip was placed in a horizontal position with the gel side up into 
an equilibration solution  consisting of 6M urea, 75 mM Tris-HCl, pH 8.8, glycerol (30%), 100 
mg of DTT to preserve the fully reduced state of denatured, unalkylated proteins and sodium 
dodecylsulfate (1%).  The SDS denatures the protein and forms negatively charged protein SDS 
complexes.  The drystrip was allowed to mix for 15 minutes at room temperature on a solution 
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rocker. Iodoacetamide (250 mg) was added to a second equilibration solution without DTT and 
the dry strip submerged in a horizontal position with the gel side up and shaken for an additional 
15 minutes.  The iodoacetamide was introduced in the second equilibration buffer to minimize 
unwanted reactions of cysteine residues especially during the analysis using mass spectrometry. 
2.3.2.3 Second Dimension Sodium Dodecylsulfate Polyacrylamide Gel Electrophoresis 
 The second dimension protocol separates the proteins from the dry strip by molecular 
weight.  The drip strip gel was equilibrated in an electrophoresis solution of 1% SDS buffer to 
lubricate it.  A precast slab gel from BioRad for the Criterion Gel System was used with a 12.5% 
acrylamide concentration specially used for IPG gels.  With a plastic ruler or thin forceps, the 
immobiline drystrip is gently pushed between the glass plates of the slab gel, ensuring that the 
plastic backing on the strip was placed against the longer plate.  The drystrip was carefully 
inspected to ensure that no air bubbles are trapped between the strip and the slab gel surface or 
between the gel backing and the glass plate.  Additionally, the the drystrip and the slab gel were 
cargfully connected at all points without any gaps.  The drystrip was then sealed with a solution 
of 1% agarose to prevent the possibility of floating or moving in the electrophoresis buffer. 
Molecular weight markers were added to the well position on the slab gel. 
 The slab gel was placed into a BioRad Criterion gel electrophoresis unit followed by the 
addition of the running buffer.  The running buffer was made by adding 30 gram of TRIS and 
144 grams of glycine, and 10 grams of SDS into one liter of ultra pure 18 mohms water.  This 
mixture is a 10X running buffer stock solution.  A 1x solution was prepared and added to the 
appropriate chamber containing the slab gel ensuring that the liquid buffer contacts the 
electrodes.  A setting of 200 volts was applied to the gel for 1 hour or until the bromophenol blue 
tracking solution migrates the full length of the gel.  
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 After the completion of the electrophoresis run, the gel was carefully removed from the 
glass plates and washed three times with ultra pure deionized water.  Between 50 to 100 ml of 
colloidal commassie blue staining solution was added to the gel and the solution was shaken on a 
rocker for maximum of 12 hours.  The staining solution was removed and the gel was carefully 
washed with ultra pure deionised water. Destaining with water is continued until the background 
of the gel is clear and protein spots can be distinguished.  
2.3.2.4 Design Study Parameters 
The lysis buffer normally consists of chaoatropes, urea and thiourea, detergent(s), and 
reducing agent(s) and carrier ampholytes [13-15].  The range of formulations for the lysis buffer 
used contains 7M urea, 2M thiourea that is normally reported to give the best 2D images with the 
immobilized pH gradient.  Guanidium hydrochloride was added to the mixture to enhance the 
removal of proteins in atherosclerotic plaques.  The use of this reagent may be restricted because 
of its ionic nature and must be removed prior to applications to the IPG dry strips.  A Box-
Behnken design was used to simultaneously investigate the effects of the design variables (lysis 
buffer composition in this study) on the response (membrane protein solubility as indicated by 
the number of spot).  The variables used for the optimization study with the Box- Behnken 
design consist of IPG buffer (v/v), CHAPS (w/v), DTT (w/v), and ASB-14 (wt/v).  Each variable 
was investigated at three different levels; IPG buffer (5, 12.5, 20µl); CHAPS (10, 25, 40 mg); 
ASB-14 (4, 10, 16 mg); and DTT (20, 60, 100 mM).  The experimental design and multivariate 
data analysis was performed using chemometric software, The Unsrambler (Camo, Corvallis, 
OR, USA, version 9.1.2).  A summary of the levels of variables and number of experimental runs 
using the Box-Behnken design is shown in Table 2.1. 
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Table 2.1. Levels and range of the design variables for Box Behnken 
  Experiment No Immobiline pH 
Gradient  
Buffer (µl/ml) 





1 20 25 10 100 
2 12.5 25 10 60 
3 20 25 4 60 
4 12.5 10 10 100 
5 12.5 40 10 60 
6 12.5 25 16 20 
7 12.5 40 10 20 
8 5 25 16 60 
9 12.5 25 16 100 
10 5 40 10 60 
11 5 25 10 20 
12 12.5 40 4 60 
13 20 40 10 60 
14 12.5 25 10 60 
15 5 25 4 60 
16 12.5 25 4 100 
17 12.5 25 16 60 
18 12.5 10 4 60 
19 5 25 10 100 
20 12.5 10 10 20 
21 12.5 25 10 60 
22 5 25 16 60 
23 12.5 10 16 60 
24 5 10 16 60 
25 20 10 10 60 
26 20 25 10 20 
27 12.5 25 4 20 
 
 The focusing of the sample onto the IPG strip (3-10 pH) was conducted at similar 
parameters for all experiments with the rehydration step run time maintained at 12 hours without 
any voltage applied.  The entire focusing steps were performed in the ceramic sample cups. 
Following the rehydration step, the current for each strip was set at 50 uA per strip.  A fast 
ramping step was necessary to increase the voltage to 500V to achieve 500 Vhrs for the initial 
stage.  This step was followed by a gradient step to 1000V to obtain 700 Vhrs.  The next gradient 
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steps were set to 6000V to obtain a total of 7000Vhr.  A final gradient setting of 6000V was 
conducted to give 4000 Vhr for this step interval with the total volt-hours for the experimental 
runs set for 12,000 volt hours.  Although variations in the IPG buffer normally require longer 
ramp times, it was held constant to maintain consistency in the design study.  The total value of 
volt-hours was based on the manufacturer’s suggestions for the strip length used. 
 Following IEF, the gel strip was prepared for SDS-PAGE by two additional preparative 
steps.  The IPG strip was equilibrated with SDS buffer and DTT, the reductant, to prevent 
reoxidation.  This step was followed by alkylation with iodoacetamide to alkylate cysteine 
residues and prevent their modification during and after SDS-PAGE.  Variable alkylation can 
cause substantial artefactual spots on 2D gels [16-17].  Excess DTT contributes to streaking in 
the final gel, causing a decrease in the resolution of protein spots.  An additional precipitation 
step composed of an acetone / trichloroacetic acid wash was necessary to remove undesirable 
salts, lipids, and nucleic acids that contribute to streaking and reduced resolution of protein spots.  
 Dithiothreitol or DTT, a commonly used reductant for 2DE, was compared to the other 
variables in the study.  The breaking of disulfide bonds in proteins is accomplished by an 
equilibrium displacement process using a large excess of free thiols.  Simple alkyl thiols are too 
volatile causing some problems in maintaining a certain concentration and possess an unpleasant 
odor.  Much less volatile thiols are frequently used in biological applications such as β 
mercaptoethanol, dithioerythiol or dithiothreitol [19].  These thiols are used in high 
concentrations to ensure maximum displacement of the thiol-disulfide equilibrium that favors the 
thiol form of the protein [19].  Since the intramolecular, cyclic condensation produced during 
oxidation of DTT or DTE the equilibrium is driven more efficiently toward the reduction of the 
protein [19].  Because of this reaction, the reductant can be used at a lower concentration 
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(100mM or less).  The drawbacks of these chemicals is due to dissolved oxygen that reoxizides 
the thiols into disulfides, consuming the free thiols.  
2.4 Results and Discussion 
The results of the number of spot obtained under various experimental conditions of lysis 
composition are shown in Figure 2.1.  From Figure 2.1, it was apparent that lysis buffer 
composition has significant influence on the membrane protein solubility and the number of spot 
counts in 2D gel electrophoresis.  The minimum number of spots (7) was obtained in experiment 
number 5 which corresponds to IPG , CHAPS, ASB – 14 and DTT concentrations of 12.5ul / 
mL, 40mg / ml, 10mg / mL, and 60mM  respectively, in  lysis buffer. The low number of spot 
count at this condition was an indication of low or poor membrane protein solubility at this lysis 
buffer composition.  However, the maximum spot count of 130 was obtained in experimental run 
23  containing lysis buffer composition of 12.5 µl / ml IPG buffer, 10 mg / ml CHAPS, 16 mg/ 
ml ASB – 14, and 60 mM DTT.  Therefore, the optimum lysis buffer composition for protein 











Figure 2.1 Bar plots of spot counts from gels from various conditions in the Box Behnken 
design study. The lowest spot count resulted from run conditions in run 5 and maximum in run 
23. 
 










Figure 2.2 is a surface response plot showing the influence of DTT concentration and 
CHAP concentration on the number of spots resolved on the 12% polyacryamide gel.  Generally, 
high protein solubility (high spot count) was obtained at low CHAPS concentration in the lysis 
buffer.  Higher protein solubility can be achieved at CHAPS concentration range of 10 to 25 
mg/ml with optimal protein solubility at 10 mg/ml. In addition, the optimum condition for 
protein solubilization was obtained for lysis buffer containing DTT concentration of 60 mM. 





Figure 2.2 Surface response plot showing the influence of DTT and CHAPS concentration on 
the number of spots. Low DTT concentration at 60mM gave the best conditions for high spot 
count 
 
The influence of the ASB-14 and IPG buffer concentration on the spot count response is 
shown in Figure 2.3.  The concentration of ASB – 14 with the optimal range for the highest 
protein spot count was found to be from 14 to 16 mg/mL, with optimum conditions at ASB-14 
concentration of 16 mg/L. High protein solubility was obtained in a lysis buffer containing IPG 
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buffer in the range of 5- 10 µL, with actual optimal condition for protein solubilization obtained 




Figure 2.3 Surface response plot of ASB – 14 and IPG concentration on the number of spots.  
The highest spot count was obtained in the buffer range 5-10 µL and ASB-14 range 14-16 
mg//ml. 
 
The SDS-PAGE images of the second dimensional analysis of experiment 5 and 23, 
where the minimum and maximum spot counts were obtained from the experimental design were 
shown in Figure 2.4 and Figure 2.5, respectively.  Experimental conditions for minimum spot 
counts produce horizontal streaking.  These streaks are due to salts or imbalances in the lysis 
buffer and are the main causes of poor resolution in gels.  In contrast, Figure 2.5 illlustrates the 
best conditions for the experimental design with the spot resolution greatly improves although 
some horizontal steaking is evident.  In addition, the use of experimental design at optimum 
condition increased the number of spot from 96 to 134 (34% increase) compared to when we 
initially optimized the lysis buffer composition using the traditional method involving optimizing 










Figure 2.4. 2DE image of experimental run 5 of Box Behnken design. Polyacrylamide 
concentration = 12 % with TRIS/ Glycine buffer with 2% SDS added. The IEF focusing totaled 













Figure 2.5 2DE image of experimental run 23 of Box Behnken design. Polyacrylamide 
concentration = 12 % with TRIS/ Glycine running buffer with 2% SDS added. The IEF focusing 




2.5. Reproducibility and Validation of the Design Method 
 The use of biological tissues for experimental design studies must be homogeneous 
enough to discern changes that are not due to changes in the compositions of the tissue.  Intima 
tissues may contain various degrees of the diseased state, but physically mixing in liquid 
nitrogen to powdered homogeneous samples was achieved. 
To further test the validity of the optimum conditions for membrane protein solubility 
obtained from the Box Behnken study on intima samples for diseased and nondiseased tissue, 
extractions using another different and independent thoracic aorta tissue samples were 
performed.  In addition, analysis of another aorta samples were used to evaluate and investigate 
the results of the optimum trends on random samples.  In order to assess the differences in the 
extent of atherosclerosis in the tissue we selected areas that were described as normal or non- 
diseased and those with complicated plaque or thrombus (diseased) for analysis.  Based on these 
criteria, tissue samples were characterized as diseased high and low while nondiseased samples 
were described as nondiseased high and low.  The high and low designation describes the 
maximum and minimum spot count conditions respectively from the experimental design study. 
The reproducibility studies were conducted using thoracic aorta tissue excised from a 56 year old 
female.  Dissection and extraction procedures followed the previous described protocol in 
experimental section.  The extractions of the samples were performed at the lysis buffer 
composition where the minimum and maximum number of spot count was obtained from Box- 
Benhken design (expt., 5 and 23, respectively in Table 2.1).  The IEF experimental runs were 
conducted in triplicate for all extracted protein samples.  
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The results of the number of spot count obtained for the diseased and non-diseased aorta 
samples are shown in Table 2.2.  Our study confirms that when the optimum conditions were 
applied in diseased tissues an increase in spot counts were observed.  In non diseased tissues, 
similarly, increases in the spot count were obtained when these parameters were used.  
 
Table 2.2. Reproducibility Studies of Diseased and Non- Diseased Aorta Extracts 




Run Number Non-Optimum Optimum Non-Optimum Optimum 
1 14 22 27 40 
2 12 35 30 35 
3 13 26 31 38 
Average No of 
Spots 
13 28 29 38 
Standard 
Deviation 
1 7 2 3 
 
 Typical polyacrylamide images of the parameters obtained at low and optimum spot 
counts from the reproducibility study for diseased and non-diseased samples are illustrated in 
Figures 2.6 and 2.7, respectively.  The studies confirmed the validity of the design as well as the 
reproducibility results.  Horizontal and vertical streaking was minimized, enhancing the 
resolution of individual spots for further analysis and identification of proteins by in-gel di-
gestion with trypsin and mass spectrometry.  Peptide mass fingerprinting or LC/MS/MS for 
denovo sequencing with tandem mass spectrometry can be used for positive identification of 
proteins found in the various plaques.  Proteins can be compared for increase or decrease in 
expressions between the disease and nondiseased tissue extracts. 
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Figure 2.6. Comparison of Nondiseased tissues from Box Behken optimization parameters A) 
Low spot count; 12.5ul IPG buffer: 40mg/ml CHAPS:10mg/ml ASB-14:60 mM DTT;  B) High 
spot count; 20 uL IPG buffer : 10 mg/ml CHAPS : 10 g/ml ASB-14 : 60 mM DTT. 
Polyacrylamide concentration = 12 % with TRIS/ Glycine running buffer with 2% SDS added. 
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Figure 2.7. Comparison of Diseased tissues from Box Behken optimization parameters A) Low 
spot count; 12.5ul IPG buffer: 40mg/ml CHAPS: 10mg/ml ASB-14:60 mM DTT;  B) High spot 
count; 20 uL IPG buffer : 10 mg/ml CHAPS : 10 g/ml ASB-14 : 60 mM DTT. Polyacrylamide 
concentration = 12 % with TRIS/ Glycine running buffer with 2% SDS added. The IEF focusing 
totaled 12,000 volt-hours. 
 
 
The data validates the use of the optimum conditions with the standard deviation within 
acceptable ranges for biological samples of varying degrees of diseased states.  The data will be 
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used to evaluate larger gel formats for higher protein concentrations that can be analyzed with 
2DE. 
2.6 Conclusions 
 This study successfully used a Box Behken experimental design to optimize the 
composition of four key components, IPG buffer, CHAPS, ASB-14 and DTT, in the lysis buffer 
for the membrane protein solubilization.  Tissues for the normal and diseased intima of thoracic 
aortas extracted using lysis buffer in IEF with IPG drystrips.  This method for optimal spot count 
(protein solubilization) reduced the number of experiments when compared to classical 
approaches that require additional time and material cost.  The method was found to be highly 
reproducible with high potential in solubilization of wide range of highly hydrophobic membrane 
protein in human and animal samples.  This approach will further utilized for the elucidation of 
proteins expressed in the formation of atherosclerosis. 
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ISOLATION AND CHARACTERIZATION OF PROTEINS FROM 
ATHEROSCLEROTIC PLAQUES USING TWO DIMENSIONAL GEL 
ELECTROPHORESIS AND MASS SPECTROMETRY 
 
3.1 Introduction 
Cardiovascular disease, primarily atherosclerosis, causes 1/3 of all deaths in the United 
States annually [1-3].  A number of distinct processes are associated with plaque development: 
lipid accumulation, inflammation, cell proliferation, cell death, and thrombosis.  Some of the 
molecular events underlying each of these processes and the stimuli for these events have been 
identified; however, much remains to be clarified [4].  Atherosclerosis is the result of 
accumulation of numerous components in the coronary arteries, resulting in the formation of 
plaque deposits.  It is a passive progressive disease characterized by the accumulation of lipids 
and fibrous elements in the large arteries [5].  The early lesions of atherosclerosis consist of sub 
endothelial accumulations of cholesterol-engorged macrophages, known as foam cells.  In 
humans, such fatty streak lesions can usually be found in the aorta and coronary arteries in the 
second decade and the cerebral arteries in the third or fourth decades.  Because of differences in 
blood flow dynamics, there are preferred sites of lesion formation within the arteries.  Fatty 
streaks are not clinically significant, but they are the accumulation of lipid-rich necrotic debris 
and smooth muscle cells.  Plaques that develop from these fatty streaks are complex, with 
calcification, ulceration at the luminal surface, and hemorrhage from small vessel wall.  
Although advanced lesions can grow sufficiently large to block blood flow, the most important 
clinical complication is an acute occlusion due to the formation of a thrombus or blood clot, 
resulting in myocardial infarction or stroke [6].  A comparison of the complex processes in 
normal and major cardiac events of a diseased artery is illustrated in Figure 3.1.  The major 
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pathological events in atherosclerosis are contained in two distinct areas: media-tunica and 









Normal Artery      Artery with Complicated Plaques 
Figure 3.1 Comparison between a normal vessel and a vessel in the diseases state. [6] 
 
Because the plaques are of heterogeneous cellular composition, a proteomic analysis of 
most lesions is difficult. Researchers have surgically excised various segments of normal and 
diseased arteries and cultured the cells invitro in protein-free medium.   
The secreted proteins from both cultures were extracted and analyzed for biological variations. 
Proteins from 2D gel electrophoresis were displayed as spots and were compared to cultured 
regions from both normal and diseased areas [7].  These findings showed that the more 
complicated the lesions, the higher the number of secreted proteins which suggested the 
production of specific proteins relating to the complexity of the atherosclerotic lesions.  Plaques 
may grow to obstruct the lumen and potentially causing peripheral vascular disease.  When this 
occurs, intima and media become indistinguishable and proteins may not be specific to the area 
determined to be the site of inflammation [8].  
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A proteomic assessment of the analysis of intima and media proteins has been developed 
in this study using a combination of techniques, including two-dimensional gel electrophoresis, 
image analysis, and mass spectrometry [9].  Proteomics has been used to study protein 
expression in tissues, cells, or fluids [10].  Other studies have documented the use of this 
technique for analysis of protein expression in various stages during the formation of 
atherosclerotic plaques [11-14].  
Mass spectrometry is the most commonly used method for the analysis of gel-separated 
proteins and is the fundamental technology for proteomics replacing Edman degradation for the 
identification of proteins.  The use of “soft ionization” techniques, matrix-assisted laser 
desorption / ionization (MALDI) and electrospray ionization (ESI) have been shown to be 
superior in the analysis of biomolecules.  The coupling of the time-of-flight mass analyzer to a 
MALDI source is widely used in the identification of proteins from peptide mass fingerprinting 
with database searches [15].  The approach is sensitive and user friendly for a variety of 
biological fields involving processing of peptides from digestion with trypsin [16].   The peptides 
masses from the mass spectrometer are fingerprints of protein cleavages by the protease.  The 
theoretical sequences of these masses are available from databases accessed through Web search 
engines [17-23]. 
Electrospray ionization technique employed in this study is an atmospheric pressure 
ionization that is coupled to a mass spectrometer for the characterization of biomolecules and 
associated noncovalent interactions in the gas phase [24].  The interfacing of ESI to high 
performance liquid chromatography has a broad spectrum of uses in the biological field.  ESIMS 
uses continuous flow operation, variable solvents, and a wide range of flow rates including nano 
flows for small volume analytes. 
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ESI-MS generates intact multiple charged ions of proteins and other biological 
compounds, reducing the harsh ionization found in other processes.  The method was first 
introduced by Dole and co-workers for the generation of gas phase ions from electrically charged 
liquid droplets produced by electrospraying an analyte solution at atmospheric pressure.  The 
coupling of ESI to mass spectrometry was accomplished by Fenn and co-workers [25] and later 
developed for the analysis of biological molecules by Fenn et al.[26,27], Henion[28], and Smith 
[29]. 
HPLC-MS has become the most widely useful analytical tool for numerous applications 
such as qualitative and quantitative analysis of complex mixtures of biochemical, inorganic, and 
organic compounds [24].  HPLC analysis is accomplished by placing an analyte of interest on a 
column containing an appropriate stationary phase. The analytes are differentially partitioned on 
the sorbent matrix.  Separation occurs by elution from a stream of liquid mobile phase.  The 
more commonly used technique for biological compounds w the reverse phase (RP) mode of 
HPLC.  The stationary phase consists of a nonpolar matrix and the polar phase is a polar solvent. 
RP-HPLC involves the interaction between the nonpolar hydrocarbonaceous matrix in the 
stationary phase and the hydrophobic group of the biomolecules.  A UV-Visible detector system 
is used to quantitate the separation of the analytes in the mobile phase. 
The RP-HPLC mobile phase is connected to the ESI ionization source prior to mass 
analysis.  The ESI source consists of numerous designs, but typically the liquid mobile phase 
flows continuously through a stainless steel capillary at 2 to 5 µl/min. However, lower flows 
nL/min to µl/min is used for nano flow operation.  A potential is usually 3-4 kV is usually placed 
on the tip of the capillary and the walls of the atmospheric pressure region or the counter 
electrode.  Nitrogen is normally used as the sheath gas heated to aid in the evaporation of the 
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solvent from the charged droplets containing the analytes.  The ionization of the droplets is 
comprised of 3 processes: droplet formation, droplet shrinkage, and gas ion formation with 
electrostatic forces applied causing the liquid to emerge from the capillary as a jet in the shape of 
a Taylor cone [30].  Two theories have been accounted to explain the mechanism of the 
formation of gas phase ion from the charged droplets: the charge residue model and the ion 
desorption model [31]. 
In peptide ion fragmentation in MS/MS cleavages of the bonds between the carbonyl 
oxygen and the amide nitrogen forms “y” ions and “b” ions.  The y ion fragmentation occurs 
when the positively charged of the peptide fragment is retained on the C – terminus of the 
original peptide ion.  Alternatively, the b-ion fragmentation is the retention of the charge on the 
N-terminal portion of the original peptide ion. 
3.2 Research Goals and Objectives 
Our studies are focused on the identification of proteins from the intima and media of 
tissue extracts of atherosclerotic plaques.  To optimize the separation of as many proteins in the 
tissue as possible including membrane and highly alkaline proteins, sodium dodecylsulfate was 
employed with carrier ampholytes (pH 3.5 – 10) ran with 12.5% polyacrylamide gels glass tubes.  
The purpose of this approach was to provide a template to separate and isolate as many proteins 
as possible from the tissue. In this work, the use of a hybrid linear trap / Fourier transform ion 
cyclotron resonance  (ICR) mass spectrometer was selected to perform protein sequencing using 
the bottom-up approach.  The hybrid system was used for the characterization of proteins from 
2D gels digested with trypsin.  Further separation of the peptides was achieved by fast reverse 
phase high performance liquid chromatography with nanospray capability directed into the linear 
quardrupole trap Fourier transform ion cyclotron resonance (LTQ-FTICR) mass spectrometer.  
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The benefit of the linear trap was seen in the ion accumulation and activation prior to detection 
in the ICR cell that produced an increase in the scan rate [32].  An increase in the duty cycle 
allowed for data-dependent mass analysis of coeluting peptides that increased peptide coverage 
without increasing the length of the gradient length [32]. 
3.3 Experimental 
3.3.1 Materials and Reagents 
 Urea, thiourea, SB 3-10, dithiothreitol, β-mercaptoethanol, nuclease inhibitors, 
acetonitrile, ammonium bicarbonate, dithiothreitol, trifluoroacetic acid, and iodoacetamide were 
obtained from Sigma Aldrich Corporation (St Louis, MO USA).  Sigma Marker protein 
standards were obtained from Sigma Aldrich Corporation (St Louis, MO USA).  All of the 
reagents were of the highest purity and when available specified electrophoresis grade. 
 Sodium dodecylsulfate was obtained from EM Scientific (Cherry Hill, NJ USA). 
Polyacrylamide gels (10%) and agarose were obtained from BioRad (San Diego, CA USA). 
Tris(hydroxymethyl)aminomethane (TRIS) was obtained from Invitrogen (San Diego, CA USA). 
3-[(Cholamidopropyl)dimethyl-ammonio]-1-propanesulfonate (CHAPS)  and protease inhibitors 
were obtained from Calbiochem ( San Diego, CA USA).  Ampholines (pH 3.5-10) were obtained 
from GE Healthcare (Piscataway, NJ USA).  Ziptips was obtained from Millipore (Billerica, MA 
USA).  Formic acid was obtained from Fisher Scientific (Waltham, MA USA).    
3.3.2 Methods 
 Human thoracic aortas stored at -70ºC were thawed in an ice bath.   The tissue of interest 
was dissected with a sterile scalpel then place in 50 ml centrifuged tubes.  The samples of intima 
and media were refrozen in dry ice for homogenization.  The samples were homogenized in 3 ml 
of osmotic buffer containing 10x nuclease stock and protease inhibitor. 400 µl of the above 
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sample was then diluted with 400 µL sodium dodecylsulfate (SDS) buffer that was heated to 
boiling without β- mercaptoethanol.  The sample was heated in boiling water for five minutes 
followed by protein determination using a BCA assay (Pierce Chemical).  The samples were then 
diluted with SDS buffer or IPG buffer to determine the effectiveness of either in protein 
separation on the gel.  The SDS buffer samples were then diluted to 5.0 mg/ml containing SDS 
buffer with β- mercaptoethanol.  The other sample was diluted with 5.0 mg/ml IPG buffer. The 
composition of the IPG buffer included: 7M urea, 2M thiourea, 30 mM TRIS buffer at pH 7.3, 
4% CHAPS, and 1% SB 3-10. 
 Two dimensional electrophoresis was performed using the method of O’ Farrell [33].  
Isoelectric focusing (IEF) was performed in glass tubes of inner diameter 3.0 mm using 2.0% pH 
3.5 – 10 ampholines for 20,000 volt-hours.  50 ng of IEF standard, tropomyosin, was added to 
each sample.  The protein migrates as a doublet with lower polypeptide spot of molecular weight 
of 33,000 and isoelectric point of 5.2; an arrow on the stained gel marks its position.  The 
enclosed tube gel pH gradient plot for this set of ampholines was determined with a surface pH 
electrode. 
 Following equilibration for 10 minutes in buffer containing 10% glycerol, 50 mM 
dithiothreitol, 2.3% SDS and 0.0625 M TRIS, pH 6.8, each tube gel was sealed to the top of a 
stacking gel of 10% acrylamide slab gel (1.0 mm thick).  SDS slab gel electrophoresis was 
conducted for 4 hours at 12.5 mA / gel.  The following protein standards in 0.5% agarose were 
added to the slab gel in a well  as the tube gel was sealed to the  slab gel: myosin (220,000),  
phophorylase A (94,000), catalase (60,000), actin (43,000), carbonic anhydrase (29,000) and 
lysozyme (14,000).  The standards appeared as bands on the basic edge of the Coomassie Blue 
stains.  The gels were dried between sheets of cellophane paper with acid end to the left. 
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  The gel spots were excised used a clean razor blade.  Necessary precautions were taken 
in handling the samples to prevent contamination particularly with keratins.  The protocol used 
was based on in-gel protocols.  The following solutions were prepared : 25 mM ammonium 
bicarbonate 100 mg / 50 ml, 25 mM ammonium bicarbonate in 50% acetonitrile / water, 50% 
acetronitrile / 5% formic acid and 12 ng/ µl trypsin (modified and freshly diluted)  in 25 mm 
ammonium bicarbonate.  Each excised gel spot was destained three times for 10 minutes with a 
solution containing 200 µl of 25 mM ammonium bicarbonate / 50% acetonitrile.  The gel 
solution was vortexed intermittently to enhance color removal.  The resulting solution from each 
extraction was discarded.  The procedure was repeated until the gels began to shrink and became 
white.  The gel pieces were further reduced with fresh solutions of 10 mM dithiothreotol in 25 
mM ammonium bicarbonate (1.5 mg /ml).  The DTT was added to cover the pieces followed by 
vortexing and spinning for 1 minute.  The samples were incubated in a water bath at 56ºC for 45 
minutes and allowed to cool to room temperature, then centrifuged.  The solution was discarded 
and immediately 55 mM iodoacetamide in 25 mM ammonium bicarbonate was added to cover 
the gel pieces.  This mixture was incubated at room temperature in the dark for 45 minutes 
followed by removal of the supernatant.  Gel pieces were washed with 100 µl of ammonium 
bicarbonate then vortexed for 10 minutes and centrifuged for 2 minutes followed by removal of 
the supernatant.  The gel pieces were dehydrated with 100 µl of 50% 25mM ammonium 
bicarbonate / acetonitrile.  This solution was then vortcxed and centrifuged for 2 minutes with 
the resulting supernatant discarded.  This procedure was repeated for a second time.  The gel 
pieces were placed in a speed vacuum centrifuge for 20 minutes and dried prior to digestion.  A 
solution of trypsin (12 ng / ml) in ammonium bicarbonate was added to cover the gel pieces and 
incubated on ice for 45 minutes.  If the gel pieces absorb the solution, additional liquid was used.  
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This solution was incubated overnight at 37º C.  The solution was acidified with 10 µl of 2 % 
trifluoroacetic acid in water for 2 minutes.  This supernatant was removed and placed in a clean 
microcentrifuge tube.  To the gel pieces, 30 ul of 50% acetonitrile / 5% formic acid was added 
followed by sonication for 20 to 30 minutes.  The gel pieces were centrifuged for 5 minutes and 
the supernatant combined with the previous solution.  The process was repeated and all 
supernatants combined.  The extracts were vortexed, centrifuged for 2 minutes and placed in a 
speed vacuum to reduce the volume of peptides to 10 µl. An additional cleanup step may be used 
with C18 Ziptip (Eppendorf) when analyzing low levels of peptides.  Peptides were eluted from 
the Ziptips using an elution buffer composed of 50% acetonitrile / 0.1% trifluoroacetic acid. The 
final solution was pumped through a micro high performance liquid chromatography system as 
described below. 
3.3.3 Instrumental Analysis 
 The peptides from the tryptic digest were diluted with 0.1% trifluoroacetic acid (10:1 v/v) 
and loaded on a C18 Biobasic 75µm x 10 cm reverse phase column (New Objective) equipped 
with a 15 µm picofrit tip for electrospray applications.  A 2 µl aliquot was injected into a mobile 
phase a flow rate of 200 nL/ min using a Surveyor Liquid Chromatographic System (Thermo 
Electron, San Jose, CA).  The solvent system consisted of a binary system composed of A) 
95:5:0.1  water:acetonitrile: formic acid (%) (v/v) and B) 5:95:0.1 water: acetonitrile: formic acid 
(%) (v/v).  A gradient flow was used with solvent A pumped at 90% for 5 minutes and 
decreasing to 50% in 60 minutes.  The final gradient was pumped from 50% A to 20% in 17 
minutes then finally increased to 90% gradient for 28 minutes.  
The mass spectrometry experiments were performed using a linear quadrupole trap 
(LTQ) Fourier transform ion cyclotron mass spectrometer (FT) (Thermo Electron, Bremen, 
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Germany) equipped with an open-ended cylindrical cell controlled by LTQ Tune 1.0.  Detection 
in the linear trap and the ICR cell was controlled by Xcalibur software increasing the duty cycle 
of the analysis.   Parallel data acquisition of MS and MS/MS can be acquired simultaneously. 
The acquired resolution settings for MS and MS/MS scans were 100000 for MS data and 25,000 
for product ions. 
Database searching of the full scans of the MS/MS spectral data was performed using the 
Bioworks version 3.2 suite of programs (Thermo Electron San Jose, CA USA).  The spectra 
information for the Bioworks database was downloaded from the National Center for 
Biotechnology Information (NCBI) website (http://www.ncbi.nlm.ih.gov/blast/db/fasta).  A mass 
tolerance for precursor was set at 1 Da.  The files in the Bioworks software were filtered 
according to cross-correlation scores as a function of charge states to increase the confidence 
limits.  The Xcorr values for the determination of acceptable peptide matches were 1.5 for 
precursor ions with a charge of one, 2.0 for fragments from doubly charged ions, and 2.5 for 
triply charged ions.  The full scan spectral analysis was searched for sequence coverage using   
Swiss Prot (uniprot_trembl_human.fasta).  The SEQUEST database was used for peptide peak 
assignments. SEQUEST is primarily to determine if MS/MS peptides are matches for the amino 
acid sequences for the precursor ion.  The proteins in the database are subjected to tryptic 
digestion and the program generates a master of peptides for comparison to the MS/MS scans. 
Theoretical MS/MS spectrum are generated and comparison against the selected peptides. A 
correlation score is calculated for each match between the MS/Ms scan and the theoretical 
spectra. The best peptide matches are reported from this data.  Post translational modifications of 
peptides such as phosphorylation of serine, threonine, tyrosine were considered in using the 
SEQUEST algorithm to determine the peptide masses of the ions from MS/MS analysis.
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3.4 Results and Discussions 
 The tissue of thoracic aortas for cadavers from a 57 year old female and an 80 year old 
male were dissected from the adventitia.  Samples of intima, intima /media, and media were 
isolated from each and homogenized with nuclease and protease inhibitors.  Boiling both sets of 
tissues with SDS for 5 minutes was necessary to maximize solubility of proteins including lipids 
usually formed as a consequence of atherosclerosis leading to foam cells and to plaque 
formation. 100 µl of sample containing 500 µg of protein was loaded on the SDS polyacrylamide 
gels for protein identification.  Two different buffer systems were studied to compare the 
effectiveness of buffers on the solubility of proteins.  One method used buffers compatible with 
immobiline pH gradient drystrips composed of 7M urea, 2M thiourea, 30 mM TRIS pH 7.3,  4% 
CHAPS and 1% SB 3-10. The other method used SDS Boiling buffer containing β-
mercaptoethanol.  The gels were stained with Coomassie Blue and imaged with a 1-D Kodak 
Logic Imaging System. Table 3.1 lists the samples in this study.   
Table 3.1. Summary of tissue extracts of atherosclerotic plaques from thoracic aortas 
Gel 
Identification 








LF210-01 80 year old 
intima 
IPG 100 500 Coomassie 
LF210-02 57 year old 
intima 
IPG 100 500 Coomassie 
LF210-03 57 year old 
media 
IPG 100 500 Coomassie 
LF210-04 80 year old 
media/intima 
IPG 100 500 Coomassie 
LF210-05 80 year old 
intima 
SDS 100 500 Coomassie 
LF210-06 57 year old 
intima 
SDS 100 500 Coomassie 
LF210-07 57 year old 
media 
SDS 100 500 Coomassie 
LF210-08 80 year old 
media/intima 
SDS 100 500 Coomassie 
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100 µl of tissue extracts for the various membranes from the aortas was loaded on the tube gels 
containing 500 µg of protein as determined by the Bradford assay.  The gel images of the SDS 
PAGE extracts of plaques from various areas in the aorta are illustrated in Figures 3.2-3.9. 
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Figure 3.2. LF210-01 Intimal extract from a thoracic aorta of 80 years old. Lysis buffer (IPG) 
containing 7M urea, 2M thiourea, 30mM TRIS pH 7.3, 4% CHAPS, 1% SB 3-10. IEF performed 
with 3mm (id) tubes using 2% pH 3.5-10 Ampholines for 20,000 volt-hours. Staining performed 

















Figure 3.3. LF210-02 Media extract from thoracic aorta from 57 year old. Lysis buffer 
 (IPG) containing 7M urea, 2M thiourea, 30 mM TRIS pH 7.3, 4% CHAPS, 1% SB 3-10. IEF 
performed with 3mm (id) glass tubes using 2% pH 3.5-10 ampholines for 20,000 volt-hours. 

















Figure 3.4. LF210-03 Media extract from thoracic aorta from 57 year old. Lysis buffer (IPG) 
containing 7M urea, 2M thiourea, 30mM TRIS pH 7.3, 4% CHAPS, 1% SB 3-10. IEF performed 
with 3mm (id) tubes using 2% pH 3.5-10 ampholines for 20,000 volt-hours. Staining performed 
















Figure 3.5. LF210-04 Intima/media extract from a thoracic aorta of 80 year old. Lysis buffer 
(IPG) containing 7M urea, 2M thiourea, 30mM TRIS pH 7.3, 4% CHAPS, 1% SB 3-10 IEF 
performed with 3mm (id) tubes using 2% pH 3.5-10 ampholines for 20,000 volt-hours. Staining 















Figure 3.6.  LF210-05 Intima extract from a thoracic aorta of 80 year old. Lysis buffer (IPG) 
containing sodium dodecylsulfate (1%). IEF performed with 3mm (id) glass tubes using 2% pH 





















Figure 3.7. LF210-06 Media extract of thoracic aorta 57 year old. Lysis buffer containing 
sodium dodecyl sulfate (1%) IEF performed with 3mm (id) tubes using 2% pH 3.5-10 
















Figure 3.8. LF210- 07 Intimal extract from a thoracic aorta of 80 year old. Lysis buffer 
containing sodium dodecylsulfate (1%). IEF performed with 3mm (id) tubes using 2% pH 3.5-10 
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containing sodium dodecylsulfate.  IEF performed with 3mm (id) tubes using 2% pH 3.5-10 
ampholines for 20,000 volt-hours. Staining performed with Commassie blue. 
 95
 The spot counts from the various samples vary based on the different tissue areas 
dissected.  Variability in the number of spots was observed from different tissue areas and from 
the components used in the lysis buffer.  The protocols for the IPG approach was more desirable 
since current 2D analysis is performed using the IPG drystrips that were not amenable to high 
concentrations of SDS.   A comparison of the two approaches is listed in Table 3.2.  In instances 
where sample are boiled in SDS and diluted with reduced SDS concentrations, higher protein 
spot results when compared to dilutions with IPG buffer components.  
Solubilization and separation of membranes are more complex due to their chemical 
character and compartmentalizaton where IPG strips are used for IEF [34].  SDS is a powerful 
ionic surfactant with high potential for hydrophilic and hydrophobic protein solubility.  The 
property for protein solubility arises from the propensity to bind highly to proteins with one SDS 
molecule per every two protein molecule as well as the ability to couple with a strong polar head 
group.  Its use is limited for IPG applications because it is a charge shifting reagent and is 
generally avoided.  The limited use can be tolerated provided the final concentration is diluted 
below 0.25%.   The uses of SDS in concentrations of 2% is compared to the same extraction 
method; however the final surfactant concentration is diluted with other surfactants using a 
nonionic or zwitterionic phase to solubilize the proteins prior to IEF on tube gel.  The number of 
spots was compared to assess the number of proteins that may be resolved using the number of 
spots as the criteria in Table 3.2.  By using this approach, the efficiency of using IPG strips with 
various chaotropes and other denaturants other than SDS can be monitored.  Additionally, the 
number of proteins that can be identified can be compared particularly the more hydrophobic 
membrane proteins that are very alkaline.  This use of urea and other chaotropes have been 
widely accepted to improve separation and solubility.  From the table below, SDS produces a 




Table 3.2 Comparison of lysis buffer type and protein spot count in various plaque tissue 
extracts from thoracic aortas. Spot count performed with Kodak 1D Gel Logic and manual. 
 
 
 Gel Identification Sample No. Tube Buffer Protein Spot Count 
LF210-01 80 year old intima IPG 74 
LF210-02 57 year old intima IPG 56 
LF210-03 57 year old media IPG 40 
LF210-04 80 year old 
media/intima 
IPG 28 
LF210-05 80 year old intima SDS 63 
LF210-06 57 year old intima SDS 95 
LF210-07 57 year old media SDS 64 




 Protein spots from sample LF210 - 06 were selected for further analysis by mass 
spectrometry.  This particular sample was selected due to larger number of protein spots 
generated by 2D electrophoresis.  The spot count is the best indication of the protein separation. 
These images were generated as regions of interest from molecular imaging software.   The spots 
were excised and in-gel tryptic digestion with porcine sequence grade modified trypsin was 
performed.  The peptides from the digested product were analyzed using the LTQ-FT mass 
spectrometer with capillary scale reverse phase high performance liquid chromatography.  Figure 
3.10 shows the gel image of LF210-06 with the initial spots that were analyzed.  In this initial 
experiment, the spots were selected that were isolated and did not present contamination with 
















Figure 3.10. Illustration of a 2D gel LF210-06 for extracts of human thoracic aortas plaques 
Stained with Coomassie Blue. IEF performed with 3mm (id) glass tubes using 2% pH 3.5-10 
ampholines for 20,000 volt-hours. Staining performed with Commassie blue. The spots were 









 10 pH 3.5 
 
Figure 3.11 Illustration of a 2D gel LF210-06 from extracts of human thoracic aortas plaques 
stained with Coomassie Blue. Arrows indicate excised protein spots that were isolated and did 
not present contamination with adjoining ones. These spots were identified by mass 
spectrometry. 
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One of the challenges of the analysis lies in the determination of intact proteins that are 
potential disease markers embedded within the human plasma proteome.  Proteins such as 
albumin and IgG comprise approximately 80% of the plasma proteome, leaving 20% as low 
abundant proteins that may have some significance in signal pathways that are critical in disease 
markers.  We attempted to investigate proteins with molecular weights less than 60 kilodaltons 
as templates for later differential protein expressions.  Mass analysis of 35 spots was conducted 
with the resulting peptide spectral data searched with the nonredundant database that was 
downloaded from the National Center for Biotechnology Information (NCBI) website (http:// 
www.ncbi.nlm.ih.gov/blast/db/fasta). 
 Data obtained from the analysis of spot 41 is shown in Figure 3.10.  The linear 
quadrupole trap is used to provide MS and MS/MS analysis due its advantages over conventional 
traps that includes reduced space charge effects due to increased ion storage volume and 
increasing trapping efficiencies from externally injection ions. [Ritter Proteomics 2006 6 1735-
1740].  The FTICR MS is used simultaneously and used for MS scan due to its high resolution 
(25,000 at m/z of 400) and its sensitivity (<2ppm).  The FTMS is used isolate various charged 
ions depicted from the RPHPLC chromatogram analysis; then further MS/MS fragmentation is 
performed by the LTQ.  Peptides selected from the full scan performed with the FTMS.  Charge 
states (usually +3) are determined from the Xcalibur software.  MS/MS scans were analyzed 
from the ITMS from the +2 charged that produced the best ion intensities measurements.  The 
fragmentation of the doubly charged states produced b and y ion sequences.  The use of 









Figure 3.12. Base peak full scan analysis of nano RPHPLC chromatogram of tryptic peptides for 
spot 41 from 2D gel electrophoresis from tissue lysate of LF210-06.   
 
linear trap and the ion cyclotron resonance cell for MS2 assignments for the peptides.  Various 
peptides have been selected and the sequences determined for the fragmentation of the b and y 
ions.  Figure 3.11 illustrates the peptide at a retention time of 18.86 minutes.  The expanded 
chromatogram of the tryptic digested peptides is shown in Figure 3.11A with peaks at retention 
times from 14.90 to 35.37.  The peptide at 18.86 minutes was selected and the MS spectra is    
 
 















































Figure 3.13. Nano  C-18 reverse phase high performance liquid chromatograph scan from 14.90 
to 35.37 minutes of base peak chromatogram of tryptic peptide for spot 41 resulting from 2D gel 
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Figure 3.14. A) ITMS (MS) of doubly charged ion (m/z 608.32) at 18.86 minutes B)ITMS 
(MS/MS)  fragmentation of doubly charge ion at m/z 608.32 producing singly charged b ions and 
y ions determined using  Bioworks 3.2 and SEQUEST. 
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shown of the doubly charged precursor ion at a mass 654.32  from the linear ion trap is shown in 
Figure 3.13 A.  The MS/MS fragmentation of the peptide from the ion trap produces y and b-ions 
whose sequence is shown in Figure 3.13B determined using Bioworks 3.2 with the database 
searches from Uniprot trembl fasta.  The amino acid sequence of the peptide from the 
experimental data corresponds to ATEHLSTLSEK.  
 Additional RP-HPLC and mass spectral scans of five tryptic peptides sequenced by MS 
and MS/MS analysis are illustrated in Figures 3.14 to 3.25.  The mass spectra of all scans first 
illustrate the base peak from the liquid chromatogram selected from the FTMS ICR cell.  The 
doubly charged ions are shown from the ITMS followed by MS/MS fragmentation.  MS/MS 
fragmentation occurs by collisional induced dissociation with helium gas.  Table 3.3 summarizes 
the selected peptides and the sequences determined from database search and Bioworks 3.2 and 
SEQUEST software analysis. 
Table 3.3 Summary of peptide sequences using MS and MS/MS analysis  
Nano RP HP 
LC Retention Time 
(minutes) 
Base Peak  
HPLC FTMS Scan 
Retention Time 
(minutes) 
ITMS Scan +2 
Charged Ion 
ITMS MS/MS 
Sequence of +1 Charged ions 
14.90-35.37 18.86 608.32 ATEHLSTLSEK 
14.90-35.37 28.80 524.26 LSPLGEEM#R 
14.90-35.37 31.77 714.34 KWQEEM#ELYR 
28.01-49.55 33.52 690.86 VQPYLDDFQKK 
28.01-49.55 35.79 637.00 LHELQEKLSPLGEEMR 
28.01-49.55 37.60 651.33 THLAPYSDELR 















Figure 3.15. Nano  C-18 reverse phase high performance liquid chromatograph scan from 14.90 
to 35.37 minutes of base peak chromatogram of tryptic peptide for spot 41 resulting from 2D gel 
electrophoresis. The peak at 28.80 was selected for further analysis using MS/MS 


















































                             
Figure 3.16 A) ITMS (MS) of doubly charged ion (m/z 524.26) at 28.80 minutes B)ITMS 
(MS/MS)  fragmentation of doubly charge ion at m/z 524.26 producing singly charged b ions and 
y ions determined using  Bioworks 3.2 and SEQUEST. 
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to 35.37 minutes of base peak chromatogram of tryptic peptide from spot 41 resulting from 2D 
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Figure 3.18. A) ITMS (MS) of doubly charged ion (m/z 714.34) at 31.77 minutes B)ITMS 
(MS/MS)  fragmentation of doubly charge ion at m/z 714.34 producing singly charged b and y 
ions determined using  Bioworks 3.2 and SEQUEST. 
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Figure 3.19. Nano  C-18 reverse phase high performance liquid chromatograph scan from 28.01 
to 49.55 minutes of base peak chromatogram of tryptic peptide from spot 41 resulting from 2D 
gel electrophoresis. The peak at 33.52 minutes was selected for further analysis by MS and 
MS/MS by ITMS. 
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Figure 3.20. A) ITMS (MS) of doubly charged ion (m/z 691.37) at 33.52 minutes B)ITMS 
(MS/MS)  fragmentation of doubly charge ion at m/z 691.37 producing singly charged b and y 
ions determined using  Bioworks 3.2 and SEQUEST. 
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Figure 3.21. Nano  C-18 reverse phase high performance liquid chromatograph scan from 28.01 
to 49.55 minutes of base peak chromatogram of tryptic peptide for spot 41 resulting from 2D gel 

































































Figure 3.22. A) ITMS (MS) of doubly charged ion (m/z 637.34) at 35.79 minutes B)ITMS 
(MS/MS)  fragmentation of doubly charge ion at m/z 637.34 producing singly charged b and y 
ions determined using  Bioworks 3.2 and SEQUEST. 
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Figure 3.23 Nano C-18 reverse phase high performance liquid chromatograph scan from 32.67 
to 50.98 minutes of base peak chromatogram of tryptic peptide for spot 41 resulting from 2D gel 
electrophoresis. The peak at 37.60 minutes was selected for further analysis by MS and MS/MS 
by ITMS. 
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Figure 3.24 A) ITMS (MS) of doubly charged ion (m/z 651.33) at 37.60 minutes B)ITMS 
(MS/MS)  fragmentation of doubly charge ion at m/z 651.33 producing singly charged b and y 
ions determined using  Bioworks 3.2 and SEQUEST. 
 




















































Figure 3.25 Nano  C-18 reverse phase high performance liquid chromatograph scan from 32.67 
to 50.98 minutes of base peak chromatogram of tryptic peptide for spot 41 resulting from 2D gel 



























































Figure 3.26 A) ITMS (MS) of doubly charged ion (m/z 735.05) at 44.95 minutes B)ITMS 
(MS/MS)  fragmentation of doubly charge ion at m/z 735.05 producing singly charged b and y 
ions determined using  Bioworks 3.2 and SEQUEST. 
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The protein identified at spot 41 was determined to be Apolipoprotein A-1 based on the 
database search parameters.  The protein identification criterion from the database has a 
probability score of 3.16E-11 and a score of 402.29.  The scoring function is produced form the 
peptide filtering software from SEQUEST.  It is a measure of the fit of theoretical spectra that is 
created for the sequences b and y ions along with water and amine lossied compared to the actual 
MS/MS spectra that are acquired by the instrument.  The spectra resemble a bar code that 
measures the mass and intensity.  The P score or probability score is based on the statisitical 
expectation of misidentification.  This value is the correlation of the fragment ion m/z values 
between the observed spectra and the theoretical spectra. Therefore, a peptide that has a low P 
value (<0.00001) is statistically a much better match than a higher P value (>.01).  The protein is 
a major constituent of human plasma with a molecular weight of 28,300.   It is a major 
constituent of high density lipoprotein and activates lecithin cholesterol acyltransferase. 
Apoliprotein B to A-1 ratio represents the balance of protherogenic and antitherogenic variable 
for coronary risk [35]. 
The ratio of low to high density lipoprotein cholesterol also represents similar coronary 
risk.  However, evidence supports the idea that the ration of apolipoprotein (Apo B/Apo A-1) is a 
better index of risk of the disease [36].  Clearly from this evidence the presence of 
Apolipoprotein A-1 alone can be utilized as a marker of proteins that promote atherosclerosis. 
  Additional full scan spectra of two proteins identified for enzymatic digestion of spot 65 
and 67 for the 2D gels are illustrated in Figures 3.26 and Figures 3.27.  Amino acid sequence for 
Fibrinogen for singly charged b and y ion fragmentation is given as LTIGEGQQHHLGGAK. 
Similarly the protein characterized for spot 67 has been identified as Apolipoprotein A4 with a 
sequence of the one the digested peptides determined by MS/MS to be TQVNTQABQLR.    
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Figure 3.27 Full scan and LCMS/MS scan of peptide fragmentation of b and y singly charged 
ions for sequence LTIGEGQQHHLGGAK for Fibrinogen (Spot 65)  
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Figure 3.28 LC MS/MS full scan of spot 67 b and y ion fragmentation for peptide sequence  
TQVNTQABQLR for Apolipoprotein A4 
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 A summary of proteins that were identified using LC/MS/MS fragmentation of the 
peptides for tryptic digest of the proteins is listed in Table 3.4.  The sequences of the peptides 
were searched using the Bioworks 3.1 and the database the National Center for Biotechnology 
Information website. SEQUEST was used to calculate theoretical masses involved in the actual 
search was used to correlate b and y ion peaks with sequences in the database search. Parameters 
for the database search included proteolysis were using trypsin with one internal cleavage residue 
possible.  A mass tolerance of 1 dalton was used in the DTA files against the predicted fragments.  
Peptide filter values were set at 10E-3.  The X correlation values  or scores that were used to 
increase confidence limits and determine acceptable peptide matches were 1.5 for digested 
peptides with a charge of one, 2.0 for +2 charge states and 2.5 for +3 charge states.  These cross 
correlations measure the best fit parameters of the theoretical amino acids that are created from 
the b and y ions.  The molecular weight and isoelectric points were calculated values from the 
accession numbers.  Peptide coverages are in percentages derived from the database as well as the 
peptide hits are derived from the same search. 
 The P-score or probability is the statistical expectation of a misidentification.  The 
magnitude of the probability empirically compares results from control mixtures of known 
proteins with similar search parameter to those used for the test.  A low P value is a much better 
fit than a higher P value.  
 The protein spots were selected initially from the 2D images that were isolated and to 
reduce cross contamination from another spot in close proximity.  The major problem in manual 
excision is the presence of plasma proteins that mask proteins of a proatherogenic nature.  This is 
one major draw back in identifying proteins in a large pool from tissues interaction with plasma. 
Techniques to remove plasma proteins also reduce some proteins of interest.    
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Q6Q785 3.16E-11 420.29 30777.83 5.56 82.40 218 
42 Pre albumin  1.01E-13 90.35 15891.0  60.50 9 
43 Alpha glob 
gene 
P78461 2.55e-30 110.30 15229.9 8.16 38.00 11 
44 Desmoplakin  1.06E-08 50.21 331,552.7  1.70 5 
45 Alpha glop 
gene 
P78461 1.00E-30 50.39 9054.8 8.16 49.40 5 
46 Keratin 2a Q4VAQ2 1.52E-13 268.30 65432.9 8.07 49.40 10 
47 IGKC protein Q502W4 1.00E-30 70.35 25936.23 8.69 36.40 104 
48 Human hyp 
protein 
Q3KPF2 6.45E-15 570.40 55928.15 8.54 71.10 224 
49 Serum albumin Q56G89 2.16E-10 242.29 69084.36 5.85 36.60 66 
50 Hypo protein Q3KPF2 1.11E-15 130.32 55928.15 8.54 31.00 15 
51 Hepatitis B 
Virus 
Q6PYX1 1.42E-13 88.26 38162.17 8.27 31.00 31 
52 Hypo Prot 
DKFZ 
Q6N093 7.82E-13 186.21 46060.96 7.63 35.00 57 
53 Keratin 2a Q4VAQ2 4.34E-16 272.31 65432.90 8.07 57.00 38 
54 Keratin 10 Q14664 2.89E-14 106.28 59518.66 8.16 21.20 13 
55 Keratin 2a Q4VAQ2 7.30E-15 442.32 65432.90 8.07 71.80 55 
56 HBV receptor Q6PYX1 5.64E-13 70.26 1873.9  31.30 29 
57 Alpha Glob 
gene 
P78461 1.00E-30 80.37 9078.5 8.16 90.59 8 
58 Beta globin 
gene 
Q14473 3.11E-14 80.33 18930.80  60.57 8 
59 Serum Alb Q56G89 8.29E-11 130.25 69084.36 5.85 31.77 18 
60 Serum Alb Q56G89 7.61E-13 130.24 69084.36 5.85 20.20 13 
61 C4A Var 
Protein 
Q4LE82 1.00E-30 142.30 193446.30 6.61 9.59 15 
 63 IGKC Protein Q502W4 1.00E-30 40.29 25936.23 8.69 21.00 4 
64 Serum Alb Q56G89 7.42E-09 230.26 69084.36 5.85 33.00 23 
65 Fibrinogen Q53Y18 8.82E-12 170.37 49496.54 5.70 41.00 17 
66 Vimentin 
Variant 
Q53H08 3.09E-12 250.31 77161.89 6.21 46.78 25 
67 Apo A4 Protein Q13784 2.79E-13 190.29 28157.52  68.00 19 
68 Hyp Prot Q3KPF2 1.44E-10 220.30 46090.96 8.54 25.80 22 
69 Vitamin D 
Variant 
Q53F31 7.77E-09 4.60 52950.61 5.34 4.60 1 
70 Keratin 10 Q8N175 2.88E-08 10.22 59518.66 8.16 3.10 1 
71 OTTHUMP Q5VSY5 1.28E-10 70.27 93313.95  15.55 7 
72 Transferrin var Q53H26 4.44E-15 108.37 77079.85 6.68 14.90 11 
74 Alpha Glob P78461 8.93E-09 20.20 9078.50 8.16 35.30 2 
 
 
 Several proteins identified from the database may be implicated in the atherosclerotic 
process.  Apolipoprotein A1, spot number 41, is a lipid containing complex found in plasma and 
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the cell that allows movement of apolar liquids through aqueous environments [37].  Its primary 
role is a passive carrier of lipids from one tissue to another. It is a major component of high 
density lipoprotein and activates lecithin cholesterol acyltransferase.  It inversely affects 
atherosclerosis and vascular disease by removing cholesterol from tissues to the liver, 
antiflammatory, produces antioxidative activities and modulates vascular function [37]. 
 Desmophlakin (spot 44) is produced in epithelial keratinocytes.  Mutations in gene 
encoding desmosomal proteins have been identified as the mauor dysplasia / cardiomyopathy in 
which the right ventricular is replaced by fibro fatty tissue resulting in lethal arrhythmias [38]. 
 Fibrinogen, spot 53 is a key factor in the coagulation cascade that exhibits 
proinflammatory properties, and plays a pivotal role in atherogenesis [39].  Fibrinogen triggers 
the formation of progressive atherosclerotic plaques.  Mauriallo et al. determined that the plaque 
composition in patients with elevated fibrinogen was characterized by the presence of thick 
fibrous atheroma resulting in an increase in plaque rupture and thrombosis.  A high number of 
inflammatory cells were localized in the shoulder and cap of the plaques [40]. 
 Shah and colleagues have reported vimentin, spot 66, as a major component of 
cytoskeletal constituents of cells of mesenchymal origin that, based on in vitro studies, interacts 
with F-actin and polyphosphoinositide lipids.  Functionally, relative to coronary heart disease, it 
was implicated in steroid synthesis via its role as a storage network for steroidogenic cholesterol 
containing lipid droplets [41]. 
 C4a variant protein, spot 61, was studied by Fritzinger et al. [42].  This variant was a 
fragment of a large glycoprotein that has an important function in immune responses and host 
defense.  The 4a component is referred to as anaphylatoxin which causes smooth muscle 
contraction, histamine release from mast cells, and enhancement of vascular permeability. 
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Additionally, these proteins mediate chemotoxins, inflammation, and generate cytotoxic oxygen 
radicals [43]. 
 Apolipoprotein A4, spot 67, inhibits lipid peroxidation demonstrating antiatherogenic 
properties [44].  Vitamin D variant, spot 69, influences lipolysis and insulin secretion.  The 
protein can be altered genetically to produce a polymorphism of the vitamin D receptor which has 
been associated with bone density mineral as well as with insulin dependent diabetes mellitus. 
There is evidence that the vitamin D receptor is also associated with calcific aortic valve stenosis 
[45]. 
  Transferrin variant, spot 72, is normally a plasma protein that combines with iron. It is the 
vehicle the bound iron is carried around the body; however, free ferric ions are toxic.  The 
presence of transition metals such as iron and copper catalyze hemolytic cleavage of LOOH to 
lipid peroxidation and other oxidation reactions [46]. 
 Two proteins were identified in multiple spots 43, 45, 46, 57 and 74 matched the alpha 
globular gene or alpha thalassemia [47].  It is unclear of the multiple locations of the sample spots 
with different masses as well as pI.  The protein is reported as deleted genes removed from 
thalassemia in which 30 different point mutations and small deletions are possible. Serum 
albumin, spots 42, 49, 59, 60, 64, 73, is a major component of plasma.  Since the protein 
composes 80% of most proteomic analysis of tissues, it is a common problem in comparative 
proteomics of diseased and non diseased tissue extracts.  A large number of proteins are normally 
represented by multiple spots that may be the result of post translational modifications such as 
phosphorylations, gylcosylations, etc.  The exact biological significance for observed 
heterogenicities is uncertain. 
Human hypothetical protein has been identified in spots 48, 50, and 52.  To extent to that 
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these proteins occurs frequently in the database searches may be due to isoforms or various 
modifications that may exist in the protein. 
3.5 Conclusions 
The use of 2D gel electrophoresis combined with mass spectrometry using a linear 
quadrupole trap Fourier transform ion cyclotron trap mass spectrometer for analysis of 34 of 95 
proteins spots from diseased areas of human thoracic aortas revealed nine proteins with 
proatherogenic properties. Nine proteins have been identified with some proatherogenic 
propensities.  However, a more precise identification method using peptide sequencing is affected 
due to keratins contamination.  The global method used to identify differences between normal 
and diseased tissues is time and labor intensive.  This approach does not fully provide a 
comprehensive of analysis of the disease.  To minimize the number of proteins for analysis, a 
method of differential imaging analysis of gels will be used to identify only those proteins that 
exhibit differences from normal tissue. 
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ISOLATION AND COMPARISONS OF PROTEINS IN ATHEROSCLEROTIC 




Atherosclerosis is a progressive disease that affects large and small blood vessels. The 
progressive process originates from the interaction between endothelial cells, the walls of the 
arteries, lipoproteins, and inflammatory cells that lead to the development of complex lesions or 
plaques that causes collapse of the arterial walls that leads to strokes or myocardial infarction and 
eventually death [1].  Lesions characterize the earliest form of the disease consist of sub 
endothelial accumulation of cholesterol filled macrophages referred to as foam cells.  In human, 
the fatty streaks are found in the aorta in the first decade of life and in the coronary in the third to 
fourth decade [2].  The disease is very complex and has been shown to progress in seven stages 
based on studies by the American Heart Association [3].  These stages create a complex 
heterogeneous cellular composition of proteins that are up-regulated or down-regulated, 
depending on the stage on the disease.  In Chapter 3, I identified proteins from whole lesions and 
tissue membranes from various parts of the aorta.  Although my initial studies were successful in 
some respects, comparisons of diseased and non diseased areas needs to be further addressed. 
  In related prior studies human vessels for proteomic analysis of proteins secreted by 
human carotid atherosclerotic plaques were obtained by endarterfectomy [1].  Segments of normal 
arteries and different regions of the surgical pieces of arteries containing noncomplicated and 
complicated plaque with thrombus were cultured in protein-free medium and the secreted proteins 
in the supernatant were analyzed by two-dimensional gel electrophoresis and matrix assisted laser 
ionization mass spectrometry (MALDI-MS).  Human saphenous vein medial smooth muscle 
proteins have been analyzed using actual tissue harvested from vein bypass grafts by McGregor et 
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al. [4].  Differential protein expression was assessed in atherosclerotic plaque progression by 2D 
gel electrophoresis (2DE) and validated by individual patients using western blotting and 
immunohistochemistry by Donners et al. [5].  Mass spectrometry analysis identified venexin –β 
and α1- antitrypsin that was differentially expressed in plaques containing a thrombus [5].  
Ghazalpour et al. have presented the integration of genetics, transcriptomics and proteomics 
combined with mathematical models to lead to an understanding of atherosclerosis and the 
networks associated with the disease [6].  Yan-Ling et al used 2DE to study the overall protein 
expression changes that were induced by oxidized low-density lipoprotein in U937 foam cells [7]. 
The study  of the change in the profiles induced by oxidized low-density lipoprotein in U937 were 
used to support fundamental studies on the macrophage-derived foam cells in atherosclerotic 
pathologic states [7].   In the vast majority of the investigations of diseased and nondiseased states 
of vessels, comparisons of the changes in protein expression were observed through gel to gel 
changes. Although 2DE, mass spectrometry and bioinformatics are well established methods for 
proteome analysis, some disadvantages may limit the use of the classical approach to the 
assessment of biological variations of tissues or cells.  The traditional approach involves the 
separation of samples on different gels and in the crudest fashion the researcher must visually 
pick the spots from the gel that is differentially expressed. This approach exposes the data to a 
high level of system variation [8].  Such variation may consist of protein uptake in the first 
dimension strip and second dimension gel protocols.  The variation in the system can also be 
observed in positional variation and volume.  One example of variability is produced when the 
same amount of protein is analyzed on different gels.  The same protein can migrate to slightly 
different positions with different spot intensities causing problems in accuracy of spot volume 
quantitation and normalization across multiple gels for comparison and spot matching [8].  The 
classical approach can mask subtle induced biological changes that the experiment was designed 
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to detect.  To overcome this problem, often numerous replications are necessary which is time 
consuming, expensive, and slow.  
One of the methods to reliably compare differences between the tissues samples in by the 
use of fluorescent dyes to label the proteins of interest.  Numerous studies have used this 
technique for changes in protein expression or the identification of biomarkers.  Yan et al. [9] 
studied the protein expression induced by treating Escherichia coli with benzoic acid.  Skynner et 
al. [10] identified the protein expression changes by different genetic alterations in mice.   Protein 
biomarkers were determined using DIGE in oesophageal cancer [10].  Gharbi et al. [11] have 
characterized differential protein expression in the growth factor ErbB-2 in epithelial cells. 
 Alban et al. have described a novel experimental method for comparative 2DE that 
incorporates a pooled internal standard [12].  Two-dimensional difference gel electrophoresis is 
an emerging technique for comparative proteomics.  The use of this technique was applied to 
Escherichia coli lysates with varying amounts of four different proteins [12].  Samples are labeled 
with spectrally resolvable dyes that are separated in the same gels which improves the 
reproducibility and reliability for differential protein expression analysis between samples.  The 
difference gel electrophoresis method involves the labeling of sample prior to electrophoresis 
with spectrally resolvable fluorescent dyes, Cydye 2, Cydye 3, and Cydye 5 (Figures 4.1 and 4.2).  
The labeling dyes are structurally similar and undergo nucleophilic substitution with the ε- amino 
dye group of lysine thus forming an amide.  The reaction is detailed in Figure 4.3 where the 
protein is labeled with the fluorophore for detection by a fluorescent imaging system.  The use of 
the DIGE technique can be used to obtain statistical confidence in the observed changes that are 
essential for biological studies to be scientifically relevant. 
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Figure 4.3 Reaction of fluorescent dye with the ε-amino acid group of lysine for differential gel 
electrophoresis analysis. Gel images detect attached proteins at the wavelength of the Cydye. 
 
 An illustration of the emission spectra of the various dyes including those used in 
this study of fluorescent imaging studies is shown in Figure 4.  The dyes used for the proteins in 
the plaque extracts have similar molecular weights and remained positively charged, matching the 
charge that is replaced on the protein lysine residue [12].  This mass and charge are important so 
that the proteins of interest comigrate to the same point during electrophoresis [13].  More 
importantly, the added mass from the reaction  
 
Figure 4.4 Fluorescence excitation and emission spectra of Cydye fluorescent dyes. The Cydye is 
detected in the gel by the Typhoon 9400 imager at the wavelengths indicated.   
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does not interfere with the identification during the analysis using peptide mass fingerprinting or 
tandem mass spectrometry interpretation.  The fluorescent tag Cydye 3 produces an excitation at a 
wavelength 532 nm and an emission at 580 nm with a 30 band pass filter.  Cydye 5 fluorophore 
has an excitation wavelength at 633 nm and an emission wavelength at 670 nm. 
4.2 Research Goals and Objectives  
The primary aim of this study was to develop a technique that distinguishes the protein 
expression differences between diseased and nondiseased tissues from human thoracic aortas 
incorporating fluorescent dyes as diagnostic tools to reduce gel changes not associated with 
changes in the biological variation.  In addition our study investigates the differences in protein 
expression in native and bypass arteries using differential gel electrophoresis with 2DE and mass 
spectrometry analysis of the proteins. 
4.3 Experimental 
4.3.1 Methods and Materials 
 Tissue of thoracic aortas were obtained from Louisiana State University Health Science 
Center in New Orleans, Louisiana.  Native and bypass arteries were also obtained from the same 
source.  The samples were received and immediately frozen at -70ºC until the extraction 
procedure. 
Urea, glycerol, glycine, thiourea, ASB -14, iodoacetamide, and Sigma Markers (for 
molecular standards) and guanidium hydrochloride were purchased from Sigma Aldrich Corp (St 
Louis, MO USA).  All of the reagents were of the highest purity and when available specified 
electrophoresis grade. Sodium dodecyl sulfate (SDS) was obtained from BioRad (San Diego, CA 
USA) for electrophoresis.  Tris (hydroxymethyl) aminomethane (TRIS) was obtained form 
Invitrogen (Carlsbad, CA USA). 3-[(3-Cholamidopropyl)dimethyl-ammonio]-1-propanesulfonate 
(CHAPS was purchased from Calbiochem (San Diego, CA USA).  Dithiothreitol was obtained 
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from Fluka Biochemika (St Louis, MO.USA).  Trichloroacetic acid was purchased from Fisher 
Scientific (Waltham, MA USA). 
The immobiline pH gradient dry strips, immobiline pH gradient buffer pH 3-10 NL and 
mineral oil were obtained from GE Healthcare Inc. (Piscataway, New Jersey USA).  The dry 
streak used was purchased from GE Healthcare, Inc. (Piscataway, New Jersey USA).  The 
colloidal coomassie blue stain was obtained from Invitrogen (Carlsbad, CA USA).  Methanol 
(HPLC grade) was obtained from EMD Chemical (Gibbstown, NJ USA).  
4.3.2 Methods 
Thoracic aortas and arteries from human hearts were obtained from Louisiana State  
University Health Science Center in New Orleans, Louisiana.  The samples were frozen 
immediately with dry ice and then stored at -70º C until dissection.  During the extraction 
procedure, the tissue was allowed to thaw to room temperature.  Intima membrane from normal 
and diseased tissue was carefully removed from the media and adventitia.  Approximately 250 to 
350 milligrams of tissue was isolated and then placed in liquid nitrogen and ground with a mortar 
and pestle into a powder.  The powder was place in lysis buffer composed of 7M urea, 2M 
thiourea, 4% CHAPS, 2% ASB -14 and 10 µl of protease inhibitor cocktail per ml of buffer.  This 
was followed by the addition of 2.5 mg phenylmethylsulfonyl fluoride per ml for protease 
inhibition.  The temperature of the lysis buffer was maintained at 4ºC and caution was taken to 
prevent the urea containing solution not to exceed 30ºC.  Tissue extract was homogenized with a 
Tarazen Homogeniser for 1 minute followed by sonication at 4ºC for 4 minutes.  The mixture was 
centrifuged at 12,000 x g for 20 minutes at 20ºC in an Eppendorf 540 Microcentrifuge.  The 
supernatant was maintained at < 20ºC until the precipitation steps or for longer periods of storage 
at -70ºC.  
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4.3.3 Protein Quantification 
 
Protein concentrations were determined by Bradford protein assay using a 6 point BSA 
standard concentration curve.  For CyDye labeling, samples were aliquotted into 50µg fractions. 
4.3.4 Cy-dye Labeling 
The mixed internal standard methodology of Alban et al. [12] was used in these studies.  
Equal protein loading of Cydyes, treated, and the standard-sample mixture was based on the 
above Bradford protein assay results resolving between pH 3-10 per gel.  Aliquots of 50 µg 
protein from each of the Cydyes and treated extracts from all samples were individually 
precipitated at room temperature with 10% TCA.  The precipitates were solubilized in lysis buffer 
(7 M urea, 2 M ThioUrea, 4% CHAPS, 30 mM Tris, pH8.5) prior to labeling with 400 pmol of 
either Cy3 or Cy5 (vehicle and treated randomized).  In a similar fashion, 50 µg of each of the 
samples (vehicle and treated) was pooled, precipitated and resuspended in lysis buffer, and 
labeled with 400 pmol Cy2 per 50µg standard.  Labeling was performed for 30 min on ice in the 
dark, after which the reactions were quenched with the addition of 10 mM lysine for 10 min on 
ice in the dark.  The quenched 50 µg Cy3 and Cy5 labeled samples for each subject were then 
combined and mixed with 50 µg of the quenched Cy2-labeled standard sample, after which an 
equal volume of rehydration buffer (7 M Urea, 2 M Thiourea, 4% CHAPS, 4 mg/ml DTT) 
supplemented with 2% BioLyte 3/10 Ampholytes (Bio-Rad) was added.  The stoichiometry of 
Cydye labeling is specifically intended to achieve a minimal labeling (~1% of all proteins) and 
results in sensitivities on the order of SYPRO Ruby (~1 ng in our hands). 
4.3.5 2-D gel electrophoresis and imaging 
CyDye labeled samples for each subject (410 µL final volume) were actively rehydrated 
into 24 cm 3-10NL immobilized pH gradient (IPG) strips (Amersham) for 15 hours, followed by 
isoelectric focusing using a Protean IEF (Bio-Rad) for a total of 80,000 Vhrs (linear 20 min at 
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250V; linear 3.5 hours at 10,000V; rapid 70,000Vhrs at 10,000V; rapid 75 hours at 250V (a final 
hold step).  The cysteines were reduced and carbamidomethylated while the proteins were 
equilibrated into the second-dimensional loading buffer by incubating the focused strips in 
equilibration buffer (6M Urea, 20% glycerol, 2% SDS, 375mM Tris, pH8.8) supplemented with 
20 mg/ml DTT for 15 min at room temperature with shaking, followed by 25 mg/ml 
iodoacetamide in equilibration buffer for an additional 15 minutes incubation at room 
temperature. IPG strips were then cemented onto 2nd dimension gels using an overlay consisting 
of 0.5% agarose in SDS running buffer (25mM Tris, 192mM glycine, 0.1% SDS, trace of 
Bromophenol Blue).  12% homogeneous polyacrylamide gels were cast with low-fluorescence 
glass plates using an Ettan-DALT caster.  One glass plate from each gel was bind-silanized 
(Amersham Biosciences).  This allows the gel to adhere to one glass plate preventing shrinkage, 
swelling and/or tearing of gels during manipulations and scanning.  The second-dimensional 
SDS-PAGE was then performed on all gels simultaneously using a DALT6 (Amersham) at 5 
W/gel for 30 min followed by 17 W/gel for 4 hours.  The Cy2 (standard), Cy3 and Cy5 (vehicle 
or treated) for each gel were individually imaged using mutually exclusive excitation/emission 
wavelengths of 488nm (ex) and 520nm (em) BP40 (bandpass) for Cy2, 532nm (ex) and 580nm 
(em) BP 30 for Cy3, and 633nm (ex) and 670nm (em) BP30 for Cy5 using a Typhoon 9400 
(Amersham).  After imaging for Cy-dye components, the non-silanized glass plate was removed, 
and the gels were fixed in 10% methanol, 7% acetic acid for 1 hour, rinsed in water three times 
and then incubated in SYPRO Ruby in the dark overnight.  The SYPRO Ruby post-stain allows 
for the correction of unlabeled protein’s migration in relation to the 1% CyDye labeled migration, 
and ensures accurate protein excision.  Sypro Ruby images were acquired on the same imager 
using 450nm (ex) and 610nm BP40 filter, as well as re-imaged post-excision to ensure accurate 
protein excision.  
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4.3.6 DIGE analysis 
DeCyder software (Amersham) was used for simultaneous comparison of abundance 
changes across all samples, and for comparisons of individual Cy3 and Cy5 samples for each 
sample.  The DeCyder differential in-gel analysis (DIA) module was used for pair-wise 
comparisons of each vehicle and treated sample to the Cy2 labeled standard present on each gel. 
For each pair-wise DIA comparison, the entire signals from each CyDye channel are normalized 
prior to the co-detection of protein spot boundaries and the calculation of the volume ratio for 
each protein spot.  The DeCyder biological variation analysis (BVA) module was then used to 
simultaneously match all protein spot maps from all gels, and using the Cy3/Cy5:Cy2 DIA ratios, 
calculate abundance changes and paired Student’s t-test p-values for the variance of these ratios 
for each protein pair across the samples were calculated.  In addition, fold abundance changes 
were reported, whereby a fold increase is calculated directly from the volume ratio and a fold 
decrease by the inverse of volume ratio.  The DIA module was also used to calculate the direct 
Cy5:Cy3 volume ratio for each paired sample individually (without the Cy2 mixed standard) to 
assess the contribution from each subject and reveal changes that were present in a group.  The 
Cy3/Cy5 gel images were manually normalized and stacked.  Because the images for each sample 
were separated on the same 2-D gel, alternating between the vehicle and treated images for all of 
the subjects simultaneously allowed for simple monitoring of protein changes that were specific 
to the samples studied, as well as targeting of proteins that were increasing in some tissues, but 
decreasing in others. 
4.3.7 In-gel digestion 
Proteins of interest were excised using the Ettan Spot Handling Workstation (Amersham) 
based on a hit list generated in DeCyder.  Spots were automatically destained by successive 
changes of 20 mM ammonium bicarbonate and 50% acetonitrile, followed by dehydration with 20 
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minute incubation with 75% acetonitrile.  Dehydrated gel plugs were digested in-gel with 10 µL 
20 µg/ml porcine modified trypsin protease (Promega) in 20 mM ammonium bicarbonate for 6 
hours at 37°C.   Tryptic peptides were then extracted from the gel plugs in two cycles of 50% 
acetonitrile, 0.1% trifluoroacetic acid and dried by evaporation.  Peptides were reconstituted in 3 
µL 50% acetonitrile and 0.1% trifluoroacetic acid and 0.6 µL was mixed with an equal volume of 
10 mg/ml α-cyano-4-hydroxy-cinnamic acid for spotting onto a MALDI plate. 
4.3.8 Mass spectrometry and database interrogation 
Matrix assisted laser desorption/ ionization time-of-flight mass spectrometry and tandem 
TOF/TOF mass spectrometry was performed on a Voyager 4700 (Applied Biosystems).  Peptide 
mass maps were acquired in reflectron mode (20 kV accelerating voltage) with 155 ns delayed 
extraction, averaging 1000 laser shots per spectrum.  Individual ions from each spectrum were 
inspected for resolution and isotopic distribution to identify potentially different peptides of 
similar mass (with overlapping isotopic distributions) and eliminate low-resolution ions that may 
result from metastable decomposition.  Ions specific for each sample (discrete from background 
and trypsin-derived ions) were then used to interrogate human sequences entered in the SWISS-
PROT and NCBInr databases using MASCOT [13]. 
Protein identifications from MALDI-TOF peptide mass maps were based on the masses of the 
tryptic peptides.  Tandem mass spectrometry (MS-MS) was used to generate limited amino acid 
sequence information on selected ions if additional confirmation was required.  Searches were 
performed without constraining protein molecular weight or isoelectric point, and allowed for 
carbamidomethylation of cysteine, partial oxidation of methionine residues, and one missed 
trypsin cleavage.  Highest confidence identifications have statistically significant search score(s), 
are consistent with the gel region from which the protein was excised (MW and pI), and 
accounted for the majority of the ions present in the mass spectrum. 
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4.4 Results and Discussion 
4.4.1 Differential In Gel Electrophoresis with Fluorescent Dyes 
Two dimensional gel electrophoresis is a widely used technique for the separation of  
proteins based on their isoelectric point and molecular weights [14].  Thousands of proteins can 
be separated on one gel depending on various parameters such as the source of the sample, 
solubility, conformation, size and charge.  For biological samples, the disease state of the sample 
to be analyzed becomes the focus of studies investigating whether the proteins are positively or 
negatively expressed.  Because of this, spot pattern recognition based on location within the gel 
such as molecular weight, pI, or intensity is very important in the identification of the proteins. 
Patterns of spots can be used to monitor and compare whether the tissue or cells are normal or 
diseased.  Protein quantitation from these studies can be determined from spot intensities.  The 
use of 2DE to accurately determine the identification of the proteins is complimented by mass 
spectrometry analysis. 
 The traditional approach uses one sample per gel.  This approach exposes the data to a 
high level of system variation due to initial sampling techniques, protein uptake onto the IPG 
drystrips, second dimension running conditions, and staining protocols [8].  The proteins that are 
imaged migrate to certain positions on the gel with volume variations.  The accuracy of spot 
volume quantitation and normalization for a multiple of gels can be problematic for gel to gel and 
different samples that must be compared [15][16]. 
The uses of bypasses with veinous grafts have been studied; however the bypass artery 
tends to be sites of enhancement calcification or proliferation of atherosclerosis faster than the 
normal process.  One of the methods to compare proteins that may contain biomarkers for 
atherosclerosis is the use of difference imaging gel electrophoresis.  From this approach, 
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biological variations in the tissue may provide valuable information and better understanding of 
the process of calcification and the formation of protein formed in the plaques.  
Proteins from human thoracic aortas extracts of intima and media membrane lining the 
walls of the vessels were separated by isoelectric focusing with an Ettan IPGhor unit with 
immobline drystrips at a 3-10 nonlinear pH range.  Extracts from diseased and non diseased 
aortas were performed.  In addition, protein extracts from intima of native and bypass coronary 
arteries were examined.  The use of bypasses with veinous grafts has been studied; however the 
bypass artery tends to be sites of enhancement calcification or proliferation of atherosclerosis 
faster than the normal process.  
 Two sets of native and bypass arteries from different hearts and one set of thoracic aortas 
were used in the labeling experiments.  The tissues were extracted in lysis buffer containing 7M 
urea, 4% CHAPS, 2M thiourea, 2% ASB-14 and protease inhibitors.  Cydye 2, Cydye 3, and 
Cydye 5 fluorescent were mixed into each individual sample and reacted.  The sulfhydryl esters 
of the dyes at pH 8.0 react with the ε-lysine of each protein forming an amide with charge 
retention.  The mass of the protein changes slightly due to the added group but since the amount 
of dye is comparatively small (400 pgrams of Cydye to 50 µg of protein) spot migration and 
molecule weight modifications are minimized.  Each plaque sample from the same heart is pooled 
and isoelectric focusing was performed.  Gels from the pooled samples (S1) contain labeled 
proteins from the native and bypass from an 80 year subject.  Sample S2 gel image contains 
fluorescent labeled proteins from a 72 year old heart of a native and bypass artery.  The last 
sample S3 contains diseased and nondiseased tissue extracts from the thoracic aortas from the 
same heart of a 60 year old with the fluorophores.  Images from the Typhoon 9400 laser imager 
are depicted in Figures 4.4-4.8.  
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Figure 4.5. Gel image Cydye 3 of normal tissue of 60 year old thoracic aorta extract on sodium 
dodecyl sulfate polyacrylamide gel 12 % polyacrylamide concentration with isoelectric focusing 
on 3-10 pHdrystrip. Blue and red circles denote up-regulation and down-regulation in protein 
expression, respectively. Protein concentration is increased areas with blue circles. 
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Figure 4.6. Gel image (Cydye 5) of a diseased tissue of 60 year old thoracic aorta extract on 
sodium dodecyl sulfate polyacrylamide gel 12% polyacrylamide concectration with isoelectric 
focusing on 3-10 nonlinear IPG drystrip.  Blue and red circles denote up-regulation and down-
regulation in protein expression, respectively.  Protein concentration is increased areas with blue 
circles. 
 
 The images shown are the results of Cydye 3 and Cydye 5 labeling of proteins.  The 
fluorescent tag Cydye 3 produces an excitation at a wavelength 532 nm and a emission at 580 nm 
with a 30 Bp.  Cydye 5 fluorophore has an excitation wavelength at 633 nm and an emission 
wavelength at 670 nm.  This process isolated a total 35 spots in the normal tissue and 37 spots in 
the diseased comparison that are identified as different expressed as up regulated or down 
regulated.  Protein expressions that are increased are depicted in blue and decreased in expression 
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in red when the gels are read from Figure 4.5 to Figure4.6.  The total number of spots exceeded 
1100. 
 The second samples that were labeled consist of native and bypass coronary arteries from 
the same heart ran under similar conditions and imaged with a Typhoon 9400 (Amersham 
Bioscience) with the composite image comparison.  Images of the native and bypass samples are 
shown in Figure 4.7 and Figure 4.8, respectively. 




Figure 4.7 Gel image (Cydye 3) of native coronary artery extract of 70 year old on sodium 
dodecyl sulfate polyacrylamide gels at a 12% polyacrylamide concentration with isoelectric 
focusing on a 3-10 pH nonlinear drystrip.  Blue and red circles denote up-regulation and down-
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Figure 4.8 Gel image (Cydye 5) of bypass coronary artery extract of 70 year old with sodium 
dodecyl sulfate polyacrylamide gels at a 12% polyacrylamide concentration with isoelectric 
focusing on a 3-10 pH nonlinear drystrip.  Blue and red circles denote up-regulation and down-
regulation in protein expression, respectively. Protein concentration is increased areas with blue 
circles. 
 
 A comparison of the proteins labeled with the fluorescent tags of the native and bypass  
artery extracts produced 25 spots from the cydye label tissues that decreased (red) in expression 
and 15 spots that increased in expression (blue). The analysis of each spot can be visualized from 
the normal tissue to the diseased tissue in each case.   
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A third tissue extract of a coronary artery (native and bypass) for an 80 year old aorta in 
which isoelectric focusing was performed on immobiline pH gradient drystrips (pH 3-10 
nonlinear). The SDS- PAGE image is depicted in Figures 4.9 and 4.10. 









Figure 4.9 Gel image (Cydye 3) of native coronary artery extract of 80 year old at sodium 
dodecyl sulfate polyacrylamide gels at a 12% polyacrylamide concentration with isoelectric 
focusing on a 3-10 pH nonlinear drystrip. Blue and red circles denote up-regulation and down-
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Figure 4.10 Gel image (Cydye 5) of bypass coronary artery extract of 70 year old at sodium 
dodecyl sulfate polyacrylamide gel at a 12% polyacrylamide concentration with isoelectric 
focusing on a 3-10 pH nonlinear drystrips. Blue and red circles denote up-regulation and down-
regulation in protein expression, respectively. Protein concentration is increased areas with blue 
circles. 
 
Examination of the images resulted in 14 spots with an increase in protein expression when 
comparing the images of native artery to bypass artery. Only one spot indicated a decrease in the 
protein expressed. 
4.4.2 SyproRuby Staining of SDS PAGE Unlabeling of Fluorescent dyes 
To ensure that the spots were differentiated proteins and no artifacts in the gels such as 
dust or gel imperfections, the gels were further stained with Sypro Ruby.  This stain has a limit of 
detection ranging from 0.25 to 1.0 ng protein / mm2 gel. Sypro stains are manually compared to 
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the previous fluorescent scans of the labeled protein to assess if the expression levels of protein 
are valid.  If similar spots are retained by the Sypro Ruby fluorescent stain, excision and protein 
identification occurs.  Sypro Ruby stains for the tissue extracts are shown in Figures 4.11 -4.13 
with spot histograms of the spots of interest. 
A            B 
 
Diseased Normal
       
Figure 4.11 (A) Sypro Ruby stain gel image thoracic aorta extract. (B) 3D histogram of protein 
expression of hemoglobin alpha chain from the same gel. (C) 3D histogram of protein expression 
of hemoglobin beta chain. (D) 3D histogram of protein expression of vimentin. 
D





 To determine the global changes in protein expression patterns that may be caused by 
Cydye 3 or Cydye 5 labeling, the same gel was stained with Sypro Ruby.  From this data, the two 
images are superimposed without gel variation and the spots the stained gel manually compared 
to the ones for the labeled dyes.  If the protein patterns are similar, the spots that either increased 
in protein expression or decreased should also be present and further analyzed.  Problems that 
fluorescent labeling produces could cause subtle differences between the two gel images may be 
due to two factors (1) the increase in molecular mass of the label protein that increases the masses 
by approximately 500 daltons, and (2) the abundance of the proteins may be increased or 
decreased depending on the number of lysine that are actually in the proteins.  The Sypro Ruby 
stained image gave 7 spots that were expressed different between the normal and diseased 
samples.  Three dimensional simulations of the proteins that were up-regulated or down- 
regulated are illustrated in Figures 4.11B -4.11D representing the normal and diseased state of the 
tissue extracts.  This analysis of protein expression was calculated using Decyder –DIA software. 
The peak of the protein spot was obtained based on pixel versus area data generated from the 2D 
Master Imager.  In quantification experiments, the protein area indicates the distribution of the 
spot and the volume is correlated with the amount [10].  The identification of the proteins of 
interest is listed on the gel and will be discussed in the protein identification section.   
 Similar 2D gel images of the Sypro Ruby were obtained from the extraction of tissues 
from native and bypass arteries from a 72 year old and an 80 year old specimen.  The two 
previous fluorescent images of the Cydye 3 and Cydye 5 gels were unlabeled and stained with 
SyproRuby.  The Sypro Ruby stain of the 72 year old is shown in Figure 12A while the 3D 




A                     
 
B                                                          C 
        D
                                                E 
bypass artery native artery bypass artery native artery
    
bypass artery native artery bypass artery native artery
Figure 4.12 (A) Sypro Ruby gel image of tissue extracts of native and bypass artery from a 72 
year old. (B) 3D image of amyloid protein from tissue extract. (C) 3D image of collagen Type VI  
protein from tissue extract. (D) 3D image of fibrinogen protein from tissue extract. (E) 3D image 
spectrin protein tissue extract.    
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   2D gel images of the Sypro Ruby resulted in 7 spots that were visualized as differentially 
expressed when the native and bypass gels were compared.  The gel patterns were consistent with 
the labeled proteins in Figure 4.8. Protein spot identification by mass spectrometric analysis of the 
tryptic digested peptides followed by database search will be covered in a later section.  The 3D 
patterns of each protein are shown in Figures 4.12 B-12E.  Serum amyloid p component of native 
and bypass (Figure 4.12B) in spot comparisons in 3D image analysis shows upregulated protein 
expression in the native artery compared with bypass.  This phenomenon may suggest that the 
protein may participate in the pathogenesis of the disease, since the bypass is normally disease 
free.  Conversely, the collagen VI protein spot shows that its presence is down regulated in the 
native vessel. 
 Fibrinogen is a protein whose concentration may increase in the plasma as a response to 
inflammatory stimuli such as arteriosclerosis [17].  Based on 3D volume and pixel comparison, it 
is upregulated or increased in the native in comparison to the bypass artery sample. 
 Spectrin, from the 3D simulation, (Figure 4.12E) is surrounded by complimentary proteins 
that may be polypeptides.  Results indicate that its presence in the vessels is upregulated in the 
native sample.  
 A second sample of tissue extracts of an 80 year old was performed and the labeling 
results previously discussed.  Removal of the labeled proteins and staining with Syproruby 
reveals if some of the spots imaged contain artifacts (Figure 4.13 A-C). 
 A SyproRuby stained gel of native and bypass coronary artery extracts of an 80 year old 
gel image is illustrated in Figures 4.13.  The use of additional staining provided a means to 
evaluate global differences between the gels eliminating false positives that may from artifacts in 
the gel or contaminates.  14 spots were found from the analysis of the labeling experiments:   





B                                                                                  C 
                  
D                                                                        E 
                    
Figure 4.13 (A) Sypro Ruby gel image of tissue extracts of native and bypass artery from a 80 
year old. (B) 3D image hemoglobin beta chain protein from tissue extract. (C) 3D image of 
hemoglobin beta unit protein from tissue extract. (D) 3D image of tubulin protein form tissue 
extract. (E) 3D image vimentin protein from tissue extract. The volume of each spot was 
calculated from Decyder –DIA software.   
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however only 4 exhibited protein that indicated changes in expression.  These spots are annotated 
in the imaged gel and the 3D volume simulations depicted (Figure 4.13 B-D).  In each case, the 
proteins were more abundant in the native artery as compared to the bypass artery  
4.4.3 Protein Identification by Matrix Assisted Laser Desorption Ionization Mass    
Spectrometry 
  
Following the staining procedure, the spots of interest were excised manually and 
subjected to in-gel digestion.  The resulting peptides were analyzed using Voyager 4700 (Applied 
Biosystems) MALDI TOF-TOF mass spectrometer.  Peptide masses were acquired in reflectron 
mode (20 kV accelerating voltage) with 155 ns delayed extraction, averaging 1000 laser shots per 
spectrum.  The individual ions from each spectrum were inspected for resolution and 
monoisotopic distribution to identify potentially different peptides of similar masses.  The 
peptides were used with search parameters for human subjects and entered in the SWISS-PROT 
and NCBInr databases using MASCOT [14].  Database searches were performed without 
constraining protein molecular weight or isoelectric point, and allowed for caramidomethylation 
of cysteine, partial oxidation of methionine residues, and one missed cleavage.  Highest 
confidence identifications have statistically significant search score(s), are consistent with the gel 
region from the protein was excised (MW and pI) and accounts for the majority of the peptides 
the spectra.  The mass spectra of the spots that were picked from the gel stained with SyproRuby 
with differences in protein expression between the diseased and nondiseased tissue.  The peptide 
mass spectra are in-gel tryptic digest of thoracic aorta extracts and illustrated in Figures 4.14 to 
4.21.  
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Figure 4.14. Peptide mass spectra of in-gel tryptic digest of intimal extract from human thoracic 
aorta (S1) of a 60 year old.  The spot numbers are the designed numbers from the gel that showed 
protein expression. The peptide masses from MASCOT database search gave low scores for 
hypothetical protein.  
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Figure 4.15 Peptide mass spectra of in-gel tryptic digest of intimal extract from human thoracic 
aorta (S1) of a 60 year old.  The spot numbers are the designed numbers from the gel that showed 
protein expression. The peptide masses from MASCOT database search gave low scores for NID 
Mus musculus.  
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Figure 4.16. Peptide mass spectra of in-gel tryptic digest of intimal extract from human thoracic 
aorta (S1) of a 60 year old.  The spot numbers are the designed numbers from the gel that showed 

















































































































































Figure 4.17 Peptide mass spectra of in-gel tryptic digest of intimal extract from human thoracic 
aorta (S1) of a 60 year old.  The spot numbers are the designed numbers from the gel that showed 
alterations in protein expression. The peptide masses from MASCOT database search gave low 































































































Figure 4.18 Peptide mass spectra of in-gel tryptic digest of intimal extract from human thoracic 
aorta (S1) of a 60 year old.  The spot numbers are the designed numbers from the gel that showed 
protein expression. The peptide masses from MASCOT database search gave low scores for 




























































Figure 4.19 Peptide mass spectra of in-gel tryptic digest of intimal extract from human thoracic 
aorta (S1) of a 60 year old.  The spot numbers are the designed numbers from the gel that showed 
protein expression. The peptide masses from MASCOT database search identified the protein as 


















































Figure 4.20 Peptide mass spectra of in-gel tryptic digest of intimal extract from human thoracic 
aorta (S1) of a 60 year old. The spot numbers are the designed numbers from the gel that showed 
protein expression. The peptide masses from MASCOT database search identified the protein as 


















































































































Figure 4.21 Peptide mass spectra of in-gel tryptic digest of intimal extract from human thoracic 
aorta (S1) of a 60 year old.  The spot numbers are the designed numbers from the gel that showed 
protein expression. The peptide masses from MASCOT database search identified the protein as 





  Six external standards used for the calibration were from a mass standard kit for the 4700 
proteomics analyzer calibration mixture.  The calibration standard solution contains 50 pmol/µl 
des-Arg1-Bradykinin, angiotensin, Glu1-fibrinopeptide B, ACTH (1-17), ACTH (18-39), and 
ACTH (7-38).  From the data shown, eight peptides from in-gel digest of protein from intimal 
extracts of normal and diseased tissue were expressed as either up-regulated or down-regulated 
from the gel analysis using DyCyder software with 3D images of the histogram of the proteins of 
interest.  The proteins ranged in molecular weights from 13.5 to 80.3 kDa.  The pI of the proteins 
ranged from 5.5 to 8.9. Four of the eight spots were identified by peptide mass fingerprinting 
using MASCOT. 
 Figures 4.22 – 4.28 are peptides produced from in-gel tryptic digest of intimal extracts of a 
native and bypass coronary artery from the same heart.  The spots were automatically excised 
from the same gel stained with SyproRuby.  The SyproRuby stain is also fluorescent with 
emission spectra at 610 nm.  The spots were selected by comparing the gel images produced from 
the Cydye and the Sypro Ruby stain to determine if quantitatively enough protein is present for 
further treatment with trypsin.  Artifacts such as dust particles may be observed in gels reacted 
with the Cydyes it is imperative validate the area of interest.  Additionally, gel to gel variations 
could possibly cause spots or streaks in stains that may produce false positives.   
MALDI-TOF TOF analysis was performed on a Voyager 4700 (Applied Biosystems). 
Peptide mass spectra were acquired in reflectron mode (20kV accelerating voltage) in positive ion 




























































































































































































Figure 4.22 Peptide mass spectra of in-gel tryptic digest of intimal extract from native and bypass 
coronary artery (S2) of a 70 year old.  The spot numbers are the designated numbers from the gel 
that showed protein expression. The peptide masses from MASCOT database search identified 
the protein as spectrin alpha.  
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Figure 4.23 Peptide mass spectra of in-gel tryptic digest of intimal extract from native and bypass 
coronary artery (S2) of a 70 year old.  The spot numbers are the designated numbers from the gel 
that showed protein expression. The peptide masses from MASCOT database search gave low 





















































































































































































Figure 4.24 Peptide mass spectra of in-gel tryptic digest of intimal extract from a native and 
bypass coronary artery (S2) of a 70 year old.  The spot numbers are the designated numbers from 
the gel that showed protein expression. The peptide masses from MASCOT database search 

































































































Figure 4.25 Peptide mass spectra of in-gel tryptic digest of intimal extract from a native and 
bypass coronary artery (S2) of a 70 year old. The spot numbers are the designated numbers from 
the gel that showed protein expression. The peptide masses from MASCOT database search 




































































































































Figure 4.26 Peptide mass spectra of in-gel tryptic digest of intimal extract from a native and 
bypass coronary artery (S2) of a 70 year old.  The spot numbers are the designated numbers from 
the gel that showed protein expression. The peptide masses from MASCOT database search gave 














































































Figure 4.27 Peptide mass spectra of in-gel tryptic digest of intimal extract from native and bypass 
coronary artery (S2) of a 70 year old.  The spot numbers are the designated numbers from the gel 
that showed protein expression.  The peptide masses from MASCOT database search identified 














































































Figure 4.28 Peptide mass spectra of in-gel tryptic digest of intimal extract from native and bypass 
coronary artery (S2) of a 70 year old.  The spot numbers are the designated numbers from the gel 
that showed protein expression. The peptide masses from MASCOT database search identified 
the protein as Mn superoxiddismutase. 
 
 Additional tissue extract of the intima from a native and bypass coronary artery from an 
80 year old subject by lysis buffer was conducted.  Following isoelectric focusing, SDS-PAGE in 
the second dimension and differential imaging, spots were excised.  In-gel digest produced 
peptides from those spots that exhibited differences based on imaging comparisons (Figure 4.29 
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and 4.31).  Four proteins were isolated and picked for analysis.  The calculated masses based on 
datasearch from MASCOT and Swissprot ranged from 15.9 to 49.7 kDa and a pI range of 4.9 to 
7.2 which is lower than expected for membrane proteins. 
 































































































































Figure 4.29 Peptide mass spectra of in-gel tryptic digest of intimal extract from native and bypass 
coronary artery (S3) of an 80 year old.  The spot numbers are the designated numbers from the gel 
that showed protein expression. The peptide masses from MASCOT database search identified 




























































































Figure 4.30 Peptide mass spectra of in-gel tryptic digest of intimal extract from native and bypass 
coronary artery (S3) of an 80 year old.  The spot numbers are the designated numbers from the gel 
that showed protein expression.   The peptide masses from MASCOT database search identified 

































































































































Figure 4.31 Peptide mass spectra of in-gel tryptic digest of intimal extract from native and bypass 
coronary artery (S3) of an 80 year old.  The spot numbers are the designated numbers from the gel 
that showed protein expression.  The peptide masses from MASCOT database identified the 







































































































Figure 4.32 Peptide mass spectra of in-gel tryptic digest of intimal extract from native and bypass 
coronary artery (S3) of an 80 year old.  The spot numbers are the designated numbers from the gel 
that showed protein expression. The peptide masses from MASCOT database search identified 






The peptides were entered in a database search with the preset search criteria set 
mentioned in the Materials and Methods section.  All peptide values were based on the algorithm 
specific in the search.  The masses were search against human protein database.  Table 4.1 lists 
the sample, spot number, rank, protein identification, accession number, molecular weight, pI, 
protein scoring algorithm (> 75%  significant criteria) and the confidence interval  which is 
equivalent to MASCOT expect values of p<0.05.  These values are the selection criteria for 
positive identification of the proteins examined.  
All proteins were identified in the NCBI and in the SwissProt database with species 
restriction.  The criteria for protein scores and protein confidence interval are > 75 and 95%, 
respectively. 
The 2D analysis of human thoracic aorta exhibiting proliferating atherosclerotic plaque 
features (foam cells, cholesterol formation, calcification, or thrombus) was differentially imaged. 
Proteins spots consisted of molecular weights ranging from 15 to 100 kDa and pI that separated 
within the range of the IPG drystrip (pH 3-10).  The use of differential in-gel electrophoresis 
analysis of sample S1 resulted in eight proteins, four of which gave positive identifications based 
on the database search criteria.  Spot assignments 767, 1196, 1841, and 1848 produced search 
parameters with protein scores of 44, 47, 42, 60 with confidence intervals not within the range 
stipulated (> 95%).  Based on these results, there were no matches for those four spots.  
Spot 1284 was identified as vimentin.  Shah and colleagues have reported vimentin as a 
major component of cytoskeletal constituents of cells of mesenchymal origin that, based on in 







Table 4.1 Summary of database search results of the proteins expressed in human atherosclerotic 
















767 1 Hypothetical 
protein 
DKFZp586F0420 
Q9UG54_HUMAN 29023.3 6.92 44 0 
 1196 1 AK045750 NID 
NID  Mus musculus 
BAC32480 80290.3 6.34 47 0 
 1284 1 Vimentin - Human Q5JVT0_HUMAN 49680 5.19 363 100 
 1841 1 SSB3 protein 
Human 
Q49A96_HUMAN 25827.8 9.62 42 0 
 1858 1 AX885349 NID 
Homo Sapiens 
CAE99479 13540.7 5.50 60 70.69 
 1995 1 Hemoglobin mutant 
Chain A 
1ABWA 30418.8 8.91 237 100 
 2001 1 Des his 
deoxyhemoglobin 
HIS 146 Beta 
removed chain B -
human 
1AXFB 15834.2 6.76 291 100 
 2325 1 Des his 
deoxyhemoglobin 




1AXFB 15834.2 6.76 433 100 
70 Y-
S2artery 
785 1 Spectrin alpha 
chain 
SPTA1_HUMAN 280884.4 4.96 73 98.462 
 839 1 Hypothetical proein 
FLJ16140 Homo-
Sapiens 
Q6ZNG1_HUMAN 85840.9 9.41 46 0 
 857 1 Collagen type VI 
alpha 1_Human 
Q7Z645_HUMAN 109602.4 5.26 80 99.679 
 1248 2 Fibrinogen beta 
chain precursor 
FGHUB 56463.6 8.72 155 100 
 1471 1 I -309 Fragment 
Human 
Q76BR7_Human 3434.6 4.79 28 0 
 1782 1 Serum amyloid p-
component chain A 
1LGNA 23358 6.12 255 100 
 1923 2 Mn-
Superoxiddismutase 
Human 
CAA01016 19945.1 7.96 65 90.068 
80 Y-
S3artery 
1003 1 Alpha tubulin 
Fragment 
Q9GLW6_MACM 49662.3 4.9 295 100 
 1071 1 Vimentin Q5JVT0_HUMAN 49680.1 5.19 244 100 
 1646 1 Hemoglobin beta 
chain 
1HBAB 15941.3 7.26 104 99.20 
 1814 1 Deshis 
deoxyhemoglobin a 
mutant HIS 146  
1AXFB 15834.2 6.76 362 100 
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 Spot 1995, human globin mutant chain A, is a dissociated dimer of hemoglobin that is 
cleared by renal filtration which can result in long term kidney damage.  The fusion of the two α-
globins units prevents dissociation into β units and eliminates renal toxicity [20].  This molecule 
is a hemoglobin recombitant designed as a blood substitute.  
 Spot 2001 was identified as des his deoxyhemoglobin HIS 146 Beta removed chain B and  
spot 2325 is a mutated site of hemoglobin Rothschild (37 beta Trp-Arg) critical for hemoglobin 
function the results in greatly reduced cooperactivity and oxygen affinity.  In des HIS – 146 β, the 
COOH terminal histidine residue that promotes lower affinity for oxygen and change in 
quarternary structure has been removed [21].  
 Coronary artery extracts in sample S2 produced eight protein expressions when native and 
bypass arteries were compared.  The expression of the individual protein spots has been 
previously discussed.  Spectrin, spot 785, have implied to play a pivotal role  in initiating integrin 
induced physiological and pathological events such as development, proliferation, cell survival, 
wound healing, metatasis, and atherosclerosis[22]. 
 Spot 857 was identified as collagen VI. Steinhubl et al. studied the role of the platelet in 
the pathogenesis of atherthrombosis [23].  Platelet tethering and adhesion to the arterial walls 
under high shear forces was achieved by multiple interactions between platelet membrane 
receptors integrins and ligands within the exposed subendothelium most notably collagen and von 
Willebrand factor [23].  
 Spots 1248 and 1282 gave excellent scores and confidential intervals (Table 4.1).  Three 
proteins that similarly respond are fibrinogen, C-reactive protein, and serum A amyloid (SAA) 
[24].  These molecules are produced by hepatocytes and are upregulated by cytokines interleukin 
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-6 (for CRP and fibrinogen) and interleukin–1 (for SAA).  Serum p amyloid component protein 
may contribute to amyloid deposition by stabilizing the fibrils and decreasing their clearance [24]. 
Although the parameters for spot 1923 were slightly lower than those meeting the criteria, Mn 
superoxiddismutase has implications in the atherosclerotic process for reducing oxidative stress 
[25]. 
Four proteins were identified from an 80 year old (S2) of native and bypass coronary 
arteries.  Three of the spots, 1071, 1646 and 1814, have already been discussed and their 
functions relative to the proliferation of atherosclerosis.  Spot 1003 was identified as tubulin. 
Evidence has suggested that alpha tublin detyrosination is a required event in the proliferation of 
vascular smooth muscles that are a hallmark of atherosclerosis and related vascular complications 
[26].  
4.5 Conclusions   
Differential gel electrophoresis was used to identify differentially expressed proteins separated 
by two dimensional gel electrophoresis.  Tissues were extracted from intimas of normal and 
diseased thoracic aorta and native and bypass coronary arteries.  Eight proteins in the aorta 
extracts were detected using fluorescent dyes Cydye 3 and Cydye 5.  In this tissue, four proteins 
were identified by MALDI- TOF MS and MALDI TOFTOF-MS.  Peptide masses were searched 
using MASCOT and SwissProt database.  The native and bypass coronary samples revealed seven 
proteins in the 70 year old extract and four proteins in the 80 year old extracts that underwent 
differential expression.  The technique has the sensitivity and dynamic range useful in the analysis 
of normal and diseased tissues. 
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SEPARATION, IDENTIFICATION AND QUANTIFICATION OF CHOLESTEROL AND 
CHOLESTEROL ESTERS IN HUMAN ATHEROSCLEROTIC PLAQUE USING HIGH 
PERFORMANCE LIQUID CHROMATOGRAPHY ATMOSPHERIC CHEMICAL 
IONIZATION MASS SPECTROMETRY 
 
5.1 Introduction 
 One of the primary risk factors for coronary heart disease is high levels of cholesterol in 
the blood.  As the levels in the blood are consistently elevated, accumulation occurs and 
contributes to the formation of atherosclerotic plaques [1].   The development of cholesterol in 
plaque in mammals by the accumulation of lipid rich necrotic debris and smooth cells has been 
investigated [2].  Plasma lipoproteins contain neutral lipids in the interior and phospholipids, 
cholesterol and protein at the surface [1].  The cholesterol in the plasma exists as free sterol and as 
cholesterol esters.  Esterification occurs at the cholesterol hydroxide position with a long chain 
fatty acid usually unsaturated.  The synthesis of the esters in the plasma is from the reaction of 
cholesterol and an acyl chain on phosphotidylcholine that is acted on by lecithin: cholesterol 
acyltransferase, an enzyme secreted from the liver into the bloodstream.  Since cholesterol esters 
are more hydrophobic than cholesterol itself, the other method for cholesterol uptake in the body 
is in food uptake.  The foremost theory for the relationship for elevated cholesterol levels and 
atherogenesis was demonstrated by Brown and Goldstein [3].  Their work demonstrated that since 
cholesterol esters are too hydrophobic to transverse cell membranes, a receptor mediated process 
is necessary and the quantity of receptors themselves is regulated [3].  
 Key to the initial response of atherosclerosis lies in the oxidation of lipoprotein that has a 
major affect on the accumulation of cholesterol in the plaque [4].  Plaque formation involves an 
inflammatory response to modified plasma lipids that have entered the intima [5].  The low 
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density lipoprotein (LDL) is modified on the endothelial surface to a proinflammatory molecule 
[6]. 
 The analysis of lipids using gas chromatography mass spectrometry has long been a 
challenge due to the high molecular weight and the nonvolatility of the compounds.  Many 
approaches have addressed this problem including particle beam, thermospray, continuous flow 
fast atom bombardment, electrospray ionization (ESI), and atmospheric pressure chemical 
ionization (APCI) [7].  ESI is the soft ionization method for biological molecules; however APCI 
is a similar technique, but some degree of fragmentation is produced for structural 
characterization.  Therefore APCI is the method of choice for the analysis for cholesterol and its 
esters in this study.  The simple design of the APCI source includes the following components: a 
capillary containing a liquid from the high performance liquid chromatograph that is sprayed 
through a nozzle with a concentric nebulizer gas that surrounds the capillary, a heated vaporizer 
tube that desolvates the analyte molecules, and a corona needle [8].  The effluent is sprayed into a 
heated chamber in which the analyte undergoes minimal degradation.  The concept of APCI 
involves gas phase ions produced by a source of electrons introduced on-axis with the heated 
spray.  The electrons are usually supplied by a discharge source such as a Ni emitter.  A coronary 
discharge is produced from a needle charged in the range from 5-10 kV.  The ions from the 
discharge are from the source gases composed of nitrogen or water.  A general reaction also 
involves ionization of N2 and O2 from the formation of hydronium ions and water clusters [9]. 
5.2 Research Goals and Objectives 
 The aim of this study is to use RPHPLC- APCI-MS technique to separate, identify and 
quantify cholesterol and its esters extracted for intimas of human thoracic aortas. Additionally, 
correlation analysis will be performed to determine the effect of ester concentration on the 




5.3.1 Materials and Reagents 
 Tissue samples of human thoracic aortas were obtained from Louisiana State University 
Health Science Center, New Orleans, Louisiana.  The sample were frozen and stored at -70ºC 
until lipid extraction.  Urea, dithiothreotol (DTT), 3-[(3-cholamidopropyl0dimethyl-ammonio]-
1propanesulfonate (CHAPS), sodium azide, sodium azide, phenyl methyl sulfonyl fluoride were 
obtained from Sigma (St. Louis, MO USA).  Chloroform, methanol, isopropanol, acetonitrile 
were obtained from Aldrich (St. Louis, MO USA).  External standards of cholesterol, cholesterol 
linolenate, cholesteryl linoleate, cholesteryl oleate, cholesterol palmitate, and cholesteryl stearate 
were purchased from Sigma (St. Louis, MO, USA). 
5.3.2 Extraction of Cholesterol Esters from Heart Plaque 
 The intial protocol for the extraction of thoracic aorta plaques is summarized for samples 
1-4.  The intima from the tissue was excised and pulverized in liquid nitrogen with a mortar and 
pestle into a fine powder.  The powdered sample was mixed with lysis buffer containing 9.5M 
urea, 2% CHAPS, 0.8% immobiline pH gradient buffer, and 1% DTT.  This mixture was 
homogenized with a Tauzon (Fisher Scientific Inc) handheld homogenizer and then sonicated in 
ice for 5 minutes.  The mixture was centrifuged at 13,000 x g at 20º C for one hour. A 10 g 
aliquot was mixed with 8 grams of deionized water followed by the addition of 1:2 (v/v) methanol 
/ chloroform with homogenization.  An additional mixture 1:1 (v/v) water/chloroform was again 
added with further homogenization.  The resulting solution was filtered with a 2 micron nylon 
filter.  The filtered solution was added to a separatory funnel and the organic and aqueous was 
allowed to form.  The cholesterol esters or lipids were solubilized in the organic layer containing 
the chloroform.  This layer was separated and dried under nitrogen to constant weight.  This final 
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weight was recorded and dissolved in 3ml of a mixture of isopropanol / acetonitrile (50:50) 
solvent.  This sample was used for analysis by RP-HPLC/ APCI-MS.  
5.3.3 Extraction of Cholesterol Esters from Heart Plaques  
 A second extraction procedure was used in sample numbers 5 through 36 to investigate 
the presence of proteins in the aqueous phase of the separation.  Denaturants and protease 
inhibitors such as sodium azide and vanadate were added to protect the proteins in the plaques 
during extraction.  Intima tissue was dissected from thoracic aortas kept cold on ice.  The tissue 
was further excised in small pieces and pulverized in liquid nitrogen into a fine powder using a 
mortar and pestle.  The powder 200 mg was added to 15 ml of a mixture of acetone / tributyl 
phosphate (80:20 v/v) and the solution was kept at -20º C for 12 hours.  The resulting mixture was 
centrifuged at 4º C for 20 minutes at 15,000 rpm and the supernatant removed and stored.  The 
mixture was added to lysis buffer composed of  9.5M urea, 2 % (w/v) CHAPS, 0.8% IPG buffer 
(w/v), 1% (w/v), sodium vanadate (12.2mg), sodium azide ( 6.5 mg), PMSF (17.4 mg)  in a 1:10 
(w/v) ratio.  The mixture was stirred overnight at 4ºC and a 10 g aliquot was mixed with 8 g of 
deionized water. 20 ml of a 50:50 (v/v) of chloroform / methanol was added and the mixture 
homogenized for 2 to 4 minutes.  An additional mixture of chloroform / methanol was added with 
further homogenization.  The solution was filtered combined with the acetone supernatant into a 
separatory funnel.  After allowing the formation of the aqueous and organic layer, the two layers 
were separated, and the organic layer dried with nitrogen to a constant weight.  The solid was 
dissolved in 3ml of a 50:50 (v/v) mixture of isopropanol: acetonitrile which was used for the 
analyte for RP-HPLC/ APCI/MS 
5.3.4 Instrumentation 
 A Shimadzu high performance liquid chromatograph LC-10Avp (Kyoto, Japan) equipped 
with a Shimadzu SiL-10ADvp auto injection system was used for the analysis of cholesterol and 
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its esters.  The analytes were separated on a ProtonSil 120-3 C-18 SH reversed phase high 
performance liquid chromatograph column, 100 x 4.6 mm i.d. purchased from MAC-MOD 
Analytical, Inc. (Chadds Ford, PA USA).  Injection volumes for the analysis were either 10 or 20 
µl; however, the optimum component analysis was achieved for the 20 µl volume.   The analysis 
was conducted in gradient mode with a mobile phase consisting of isopropanol: acetonitrile: 
formic acid (71:29:0.10, v/v/v) at a constant flow rate of 0.30 ml/min.  The mobile phase 
concentration prepared for HPLC pump A was 90% isopropanol/9.9% acetonitrile/0.10% formic 
while the concentration of pump B was 90% acetonitrile/10% isopropanol/0.10% formic acid. 
Each separation was programmed at 100% pump A initially and decreased to 0% for a period of 
one hour.  The mobile phase was pumped through a UV-Visible detector equipped with a 
continuous flow cell with the analytes detected at 201 nm.  
 The mass spectrometer for the study was a Shimadzu LCMS 2010 system coupled to an 
atmosphere pressure chemical ionization (APCI) probe.  The ionization occurs outside the mass 
spectrometer that outside high vacuum needed to conduct the mass analysis.  The samples 
molecules ion probe directly from the liquid chromatograph and becomes ionized to produce an 
ion beam of pseudo molecular ions for the APCI probe by charging the ions with high voltage 
from a corona needle. Ions enter the mass spectrometer where a quadrupole analyzer separates the 
gas phase pseudo molecular ion by mass.  The ion mode was conducted in positive mode where 
the initial step involves the creation of proton hydrates H30+[H20]n, by a cascade of other 
processes that produce primary ions such as N2+, O2+, H2O+ and NO+.  These particular ions are 
formed by electron impact from the corona needle.  The APCI probe was operated in the positive 
mode at a nitrogen flow rate of 2.5 L/min.  The curved desolvation line was adjusted to a 
temperature of 250ºC and a block temperature of 400ºC was maintained.  Voltage parameters for 
the mass analyzer detector and the probe needle were 1.7kV and 4.5kV, respectively. 
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5.4 Results and Discussion 
Cholesterol and cholesterol esters are key components in the formation of atherosclerosis.  
The structural elucidation of the sterols in this study is illustrated in Figure 5.1.  Selection of these 
are based on previous studies by Smith et al[11,12]  that predict the severity of the disease based 
on the relative ratios of these components.  The analytes are the simplest of the lipids that are 
more complex when covalently bound to proteins such as lipoproteins.  Naturally occurring fatty 
acids are usually unsaturated containing an even number of carbons and exist in the cis form.  
Unsaturated fatty acids bound to cholesterol in this study include the oleate, linoleate, and 
linolenate, while the saturated fatty acids consist of the palmitate and stearate esters.  
 Standard mixture of   cholesterol, cholesteryl linolenate, cholesteryl linoleate, cholesteryl 
oleate, cholesteryl palmitate, and cholesteryl stearate was prepared in isopropanol: acetonitrile 
(50:50, v/v) with concentrations of 0.4 mg/ml; however the oleate concentration was 0.375 
respectively.  The UV-Visible chromatogram of the standards detected at 210 nm is shown in 
Figure 5.2.  The mass spectral analysis using APCI interfaced with a mass analyzer operated in 
positive ion mode is illustrated in Figure 5.2. Initial analysis operated in the scan mode resulted in 
low resolution and low sensitivity of the extracted analytes. Since quantitation of standards was 
performed using RP-HPLC, the method of scanning the peaks of interest was altered to take 
advantage of fragmentation of certain ions to optimize sensitivity and reduce interfering analytes. 
The total ion chromatograph and the mass spectra were determined by operating the mass 
analyzer in the selective ion monitoring (SIM) mode.  The extracted peak isolated produced mass 
of 369 is isolated for each peak for the cleaved cholesterol mass.  This ion was fragmented in each 
of the esters when the mass analyzer is operated in positive ion mode with the loss of the mass of 
the ester.  SIM of the ester masses alone were not as reproducible as the fragment ion attributed to 
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Figure 5.1 Structure of cholesterol and cholesterol esters analyzed in atherosclerotic plaques from 
thoracic aortas 
3 1 7 3 
Cholesteryl oleate R = o
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Mass detection of cholesterol at mass 369 was performed to enhance the signal-to noise 
ratios by acquiring the mass chromatograms during the analysis by means of selected ion 
monitoring (SIM).  In this mode of operation, the data is acquired in a particular mass window 
that is approximately 0.6 daltons in width.  Although structural information is lost the signal-to-
noise ratio is improved and useful when quantitative analysis is performed.  One disadvantage 
may be encountered when baseline noise is interpreted as actual masses at the retention time 
specified for the cholesterol fragment. 
 
 


























Figure 5.2 A) Standard UV- visible chromatogram of cholesterol and cholesteryl esters detected 
at 210 nm. Peaks in the chromatogram are identified as: 1. cholesterol 2. cholesteryl linolenate; 3. 
cholesteryl linoleate; 4. cholesteryl oleate; 5. cholesteryl palmitate; 6. cholesteryl stearate . B) 
Total ion chromatograph of each standard. C) Selective ion monitoring mode at m/z 369 
corresponding to cholesterol. 
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 External standard calibration curves constructed for each analyte are shown in Figure 5.3. 
A plot of peak area versus concentration gave excellent correlation coefficients (R2 = 0.9965 to 
1.0000).  
 
































Figure 5.3 Calibration curves for quantitation of cholesterol and cholesteryl esters in extracts of 
thoracic aortas. 
 
 Thirty five thoracic aortas were examined from autopsied cadavers varying in age from 20 
to 80 years old.  Crystalline cholesterol (sample no. 1 Figure 5.4) was collected from a calcified 
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plaque without dissection in our laboratory.  The composition of the plaque contained a higher 
concentration of cholesterol; however, the linoleate ester gave a higher concentration (0.156 %) 


















Figure 5.4 A) UV-visible chromatograph of crystalline cholesterol. 1. cholesterol, 2. cholesteryl 
linolenate, 3. cholesteryl linoleate, 4. cholesteryl oleate, 5. cholesteryl palmitate, 6. cholesteryl 
stearate. B) Total ion chromatograph of crystalline cholesterol; C) Selective ion monitoring of 
cholesterol m/z 369. 
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The analysis of atherosclerotic plaque gruel from sample two gave higher concentrations 
(w/w) of esters as well as cholesterol (Figure 5.5).  These two samples illustrate the complexities 
and variability in the composition of plaques.  UV visible chromatogram and MS analysis of all 


























Figure 5.5 A) UV-visible chromatogram of atherosclerotic plaque gruel; 1. cholesterol, 2. 
cholesteryl linolenate, 3. cholesteryl linoleate, 4. cholesteryl oleate, 5. cholesteryl palmitate, 6. 
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Table 5.1 Summary of the Quantitative Analysis of Cholesterol and Cholesteryl Esters using 



































2.66 1.81 1.83 1.48 1.45  9.23 
3 33 year old 
male Aorta  
5.19 4.32 10.0 5.60 4.19 0.599 29.9 
4 80 year old 
male Aorta  
1.31 0.860 2.12 1.15 0.870  6.31 
5 74 year old 
female Aorta 
Extract 
0.206 0.113 0.223 0.102 0.0467  0.690 
6 62 year old 
male Aorta  
1.49 0.427 0.815 0.367 0.131  3.23 
7 70 year old 
male Aorta 
Media Extract 
1.67 0.556 1.35 0.663 0.186  4.43 
8 70 year old 
male Aorta 
Intima+Media  
13.8 4.15 8.60 3.27 1.39  31.2 
9 79 year old 
male sample  
0.121 0.142 0.260 0.151 0.135  0.667 
10 81 year old 
male Aorta  
31.7 10.4 20.1 14.3 21.4  97.9 
11 80 year old 
male Aorta  
3.47 0.556 1.37 0.91 0.53  6.83 
12 62 year old 
male Aorta  
18.1 12.3 22.1 13.3 16.5 5.16 87.4 
13 68 year old 
male Aorta  
5.74 2.29 4.84 3.43 3.93  20.2 




17.7 7.95 17.1 11.9 10.0 4.43  69.1 
15 56 year old 
male Aorta  
6.10 2.45 3.64 3.12 3.55  18.9 
 
16 64 year old 
male Aorta  
7.08 3.71 7.41 5.70 5.72  29.6 
17 81 year old 
male Aorta 
plaque  
20.5 6.32 14.6 9.65 11.2  62.3 
18 54 year old 
male Aorta  
12.9 3.49 16.6 11.0 6.74  50.7 
19 56 year old 
male Aorta 
4.87 16.3 5.32 4.74 3.74  34.9 
20 56 year old 
male Aorta  
24.5 9.58 23.8 10.5 5.15  73.5  
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Table 5.1 (continued) Summary of the Quantitative Analysis of Cholesterol and Cholesteryl 
Esters using HPLC APCI MS Analysis 
 
 
21 57 year old 
male Aorta  
63.7 1.24 14.6 8.67 7.28  95.6 
22 61 year old 
male Aorta  
29.7 8.97 16.3 9.58 5.40  69.9 
23 69 year old 
male Aorta  
4.76 3.56 6.18 3.76 1.28  19.5 
24 36 year old 
male Aorta  
14.1 2.05 3.94 2.51 1.30  23.9 
25 53 year old 
female Aorta  
26.1 10.9 19.6 11.2 8.66  76.3 
26 59 year old 
male Aorta  
8.89 4.10 8.04 5.19 4.45  30.7 
27 60 year old 
male Aorta  
22.3 13.9 25.6 14.7 14.1  90.6 
28 66 year old 
female Aorta  
20.1 7.80 14.1 10.5 12.9  65.5 
29 86 year old 
male Aorta  
15.1 6.28 13.9 10.1 9.11  54.6 
30 47 year old 
female Aorta  
15.5 8.87 19.7 15.9 18.8  78.9 
31 52 year old 
male Aorta  
11.2 6.79 14.6 10.7 7.40  50.6 
32 53 year old 
female Aorta  
28.1 22.2 40.3 24.9 31.7  147 
33 54 year old 
male Aorta  
27.4 14.1 26.6 17.7 18.3  104 
34 34 year old 
male Aorta  
43.7 12.0 17.6 3.82 1.95  79.0 
35 20 year old 
male Aorta  
3.81 0.400 2.81 2.97 3.90  13.9 
 
 The results of the levels of the cholesterol and cholesterol esters in various samples are 
shown in Table 5.1.  The data in Table 5.1 was analyzed for correlations between the age of an 
individual and the concentration of cholesterol and its esters.  The implications of cholesterol and 
its esters that accumulate in the arterial walls are important contributions to atherosclerosis [13]. 
A graphical depiction of the correlation of age to cholesterol and its esters is shown in Figures 5.6 
to 5.8.  Using one dimensional analysis, no apparent correlation can be observed between the 
cholesterol and age.  Additionally, same scattered data is seen in linolenate, linoleate, or oleates 
which are unsaturated fatty acids.  This same holds true when examining patterns in the palmitate 
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Figure 5.6 Plot of age versus the concentration of cholesterol and cholesteryl linolenate.  
Linolenate is a naturally occurring fatty acid formed as lipid droplets in arterial walls.  No 











































Figure 5.7 Plot of age versus the concentration of cholesteryl linoleate and cholesteryl oleate.  
Each ester is a naturally occurring fatty acid formed as lipid droplets in arterial walls.  No 





















Figure 5.8 The plot of age versus cholesteryl palmitate in aorta extracts.  
 
5.4.1 Principal Component Analysis 
The graphical representation of age with the concentration of cholesterol and its esters 
shown in Figures 5.6 -5.8 provide no useful correlation or pattern for all the samples analyzed. 
Therefore, traditional approach of data analysis for pattern recognition between variables could 
not be used in this study.  The modern method of pattern recognition in data for the determination 
of important similarities and differences involves the use of principle component analysis (PCA). 
PCA technique uses mathematical relationships of functions derived from matrices and 
eigenvalues to represent the data in a new orthogonal system known as principal component. 
Usually, the first initial principal components are enough to represent the data set since they 
contain the most useful information in the data.  In addition, the plot of the data set in the new 
orthogonal system may reveal the hidden information not apparent in the raw data set. In most 
cases, the grouping of data is always observed in the principal component plot data with similar 
characteristic groups.  The summary of the PCA using the results of concentration of cholesterol 
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and its esters in Table 5.1 is shown in Figure 5.9.   The numbers in Figure 5.9 correspond to 
experiment numbers from Table 5.1. 
Group 2 Group 1 
  
Figure 5.9 Principal component analysis of age of the individual and the concentration (wt %) of 
cholesterol and its esters. The data points separate the sample analysis into two groups or clusters. 
 
 From Figure 5.9, it is apparent that the data can be grouped be separated into two distinct 
groups.  Lower concentrations of cholesterol and its esters were demonstrated in group 1; 
however higher concentration are illustrated in group 2.  The data from group 1 and 2 were 
averaged and compared with overall averages (Figure 5.10).  The average concentrations of 
cholesterol as well as concentrations of the esters in group 1 are comparatively higher than group 

















































CLUSTER 1 AVERAGE CONC
CLUSTER 2 AVERAGE CONC
OVERALL AVERAGE CONC
     
Figure 5.10 Comparison of PCA group 1 and group 2 age averages and the concentration of the 
cholesterol and its esters. 
 
 
obtained in group 2 compared with the overall concentration of the analytes in the entire data set. 
In contrast, higher concentrations of analytes were obtained for group 1 data set compared to the 
overall concentration analytes.  Furthermore, the average age of the individuals in group 2 is 
lower than group 1. 
5.4.2 Disease Severity Index (DSI) 
 
 Studies by Kritchevsky et al. [14] have demonstrated the atherogenic effects of using 
saturated fatty acids such as palmate in comparison to unsaturated acids in the diet.  Their 
findings also emphasized the beneficial effects of polyunsaturated fatty acids and further showed 
that the monounsaturated fats lowered total serum cholesterol without reducing the high density 
lipoprotein (HDL) cholesterol levels [14]. 
Cholesterol and its esters have been isolated in the arterial walls at various stages of 
disease development.  These compounds have also been implicated as agents in atherosclerosis. 
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[14].  In our study, a further analysis of the data was performed to determine if any correlations 
exist between the cholesteyl esters and the extent of the disease by calculating the disease severity 
index (DSI).  The disease severity index (DSI) is defined as the ratio of concentration of the ester 
to the free cholesterol in the plaques.  The results of the calculated DSI of group 1 and group 2 are 
shown in Table 5.2.  A low DSI is indicative of a decrease in atherosclerosis. In contrast, a high 
ratio shows an increase in disease state [14].  Comparisons of the average DSI for group 1 and 
group 2 shows that a lower index is observed in group 1 resulting in a decrease in atherogenicity. 
When this pattern is compared with age, the lower index is also observed in the lower age group 
indicating that DSI is related to the age.  Older individuals tend to have higher DSI and have 
higher risk for atherosclerosis.  
Table 5.2 Comparison of disease severity index of cholesterol esters in group 1 and group 2 
 








Group 1 0.57 0.91 0.62 




The Diseased Severity Index gave higher ratios in group 2, the older average age group. 
The higher index (average), which is the ratio of low free cholesterol to ester, indicates greater 
severity of atherosclerosis.  
Our study has demonstrated the use of APCI-HPLC MS in the separation and analysis of 
cholesterol and various fatty acid esters extracted for thoracic aortas.  Thirty-seven samples were 
separated using reverse phase high performance liquid chromatography from various age groups. 
Correlation coefficients of >0.999 were derived for cholesterol, cholesteryl linolenate, cholesteryl 
linoleate cholesteryl oleate, cholesteryl palmitate and cholesteryl sterate, respectively.  The 
selective ion monitoring mode from the APCI-MS using m/z of 369, the mass of the free 
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cholesterol molecule, provided a qualitatively identification of the each component at the 
corresponding retention times from the UV detector. 
 The data was further analyzed for pattern recognition by principal component analysis. 
Two different groups resulted from the average of the cholesterol and its ester composition and 
age.  The data in goup 1, the younger age group, produced lower average cholesterol /ester ratios.  
Conversely, group 2 with the higher average age similarly has higher average concentrations of 
cholesterol and its esters.      
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CONCLUSIONS AND FUTURE STUDIES 
The objectives of this dissertation were to utilize techniques in proteomics to isolate and 
characterize protein involve in atherosclerotic plaques. The study was used to note differences 
between plaques in (a) heart bypass (b) native heart arteries and (c) aortas. The aorta comparison 
was between diseased and nondiseased states as well. Several techniques analytical tools were 
used to study proteins in this disease. These techniques include two dimensional gel 
electrophoresis, SDS-PAGE, fluorescent dyes for protein expression in normal and diseased 
tissues, mass spectrometry, and high performance liquid chromatography. 
In the introduction, the description of the pathogenesis of atherosclerosis and the present 
predominant theories responsible for the disease was discussed.  Various analytical techniques 
and instrumentation were discussed in addition to the theories involved for each instrument. 
Chapter 2 used a design study based on the Box Behnken design to optimize the number 
of spots (proteins) by two dimensional gel electrophoresis analysis. The components in the lysis 
buffer, usually to solubilize membrane proteins, were necessary to maximize separation during 
isoelectric focusing on to an immobiline pH gradient strip. The first separation of the proteins 
was conducted based on pI followed by separation by molecular weight using SDS-PAGE. 
In the Chapter 3, proteins were separated using carrier ampholytes and tube gels in two 
two dimensional gel electrophoresis. The proteins were digested with trypsin and the resulting 
peptides were sequenced using a linear quadrupole ion trap Fourier transform ion cyclotron 
resonance mass spectrometer. Nine proteins were identified that were involved in 
atherosclerosis. 
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A differential gel electrophoresis technique was used in Chapter 4 to determine protein 
expression in normal and diseased tissues from thoracic aortas with fluorescent dyes. This 
method was also used to detect variations in native and bypass arteries. Proteins that were 
differentially expressed were analyzed using MALDI –MS and peptide mass fingerprinting from 
database searches. 
 Chapter 5 used RPHPLC-APCIMS to separate and quantify cholesterol and cholesteryl 
esters formed in the intima of various plaques in thoracic aortas. To elucidate patterns in the data 
principal component analysis was used. Our data analysis technique determined that two distinct 
groups were present for the correlation of concentration of the cholesterol and its ester to the age 
of the individual.  
6.1 Future Studies 
  Additional studies to determine protein expressions in normal and diseases vessels 
involved in atherosclerosis should focus on the use of surfactants that enhance the solubility of 
hydrophobic membrane protein separated by gel electrophoresis. In addition, molecular micelles 
are used as denaturates in capillary electrophoresis; however, their use may enhance protein 
solubility and resolution in both two dimension gel electrophoresis and SDS-PAGE. Due to their 
nonionic nature, the molecular micelles are attractive for use in isoelectric focusing on a 
immobiline pH gradient strips. Ionic surfactants, such as SDS cannot be use because of cathode  
charge overload, preventing protein separation. 
 The use of differential gel electrophoresis was useful in demonstrating protein expression 
in various plaques samples. To assess biological variations in the protein expressions in various 
plaques, a larger sample pool is needed. From this data statistical analysis can be derived and a 
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database created for protein expression in normal and diseased samples. Further 
immunochemical studies may be used to assess the role that glycoproteins play in the disease. 
 The disease severity index was calculated in the analysis of cholesterol and its esters in 
chapter 5. Metals in the plaque may play a role in atherosclerosis. ICPMS analysis of various 






















RPHPLC CHROMATOGRAMS AND MASS SPECTRA OF CHOLESTEROL AND  




Sample 5: 74 year old female Aorta Extract 
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Sample 6: 62 year old male Aorta Extract 
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Sample 7: 70 year old male Aorta Media Extract 
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Sample 14  81 year old male aorta plaque intima-media 
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Sample 15  56 year old male aorta extract 175-35 
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Sample 17  81 year old male aorta extract  175-7 
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Sample 19  56 year old male aorta extract  175-29 
 
 







UV: 210 nm 3 1 
2 
4 5 






MS: Total Ion 
Chromatography 
 
















Injection: 10 µL  































3 1 UV: 210 nm 2 
4 5 

























Injection: 10 µL  



























3 UV: 210 nm 2 1 
4 5 























 Injection: 10 µL  



























1 UV: 210 nm 3 2 
4 5 






MS: Total Ion 
Chromatography 
 













 Injection: 10 µL  


















Sample 23  69 year old male aorta extract  175-28 
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Sample 24  36 year old male aorta extract  175-42 
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Sample 26  59 year old male aorta extract  175-58 
 
 







1 3 2 UV: 210 nm 
4 
5 





MS: Total Ion 
Chromatography 
 














 Injection: 10 µL  



























3 2 UV: 210 nm 1 
4 
5 







MS: Total Ion 
Chromatography 
 















Injection: 10 µL  




























UV: 210 nm 
3 2 
4 5 






MS: Total Ion 
Chromatography 
 














Injection: 10 µL  





































MS: Total Ion 
Chromatography 
 














Injection: 10 µL  





























1 3 UV: 210 nm 2 
4 
5 







MS: Total Ion 
Chromatography 
 














 Injection: 10 µL  


























UV: 210 nm 
2 4 
5 







MS: Total Ion 
Chromatography 
 

















Injection: 10 µL  
































UV: 210 nm 1 
4 5 








MS: Total Ion 
Chromatography 
 















Injection: 10 µL  































1 3 UV: 210 nm 2 
4 5 
 






MS: Total Ion 
Chromatography 
 














Injection: 10 µL  
































UV: 210 nm 
3 2 
4 5 







MS: Total Ion 
Chromatography 
 












 Injection: 10 µL  


























UV: 210 nm 
1 
3 2 4 5 
 








MS: Total Ion 
Chromatography 
 













 Injection: 20 µL  



















 Samuel Jean Washington was born in Monroe, Louisiana, on April 16, 1952, to J.D. and 
Ruby Washington. He attended primary school at Franklin High School in Winnsboro, 
Louisiana. After receiving his high school diploma in 1970, he attended Northeast Louisiana 
University and graduated with a Bachelor of Science degree in chemistry in 1973.  In 1973, he 
attended the University of Nebraska-Lincoln under the guidance of Professor Desmond Wheeler. 
He received his Master of Science degree in 1978. 
 Samuel has been at Southern University since 1996. Samuel initiated the Department of 
Defense Mentor-Protégé Program and Student Mentor-Protégé at Southern University. His 
experience with Mentor-Protégé programs at Southern allowed him to provide oversight, 
coordination, and guidance to task managers and staff support at Southern involved with various 
projects. Prior to his work at Southern, Samuel was employed for 20 years in the research and 
development area at Dow Chemical Company in Plaquemine, Louisiana.  
 In the fall of 1999, Samuel was admitted to Louisiana State University to pursue graduate 
studies in the Department of Chemistry under the guidance of Professor Isaiah Warner and 
Professor Patrick Limbach. His dissertation focuses on the separation and identification of 
proteins associated with the formation of atherosclerotic plaques using two dimensional gel 
electrophoresis and mass spectrometry.  
 234
